therapies under investigation	4613
treatment of manifestations	4606
evaluation of relatives at risk	4585
search clinicaltrials	4494
surveillance	4347
agents/circumstances to avoid	3017
prevention of secondary complications	2772
pregnancy management	2002
other	1505
prevention of primary manifestations	1470
consultation with a clinical geneticist and/or genetic counselor	1365
clinical genetics consultation	1141
the following are appropriate:	924
medical genetics consultation	511
evaluations can include:	336
neurologic examination	273
avoid the following:	245
ophthalmologic examination	231
developmental assessment	224
ophthalmologic evaluation	217
the following should be avoided:	210
neurologic	182
brain mri	161
cardiovascular	147
consultation with a medical geneticist and/or genetic counselor	147
gastrointestinal	140
respiratory	140
seizures	140
echocardiogram	140
hearing loss	140
eyes	126
skeletal	119
growth	112
cardiac	112
skin	112
dental	112
see treatment of manifestations	112
musculoskeletal	112
hearing	105
gene therapy	105
hearing evaluation	98
search clinical trials	98
endocrine	91
renal ultrasound examination	91
eye	77
and	77
the following are indicated:	77
table 4	77
surveillance includes the following:	70
pulmonary	70
hearing assessment	70
org	70
treatment includes the following:	70
ophthalmologic	70
gov)	70
complete blood count	63
renal disease	63
echocardiography	63
developmental evaluation	63
evaluations include:	63
audiology evaluation	63
evaluation	63
enzyme replacement therapy (ert)	56
genetics consultation	56
nutrition	56
nutritional assessment	56
renal	56
sensorineural hearing loss	56
ecg	56
medications	56
table 3	56
liver transplantation	56
appropriate surveillance includes:	56
eeg	56
obesity	49
diabetes mellitus	49
treatment is symptomatic	49
appropriate surveillance includes the following:	49
renal anomalies	49
neurologic evaluation	49
audiologic evaluation	49
audiologic assessment	49
liver function tests	49
dental evaluation	49
eeg if seizures are suspected	49
medical history	49
neurologic assessment	49
iopd	49
development	42
cardiac evaluation	42
urinalysis	42
pulmonary disease	42
hypothyroidism	42
bleeding	42
motor dysfunction	42
gross motor dysfunction	42
consider use of durable medical equipment as needed (e	42
fine motor dysfunction	42
oral motor dysfunction	42
craniofacial	42
dehydration	42
anesthesia	42
malignancy	42
treatment is supportive	42
forearm crutches or canes for gait stability	42
special shoes, including those with good ankle support	42
5 g/m2	42
pulmonary fibrosis	42
developmental pediatricians can provide assistance with transition to adulthood	42
some issues to consider:	42
recommended evaluations following initial diagnosis	42
lopd	42
canes and walkers help prevent falls	42
short stature	35
anemia	35
no specific therapy is available	35
hypertension	35
prevention of secondary manifestations	35
electrocardiogram	35
nutritional status	35
hyperlipidemia	35
hepatic disease	35
neurologic manifestations	35
intellectual disability	35
cancer	35
physical therapy	35
bone marrow transplantation (bmt)	35
mothertobaby	35
the following are recommended:	35
special education	35
failure to thrive	35
see www	35
consultation with a clinical geneticist	35
dermatologic evaluation	35
1-0	35
hematopoietic stem cell transplantation (hsct)	35
evaluations can include the following:	35
orthopedic	35
hematologic	35
alcohol	35
treatment is symptomatic and may include the following:	35
complete physical and neurologic examination	35
family history	35
physical therapy assessment	35
physical and neurologic examination	35
no clinical guidelines for surveillance are available	35
fasting	35
children	35
table 2	35
ophthalmology	35
comment	35
manifestation	35
treatment	35
ages 0-3 years	35
ages 3-5 years	35
ages 5-21 years	35
all ages	35
communication issues	35
system	35
surgery	35
liver phk deficiency	35
muscle phk deficiency	35
agents	35
yes	35
tremor-controlling drugs do not work well for cerebellar tremors	35
no dietary factor has been shown to curtail symptoms	35
hbh disease	28
complete skeletal survey	28
respiratory status	28
ocular	28
see agents/circumstances to avoid	28
plasma amino acids	28
liver	28
cardiomyopathy	28
appropriate measures include the following:	28
ataxia	28
smoking	28
inquire about frequency and severity of chest infections	28
deafness	28
dietary management	28
use of antiepileptic medication during pregnancy reduces this risk	28
developmental delay	28
eye examination	28
5-1	28
annual:	28
measurement of blood pressure	28
exocrine pancreatic insufficiency	28
audiologic	28
dermatologic	28
scoliosis	28
mri	28
nutritional evaluation	28
treatment follows routine practices	28
immunologic	28
gov	28
aro	28
adoii	28
measurement of height, weight, and head circumference	28
speech therapy	28
detailed family history	28
multidisciplinary developmental evaluation	28
cognitive	28
caregivers	28
developmental and neurologic assessment	28
genitourinary	28
heart defects	28
psychotropic medication may also be indicated	28
constipation	28
antiepileptic drugs	28
considerations/other	28
global developmental disability / intellectual disability educational issues	28
standard recommendations may vary from country to country	28
consider evaluation for alternative means of communication (e	28
routine	28
0-3	28
ophthalmologic assessment	28
deep brain stimulation (dbs)	28
table 5	28
immunizations	28
pulmonary function testing	28
author, personal observation]	28
developmental	28
psychomotor development	28
8-2	28
growth parameters	28
val804met+p	28
baseline ophthalmologic examination	28
antioxidants	28
organ transplantation	28
hypogonadism	28
see published guidelines/consensus statements	28
audiology	28
or x	28
low-frequency sensorineural hearing loss (lfsnhl)	28
audiometry	21
skeletal assessment	21
hydrocephalus	21
org)	21
urologic	21
adrenal insufficiency	21
other treatments	21
see therapies under investigation	21
hepatic	21
cbc	21
urine organic acids	21
liver disease	21
evaluation of renal function	21
molecular genetic testing	21
see mothertobaby for further information on medication use during pregnancy	21
pulmonary function tests	21
progressive sensorineural hearing loss	21
renal manifestations	21
dialysis	21
valproic acid	21
emg	21
surveillance should include annual neurologic examination	21
surgical stabilization of the spine may be required	21
pectus excavatum can be severe	21
contact sports, competitive sports, and isometric exercise	21
optic atrophy	21
chelation therapy	21
annual	21
uveal melanoma	21
malignant mesothelioma	21
bethlem myopathy	21
appropriate treatment includes the following:	21
05-0	21
precocious puberty	21
blood pressure	21
neonatal/infantile canavan disease	21
orthopedic evaluation	21
audiologic examination	21
feeding difficulties	21
osteopenia	21
regular follow up of ophthalmologic and/or audiologic abnormalities	21
cardiac ultrasound examination	21
management is supportive	21
hearing screen	21
immunization for hepatitis a and b is recommended	21
avoidance of sunlight and uv light	21
, estrogens)	21
pulmonary function studies	21
colitis	21
electroretinogram	21
feeding and nutrition	21
orthopedic surgery	21
exercise within the individual's capability	21
complete family history	21
fewer than 5% need wheelchairs	21
symptomatic treatment	21
respiratory dysfunction	21
some individuals require forearm crutches or canes for gait stability	21
see prevention of primary manifestations	21
pharmacologic treatment	21
central nervous system	21
endocrinopathies	21
hypoglycemia	21
spine	21
5-0	21
0 g/m2	21
dystonia	21
fitting with appropriate hearing aids	21
enrollment in an appropriate educational program for the hearing impaired	21
comprehensive neurologic examination and developmental/cognitive assessment	21
adults	21
see hereditary hearing loss and deafness overview	21
baseline audiologic evaluation	21
growth hormone deficiency	21
genetic counseling	21
tolerance to different primary layers varies	21
nonstick products (e	21
silicone-based products without adhesive (e	21
rolls of gauze (e	21
the most common secondary complication is infection	21
both antibiotics and antiseptics need to be employed	21
affected system	21
if seizures are suspected	21
spasticity	21
in the united states:	21
cleft palate	21
the following should be performed on a regular basis:	21
iron chelation	21
consultation w/a clinical geneticist and/or genetic counselor	21
neutropenia	21
surveillance includes:	21
the following measures are appropriate:	21
papillomatosis	21
genetic	21
no specific treatment is available	21
abdominal ultrasound examination	21
pain	21
age	21
ketogenic diet	21
height	21
neuropsychological assessment	21
7-2	21
nutrition/feeding	21
annual hearing evaluation	21
cardiac manifestations	21
pediatric issues	21
none	21
cataract	21
complete blood count with differential	21
sodium benzoate	21
liver function	21
urinary tract	21
enzyme replacement therapy	21
hearing test	21
the transplanted kidney does not develop the disease	21
supportive therapy includes the following:	21
neurology consultation	21
genitourinary abnormalities	21
developmental progress	21
feeding	21
clinical evaluation	21
epilepsy	21
see hereditary hearing loss and deafness	21
8 yrs	21
men 2a	21
fmtc	21
men 2b	21
complete ophthalmologic examination	21
supportive and symptomatic management is indicated	21
antibiotic prophylaxis	21
click here for full text	21
9-2	21
2(1	21
0(1	21
5-2	21
7-4	21
neuroimaging	21
infection	21
dysphagia	21
vision	21
pulmonary hypertension	21
1 year	21
care by a pediatric endocrinologist is recommended	21
pituitary blastoma	21
pineoblastoma	21
standard management	21
dental examination	21
assessment of iron status	21
for trps ii only	21
x(until normal)	21
blood tests	14
consider consultation with a clinical geneticist and/or genetic counselor	14
craniosynostosis	14
obstructive sleep apnea	14
kyphosis	14
spinal stenosis	14
neurologic findings	14
retinal degeneration	14
complete blood count (cbc)	14
cutaneous/cranial	14
limb	14
measurement of intraocular pressure	14
slit lamp examination	14
measurement of axial length	14
there are no published guidelines for surveillance	14
psychiatric evaluation if behavioral problems are present	14
cleft lip/palate	14
chronic treatment	14
hypogonadotropic hypogonadism	14
european porphyria network	14
complete neurologic assessment	14
urology	14
formal assessment of vision and hearing	14
movement disorder	14
ophthalmologist	14
annually	14
lung disease	14
vaccination against hepatitis a and b	14
antioxidant therapy	14
males	14
females	14
speech evaluation	14
dilated cardiomyopathy	14
orthopedic abnormalities	14
rod-cone dystrophy	14
exercise	14
renal function	14
these include:	14
examination of cranial nerve function	14
routine visits to the neurologist are appropriate	14
gait	14
see author notes	14
platelet count	14
splenomegaly	14
abdominal pain	14
thrombocytopenia	14
kidney transplantation	14
plasma ammonia concentration	14
complete neurologic evaluation	14
reducing the risk of neurologic damage	14
9-13	14
8-15	14
excess protein intake	14
obvious exposure to communicable diseases	14
see deafness and hereditary hearing loss overview, management	14
holter monitoring	14
cbc with differential	14
immunodeficiency	14
additional studies are in progress	14
cardiac examination	14
some symptoms (e	14
bone marrow transplantation	14
osteoporosis	14
3 years	14
coenzyme q10	14
rapid enlargement should prompt evaluation for possible hydrocephalus	14
no evidence for the efficacy of regular neuroimaging exists	14
skin should be examined at least annually	14
evaluation of degree of muscle weakness and mobility	14
assessment of respiratory status	14
ullrich cmd	14
assessments of respiratory function to detect asymptomatic decline	14
in-depth neurologic examination	14
kcnq2-bfne	14
kcnq2-nee	14
the eeg at 24 months should be normal	14
there is no consensus on clinical surveillance	14
radiation exposure	14
evaluation for psychomotor deficits	14
evaluation for sensorineural hearing loss	14
consultation with a metabolic specialist or clinical geneticist	14
second branchial arch anomalies	14
otologic anomalies	14
education of parents regarding common seizure presentations is appropriate	14
for ages 0-3 years	14
for ages 3-5 years	14
for ages 5-21 years	14
for all ages	14
, contractures, scoliosis, hip dislocation)	14
parkinsonism	14
other features	14
ovarian insufficiency	14
hormone replacement therapy (hrt)	14
infertility	14
breast cancer	14
chemoprevention	14
oral glucose tolerance test	14
cardiology and/or echocardiographic assessment for structural heart defects	14
cardiac defects are managed in a routine manner	14
medical genetics consultation may also be considered	14
assessment of neonates for hypoglycemia	14
blood gases	14
lipid profile	14
bone mineral density	14
mild/juvenile canavan disease	14
evaluation for scoliosis	14
may be repeated as needed)	14
educational intervention is insufficient to completely remediate these deficiencies	14
weight control to avoid obesity	14
(see malignant hyperthermia susceptibility	14
complete blood count to monitor for cytopenias	14
eeg and brain mri in symptomatic individuals	14
levocarnitine	14
developmental and neurocognitive progress, as age-appropriate	14
physical therapy and rehabilitation to improve motor function	14
orthopedic complications	14
headaches	14
neurologic deficits	14
see malignant hyperthermia susceptibility for more details	14
orthopedic referral	14
to prevent secondary complications:	14
echocardiogram and electrocardiogram	14
0-2	14
complete neurologic examination	14
dental assessment	14
ocular manifestations	14
aeruginosa in airway cultures	14
bronchodilator	14
hypertonic saline	14
dornase alfa	14
airway clearance	14
endocrine evaluation	14
electroencephalogram if seizures are suspected	14
cognitive development	14
refractive errors may be managed with spectacles or contact lenses	14
to improve alignment in primary gaze position	14
contractures	14
sleep studies	14
swallowing assessment	14
a structured general medical history and family history	14
physical examination and neurologic examination	14
pulmonary function testing to detect and stage respiratory involvement	14
adequate nutrition and weight maintenance are essential	14
appropriate bracing and stretching can minimize contractures	14
antidepressants are often required to treat concurrent depression	14
further studies are needed to clarify this issue	14
neurologic examination including:	14
ocular abnormalities	14
imaging	14
skeletal dysplasia	14
immunodeficiency and infection	14
funduscopic examination	14
services provided vary based on age and needs	14
clinicaltrials	14
niccd	14
investigate feeding pattern	14
fttdcd	14
ctln2	14
radiologic examinations if spinal deformity is observed	14
physical and occupational therapy	14
ventilatory support	14
daily heel cord stretching exercises to prevent achilles tendon shortening	14
click here for an up-to-date list	14
nerve conduction velocity (ncv)	14
emg with ncv	14
visual evoked potentials	14
odontoid hypoplasia	14
trpv4-associated neuromuscular disorders	14
trpv4-associated skeletal dysplasias	14
exercise within the individual's capability to remain physically active	14
hearing aids as needed	14
management includes the following:	14
0 mm in diameter	14
ophthalmology evaluation	14
bone density	14
general anesthesia	14
otolaryngologic evaluation	14
assessment for exposure keratopathy	14
sodium benzoate: 250 mg/kg or 5	14
sodium phenylacetate: 250 mg/kg or 5	14
10% arginine hcl: 600 mg/kg or 12	14
reversal of catabolism	14
age-appropriate immunizations including the influenza vaccine should be provided	14
gene therapy has been suggested	14
thyroid function studies	14
resting ecg	14
recommended drugs are nadolol (1-2	14
prednisone	14
bmd	14
blood	14
measurement of height and weight	14
physical examination for skeletal anomalies (e	14
gastroesophageal reflux should be addressed in a standard manner	14
ophthalmologic abnormalities are treated in the standard manner	14
skeletal abnormalities (e	14
hearing loss is treated with a trial of hearing aids	14
infants benefit from enrollment in an early-intervention program	14
73 m2 (ckd stage 3b)	14
repeat audiometry to confirm stability of hearing loss	14
hepatic function	14
afp and hepatic sonography to monitor for hepatocellular carcinoma	14
preterm delivery	14
physical therapy consultation	14
cancer surveillance	14
blood transfusions	14
thiamine	14
riboflavin	14
levodopa	14
treatment of psychiatric problems with appropriate psychotropic medications	14
adaptation of environment and care to the level of dementia	14
heart	14
kidneys	14
individuals with severe heart block may require pacemaker implantation	14
growth retardation	14
general physical examination	14
0 mg/dl	14
complete review of systems	14
physical examination	14
general clinical examination	14
cardiology evaluation	14
surveillance for individuals with the 7q11	14
23 duplication syndrome	14
test/measurement	14
clinical examination	14
oral medications are usually tried first:	14
baclofen (lioresal®)	14
benzodiazepines	14
renal ultrasound	14
primary layers include the following:	14
, telfa®, n-terface®)	14
, mepitel®, mepilex®)	14
calcium and vitamin d replacement for osteopenia and osteoporosis	14
in general, activities that traumatize the skin (e	14
clinical genetics consultation may also be considered	14
, kerlix®) are commonly used	14
hypotrichosis	14
psychiatric	14
eeg and video eeg	14
consultation w/clinical geneticist and/or genetic counselor	14
treatment of manifestations in individuals with ethylmalonic encephalopathy	14
gorman et al [2016]	14
private supportive therapies based on the affected individual’s needs	14
, contractures)	14
recommended surveillance for individuals with ethylmalonic encephalopathy	14
chest roentgenogram	14
hernia	14
arterial abnormalities	14
acute photosensitivity	14
grey or smoke-colored filters provide only partial protection	14
topical sunscreens are typically not useful	14
close monitoring is warranted	14
hepatic function should be monitored every six to 12 months	14
respiratory function	14
examination by an ophthalmologist	14
referral to an endocrinologist	14
cardiac evaluation, including echocardiography	14
testing should include:	14
multiple phospholipid-dependent coagulation assays for a lupus inhibitor	14
protein c activity	14
antithrombin activity	14
protein s activity or free protein s antigen	14
treatment of thrombosis in children	14
pregnancy	14
prophylactic anticoagulation during pregnancy:	14
prevention of pregnancy loss	14
other pregnancy complications	14
intrathecal baclofen pump	14
adrenal tumors	14
see clinicaltrials	14
pulmonary vessel angiogram	14
inguinal hernias	14
miscellaneous / other	14
antoun et al [2016]	14
huemer et al [2015]	14
physical therapy is recommended to maximize mobility	14
recommended surveillance for individuals with fbxl4-related mtdna depletion syndrome	14
ent/mouth	14
referral of the family to support groups and other resources	14
cryptorchidism	14
dental problems	14
audiologic screening	14
cervical spine instability	14
fragile x syndrome	14
fxtas	14
poi	14
epi-743	14
other therapies	14
ophthalmologic disease	14
repair of polydactyly should be undertaken on an elective basis	14
seizures are treated symptomatically	14
thus, good sleep hygiene should be encouraged	14
corticosteroids	14
immunoglobulins	14
joint range of motion by an orthopedist/physiotherapist	14
gm1 gangliosidosis	14
mps ivb	14
assessment for the following:	14
evaluation by an otolaryngologist for adenotonsillectomy	14
educational programming directed to the specific disabilities identified	14
ongoing pediatric care with regular immunizations	14
3 mmol/l	14
and after activity	14
6 to 2	14
(see malignant hyperthermia susceptibility)	14
consult with a clinical geneticist and/or genetic counselor	14
prevention of acute attacks	14
com	14
referral to a hemophilia treatment center	14
for locations:	14
worldwide, see world federation of hæmophilia	14
us only, see national hemophilia foundation	14
intramuscular injections should be avoided unless under factor coverage	14
intramuscular injections	14
identification of at-risk relatives	14
early determination of the genetic status of males at risk	14
determination of genetic status of females at risk	14
obstetric issues	14
newborn males	14
non-expressing p	14
cys282tyr homozygotes	14
cys282tyr	14
evaluation for excess hepatic iron	14
dietary guidelines for hereditary fructose intolerance (hfi)	14
adapted from www	14
edu/aldolase/hfi/treatment/sugar_table	14
htm	14
baseline complete blood count with differential	14
lung	14
pancreas	14
colon cancer	14
adolescents and adults	14
250 mg/kg/day	14
sodium phenylacetate	14
mechanisms of drug action in treatment of hyperammonemia	14
raises insulin levels	14
induces anabolic state	14
causes protein sparing effect from skeletal muscle amino acids	14
stimulates secretion of insulin	14
eliminates one amino group in the urine	14
eliminates two amino groups in the urine	14
a non-essential amino acid in humans	14
evaluation and monitoring of pt, ptt, and fibrinogen	14
evaluation of swallowing and nutritional status	14
renal and liver function	14
full blood count	14
electrolytes	14
treatment may need to be discontinued if:	14
saffron	14
nuts	14
mussels	14
dark chocolate	14
psychological support	14
table 7	14
principles of treatment for individuals with hokpp	14
avoid:	14
add 0	14
3 meq/kg/h	14
(2) in the work setting	14
prolonged immobility	14
myopathy	14
behavior	14
depression	14
cd46	14
cfh	14
dgke	14
thbd	14
beta blockers	14
adapted from gersh et al [2011]	14
symptoms	14
hyperuricemia/gout	14
lifelong therapy with allopurinol may be required	14
high meat and seafood intake could exacerbate gout	14
particularly important are:	14
current recommended drug therapies for adults with fh	14
15% 1, 3	14
50% 5	14
often ineffective in hofh	14
kastelein et al [2008]	14
rader et al [2003]	14
approved only for adults with hofh	14
cuchel et al [2014]	14
raal & santos [2012]	14
240 (170)	14
a parent, sib, or child	14
first-degree relatives share about half of their genes	14
a first cousin, great-grandparent, or great-grandchild	14
during pregnancy	14
ezetimibe	14
physical therapy to improve motor function	14
use of respiratory aids when indicated	14
pharmacologic treatment of spasticity and seizures	14
serum concentration of bun and creatinine	14
nutrition assessment	14
formal developmental assessment	14
maintenance therapy	14
neuroleptic treatment may exacerbate parkinsonism	14
clinical genetics consultation is appropriate	14
thyroid function tests	14
evaluation of males for cryptorchidism	14
echocardiogram for congenital heart defects	14
evaluation for laryngomalacia if respiratory issues are present	14
genital anomalies	14
surgery as required	14
routine management	14
thyroid hormone replacement as needed	14
contractures and/or scoliosis	14
recommended evaluations following initial diagnosis of kcnk9 imprinting syndrome	14
treatment of manifestations in individuals with kcnk9 imprinting syndrome	14
standard treatment for scoliosis	14
recommended surveillance for individuals with kcnk9 imprinting syndrome	14
frequency/comment	14
every 6 months until age 2 years, then annually	14
at least annually	14
developmental disabilities administration (dda) enrollment is recommended	14
social/behavioral issues	14
speech	14
gynecomastia	14
sleep history	14
therapeutic management of the sleep disorder	14
specialized neurologic care for individuals with epilepsy	14
management of seizures in accordance with standard practice	14
auditory amplification if hearing loss is identified	14
gonadotropin therapy	14
spastic paraplegia	14
general guidelines can be followed	14
physical therapy/occupational therapy assessment	14
antiepileptic drugs (aed) if epileptic seizures are present	14
cardiac evaluation with echocardiography and electrocardiography	14
clinical and radiographic assessment of spine and rib cage	14
brain and cervical spine mri if neurologic symptoms are present	14
gerd	14
neurobehavioral symptoms	14
0 cm	14
the choice should be left to personal preference	14
dural ectasia is usually asymptomatic	14
no effective therapies for symptomatic dural ectasia currently exist	14
hernias tend to recur after surgical intervention	14
activities that cause joint injury or pain	14
, scuba diving)	14
long-term treatment	14
additional therapies	14
fibrous dysplasia	14
fgf23-mediated phosphate wasting	14
hypercortisolism	14
thyroid	14
see thyroid evaluation	14
kidney transplantation cures adtkd-umod	14
joint contractures	14
developmental delay/cognitive impairment	14
3 microdeletion, the following evaluations are recommended:	14
comprehensive developmental assessment	14
specialized learning programs to meet individual needs	14
no specific antiepileptic or antipsychotic medications are indicated	14
routine pediatric care	14
cardiac malformations	14
treatment should follow standard practice	14
mody5	14
measurement of height and weight to assess growth	14
assessment of cognitive abilities	14
pituitary tumors	14
biochemical investigations	14
yearly, beginning at the specified age:	14
risk for aggressive mtc based on genotype and recommended interventions	14
20 yrs	14
ata = american thyroid association	14
ser649leu and p	14
hpt = hyperparathyroidism	14
pathogenic variants in cis configuration on one allele	14
criteria: normal annual basal and or stimulated serum calcitonin	14
normal annual neck ultrasound examination	14
family history of less aggressive mtc	14
pheochromocytoma	14
menkes disease	14
baseline audiology evaluation	14
congenital heart defects	14
stretching exercises are ineffective and painful	14
sillence, personal communication]	14
fiberoptic intubation must be available	14
the following treatment is appropriate:	14
joints	14
pathophysiology	14
all individuals	14
reasons for 28 hospitalizations in 15 infants with msud	14
strauss et al [2010]	14
4(2	14
3(1	14
1(1	14
5-6	14
3-9	14
3-1	14
0(3	14
7(3	14
7-7	14
2(5	14
50(0	14
43-0	14
58)	14
from strauss et al [2010]	14
with permission from elsevier	14
acute pancreatitis	14
developmental assessment in children	14
see hirschsprung disease overview	14
audiometric evaluation	14
bleeding tendency	14
circumstances	14
, contact sports)	14
neuropsychiatric	14
baseline neurologic examination	14
pulmonary function test	14
assessment of cognitive ability	14
cataracts can be removed if they impair vision	14
dietary assessment	14
head mri	14
other tumors	14
assessment of growth	14
npd-b	14
child syndrome	14
ck syndrome	14
orthopedic treatment	14
dental treatment	14
clinical evaluations to characterize cchs phenotype based on phox2b variant	14
x 2	14
adapted from weese-mayer et al [2010]	14
, 20/24	14
nparm = non-polyalanine repeat expansion mutation (i	14
exogenous and endogenous gas challenges	14
comprehensive age-appropriate clinical autonomic testing	14
exon or whole-gene deletion or duplication	14
treatment of decreased visual acuity is symptomatic (e	14
, low-vision aids)	14
250 mg/kg	14
5,500 mg/m2	14
batshaw et al [2001]	14
loading dose given over 90 to 120 minutes	14
maintenance dose given over 24 hours	14
the typical dilution is 1:10	14
arginine infusion not to exceed 150mg/kg/h	14
bleeding disorder	14
cardiac fibrosis	14
evaluation of pancreatic endocrine function (i	14
, assessment of glucose tolerance)	14
consideration of pancreatic cancer surveillance in persons with chronic pancreatitis	14
surgery has been reported to be helpful by many patients	14
fecal elastase-1 analysis (schebo® biotech ag	14
, cck-8) or receptor agonists (e	14
their nature (e	14
blocking of pancreatic lipase (e	14
diseases of the intestinal mucosa	14
diffusion-weighted mri	14
monitoring for glucose intolerance	14
low-fat diet	14
no formal guidelines for amount of dietary fat exist	14
multiple small meals	14
no evidence-based guidelines exist	14
good hydration	14
dehydration worsens episodes of acute pancreatitis	14
dilated eye examination	14
monitoring includes the following:	14
hypoventilation	14
respiratory infections	14
forced vital capacity (fvc)	14
grade 1	14
grade 2	14
grade 3	14
consider aspirin treatment	14
thyroid function testing	14
electrocardiogram to evaluate for an associated atrioventricular block	14
reduction of calcium oxalate supersaturation	14
only if affected person is known to be b6 responsive	14
from cochat et al [2012]	14
recommendations assume the availability of facilities	14
pox= plasma oxalate	14
mcap syndrome	14
see note	14
screening and surveillance guidelines for peutz-jeghers syndrome	14
8, 18 1	14
3 years 1	14
monthly	14
adapted from syngal et al [2015]	14
mre = magnetic resonance enterography	14
mrcp = magnetic resonance cholangiopancreatography	14
ct enterography may be used as an alternative	14
digital mammography if mri not available	14
discuss prophylactic mastectomy	14
discuss prophylactic hysterectomy and oophorectomy	14
aortic dissection	14
renal cell carcinoma	14
visual impairment	14
assessment of special educational needs	14
cys282tyr / p	14
ovarian sex cord-stromal tumors	14
chemotherapy	14
5 years	14
joint pain	14
medical genetics consultation is appropriate	14
as needed	14
assessment for constipation	14
treatment of manifestations in individuals with pura-related neurodevelopmental disorders	14
gerd = gastroesophageal reflux disease	14
recommended surveillance for individuals with pura-related neurodevelopmental disorders	14
brain imaging to exclude stroke	14
eeg to evaluate possibility of seizures	14
rdp	14
ahc	14
sleep	14
capos syndrome	14
psychiatric symptoms	14
psychological stress	14
the frequency has not been well established	14
biannual:	14
occupational therapy and physical therapy assessments	14
skeletal abnormalities	14
speech assessment	14
every four months until age four years	14
annually after age seven years	14
refer to clinicaltrials	14
results of these trials are not yet available	14
blood pressure measurement	14
early regular physiotherapy can prevent contractures to a certain extent	14
treatments include the following:	14
standard treatment with antiepileptic drugs for seizures	14
physical, occupational, and speech therapies, if necessary	14
see also therapies under investigation	14
ongoing developmental assessments	14
standard treatment is indicated	14
for trps i and trps ii	14
afp = alpha-fetoprotein	14
alt/ast = alanine transaminase/aspartate transaminase	14
bun = blood urea nitrogen	14
cbc = complete blood count	14
ggt = gamma-glutamyl transferase	14
pt/ptt = prothrombin time/partial thromboplastin time	14
treatment of manifestations in individuals with unc80 deficiency	14
vestibular function	14
see retinitis pigmentosa overview, management	14
vitamin a supplements	14
lutein supplements	14
endolymphatic sac tumors (elst)	14
educational support	14
consultation with other specialists as applicable	14
hearing impairment	14
wolfram syndrome	14
surveillance for williams syndrome	14
renal and bladder ultrasound	14
except as noted	14
if normal, ogtt should be repeated every five years	14
ectodermal	14
neuropsychological testing to establish functional level and learning capacity	7
clinical examination and immunologic tests (e	7
bone densitometry to detect osteopenia or osteoporosis	7
medical measures	7
early use of antibiotics for bacterial infections	7
insertion	7
physiotherapy including hydrotherapy to avoid strain on the joints	7
use of a wheelchair if necessary	7
orthopedic intervention if necessary	7
special shoes may help with ankle and foot support	7
therefore, ventriculocaval shunts are preferred	7
educational opportunities/social considerations	7
use of sign language in individuals with significant hearing loss	7
early educational intervention for development of social skills	7
speech therapy to improve speech	7
special education to maximize learning	7
planning housing for possible future wheelchair use	7
most affected individuals are clinically normal at birth	7
neuropsychological testing to establish functional level and learning capacities	7
immunologic status, focusing on sle, is recommended	7
bone densitometry every two to five years to assess osteopenia	7
peripheral blood stem cell transplantation (pbsct)	7
enzyme activity was slightly below normal	7
fibroblasts	7
mouse	7
human	7
hemoglobin bart hydrops fetalis (hb bart) syndrome	7
see prenatal testing and preimplantation genetic diagnosis	7
hemoglobin h (hbh) disease	7
consider referral to a hematologist	7
hb bart syndrome	7
inappropriate iron therapy	7
oxidant drugs including sulphonamides	7
some antimalarials because of the risk of hemolytic crisis	7
monitoring for these possible complications is recommended	7
assessment for airway problems in individuals with skeletal malformations	7
additional studies that may be indicated:	7
echocardiogram if a heart defect is suspected	7
cortisol deficiency	7
genital abnormalities	7
hypospadias and cryptorchidism may be corrected with surgery	7
vaginal reconstruction may be performed in females with vaginal hypoplasia	7
ovarian cysts	7
nasal stints or tracheotomy may be required	7
joint contractures and elbow synostosis	7
adrenal crisis	7
lack of or poor pubertal development in males and females	7
sleepiness and fatigue	7
screening evaluations are likely to underestimate cognitive abilities	7
the characteristic urinary steroid profile:	7
significantly elevated metabolites associated with:	7
fertility may be a concern	7
no reports describe reproduction in individuals with pord	7
hepatic drug metabolism	7
the common pathogenic variant p	7
physical therapy assessment to determine strength and self-help skills	7
early developmental/educational intervention is appropriate for cognitive delays	7
low-dose neuroleptics may be useful for psychiatric manifestations	7
referral for psychiatric evaluation is appropriate	7
no specific treatment is available for the sensorimotor neuropathy	7
standard clinical ophthalmologic evaluation and testing	7
electrophysiologic examination	7
color vision evaluation	7
dark adaptometry	7
low vision aids include high-powered magnifiers for reading	7
achromat	7
ophthalmologic examination is indicated:	7
every two to three years in adults	7
provide palliative care for viable newborns	7
clinical manifestations in achondroplasia vary modestly	7
baseline computerized tomography of the brain	7
only modest effects on adult stature seem to accrue	7
measures to avoid obesity should start in early childhood	7
craniocervical junction constriction	7
the best predictors of need for suboccipital decompression include:	7
lower-limb hyperreflexia or clonus	7
central hypopnea demonstrated by polysomnography	7
treatment may include the following:	7
adenotonsillectomy	7
weight reduction	7
continuous positive airway pressure	7
tracheostomy for extreme cases	7
middle ear dysfunction	7
varus deformity	7
various interventions may be elected (e	7
socialization	7
head growth and risk for hydrocephalus	7
craniocervical junction	7
sleep apnea	7
ears and hearing	7
legs	7
adaptation to difference	7
iron deposition	7
glucose tolerance test	7
blood concentrations of insulin and hba1c	7
examination of the optic fundi and fluorescein angiography	7
desferrioxamine	7
treatment with iron chelating agents (i	7
deferasirox	7
deferiprone	7
fresh-frozen human plasma	7
iron supplements	7
serum potassium concentrations at baseline and during attacks of weakness	7
12-lead ecg and 24-hour holter monitor	7
verification that serum tsh concentration is within normal limits	7
if the serum potassium concentration is low (<3	7
lifestyle and dietary modification to avoid known triggers	7
affected individuals should avoid medications known to prolong qt intervals	7
see crediblemeds® for a complete and updated list	7
clinical genetics consultation with complete family history	7
treatment for actg2-related disorders remains supportive	7
urologic manifestations	7
management of bladder dysfunction by an urologist is recommended	7
gastrointestinal manifestations	7
however, bladder catheterization was still required	7
, cipo)	7
surveillance should be individualized using a multidisciplinary approach	7
measurement of erythrocyte daxp concentration to evaluate metabolic severity	7
liver function testing to assess for metabolic hepatitis	7
auditory testing	7
prophylaxis for pneumocystis jiroveci	7
intravenous immunoglobulin (ivig)	7
bmt/sct from a “non-ideal” donor	7
ert is not curative	7
more than 300 affected individuals have received peg-ada	7
in individuals who lack an hla-identical donor)	7
chan et al 2005	7
kaufman et al 2005	7
husain et al 2007	7
author, unpublished data]	7
a third affected individual died of hepatoblastoma after 2	7
5 years of ert	7
these are of no clinical significance	7
individuals on ert also require periodic monitoring as follows:	7
plasma levels of peg-ada activity	7
erythrocyte daxp concentration	7
monitoring for the appearance or recurrence of dermatofibrosarcoma protuberans	7
consideration of skull x-ray	7
ultrasonography and ct can also help assess skull involvement	7
consultation with a pediatric cardiologist	7
any evidence for pulmonary hypertension should be sought	7
systemic blood pressure should be checked	7
mr angiography and venography to show the vascular anatomy	7
abdominal ultrasound to look for liver or renal anomalies	7
wounds without calvarial involvement	7
plastic wrap (e	7
, duoderm®)	7
other less preferred, less costly dressings are:	7
wounds with calvarial defects: acute care	7
wounds with calvarial defects: late calvarial reconstruction	7
early physiotherapy can maximize motor function and range of motion	7
management of seizures is per routine	7
determination of visual acuity and refractive error	7
ophthalmoscopy	7
the following may also provide important information:	7
orthoptic examination, particularly in children	7
corneal topography including measurement of central corneal thickness	7
gonioscopy	7
if typical signs (e	7
medication has been variably effective in suppressing debilitating symptoms	7
j friedman, personal observation]	7
fm hisama, personal observation]	7
stress management	7
intrafamilial variation in pharmaco-responsiveness occurs	7
therefore, all appropriate aeds should be tried	7
serial evaluation of eegs to monitor disease progression is appropriate	7
anamnestic interview focusing on sleep problems and feeding difficulties	7
evaluation for autism spectrum disorder and intellectual disability	7
ultrasound of the heart to evaluate for cardiac anomalies	7
speech, occupational, and physical therapy	7
specialized learning programs depending on individual needs	7
nutritional support if necessary	7
routine treatment of cardiac and ophthalmologic findings	7
gastroenterology for growth and nutrition issues	7
dietary if there are concerns about failure to thrive	7
audiology to evaluate for hearing loss	7
dental to evaluate and address issues of hypodontia	7
prosthodontics to address potential need for dental implants	7
ankyloblepharon filiforme adnatum	7
larger ones may require surgical separation by an ophthalmologist	7
ectodermal defects	7
skin erosions	7
empiric treatment (i	7
clefting should be addressed as soon as developmentally possible	7
in particular:	7
dental findings over time may warrant use of dental prosthetics	7
nfed	7
assessment of feeding and nutritional status	7
eeg to evaluate for seizures, if suspected	7
chest physiotherapy and vigorous treatment of respiratory complications	7
management of seizures using standard protocols	7
monitoring for signs of diabetes insipidus in the neonatal period	7
monitoring of the spine for the development of scoliosis	7
the clinical benefit of such treatment is unproven	7
serum and urine concentrations of electrolytes	7
serum concentration of glucose, cortisol and acth	7
assessment of arterial blood gases in those who are unwell	7
measurement of aldosterone and plasma renin activity	7
some samples may need careful handling (e	7
acute episodes	7
correction of hyperkalemia may be needed	7
, solu-cortef®)	7
adequate sodium must be provided	7
treatment during stress	7
, intercurrent illness, surgery, trauma)	7
glucose and sodium may be needed	7
parents should have access to rapid medical advice	7
guidelines for hospital admission should be clear	7
acth levels should normalize when replacement therapy is adequate	7
this should not be delayed unnecessarily	7
if puberty does start spontaneously it is likely to arrest	7
thus, careful monitoring of testosterone levels is needed	7
if physiologic stress is unavoidable (e	7
costovertebral defects can lead to scoliosis	7
routine dermatologic evaluation to monitor for vascular and other malignancies	7
referral to clinical genetics for counseling	7
acute neurovisceral attack	7
clinical assessment should include a full neurologic evaluation	7
investigations should include:	7
full blood count (fbc)	7
serum and urine osmolality	7
urine sodium concentration if hyponatremic	7
, crp, blood cultures, ck, magnesium	7
mri should be considered if cns symptoms are present	7
general measures	7
restore energy balance using an enteral route if possible	7
treat intercurrent infections and other diseases promptly	7
supportive treatment	7
pain relief	7
nausea and vomiting	7
prochloperazine, promazine or ondansetron are considered safe	7
beta blockers are considered safe	7
fluid balance and electrolytes	7
dextrose saline is preferred	7
specific treatment	7
it is infused over at least 30 minutes	7
recurrent acute attacks	7
gynecological review and bone density monitoring are recommended	7
prophylactic hemin infusion	7
however, evidence for clinical efficacy remains elusive	7
, medicalert® or similar)	7
see resources	7
seek timely treatment of systemic illness or infection	7
avoid excessive alcohol consumption and smoking	7
a few other countries have also initiated screening	7
note: serum α-fetoprotein measurement is not helpful	7
excessive alcohol consumption and smoking should be avoided	7
the drug database for acute porphyria	7
the american porphyria foundation	7
porphyria south africa	7
welsh medicines information centre - porphyria information service	7
british national formulary (subscription required)	7
stress should be minimized by providing good analgesia	7
es/aipgene for details)	7
a full cardiac evaluation, including echocardiogram	7
an ophthalmologic examination to identify anterior chamber involvement	7
liver transplantation for end-stage liver disease has an 80	7
cardiac involvement is treated in a standard manner	7
renal anomalies are treated in a standard manner	7
vascular accidents should be treated in a standard manner	7
head injuries and neurologic symptoms should be evaluated aggressively	7
ophthalmologic abnormalities rarely need intervention	7
vertebral anomalies are rarely symptomatic	7
optimization of nutrition to maximize growth and development	7
individuals with liver disease should avoid alcohol consumption	7
formal, age-appropriate developmental assessment	7
examination for possible scoliosis	7
no specific therapy is currently available for alexander disease	7
swallow studies and nutritional intervention (i	7
early recognition of abnormal tone and spinal problems (i	7
neuroblastoma and ganglioneuroblastoma	7
asymptomatic children at risk	7
less frequent intervals may also be appropriate	7
every 1-2 months in infants age ≤12 months	7
every 3-4 months in children age ≤10 years	7
electrocardiogram and echocardiogram in individuals older than age 40 years	7
aortic stenosis may necessitate valve replacement	7
ochronotic prostate stones appear on radiography	7
all had elevated plasma tyrosine concentrations	7
plasma tyrosine averaged 800μm without dietary restriction	7
side effects were minimal	7
additional trials are currently underway to establish clinical benefit	7
electroencephalogram (eeg) and video eeg monitoring	7
swallowing study, if bulbar signs are present	7
baseline pulmonary function testing	7
treatment is limited to symptom management and supportive care	7
alpers-huttenlocher syndrome	7
family education is critical	7
supportive therapies	7
treatment with cpap or bipap as indicated is appropriate	7
seizure control is a goal of treatment	7
other phenotypes	7
gastrostomy may be required to provide adequate nutrition	7
surgery for ptosis may provide symptomatic relief for some	7
primary care provider	7
neurologist	7
clinical geneticist	7
hepatologist or gastroenterologist	7
physiatrist	7
psychiatrist	7
pulmonologist	7
laboratory tests	7
every three months	7
urine analysis	7
serum concentration of lactic acid	7
biannually	7
imaging and diagnostic procedures	7
liver ultrasound examination annually	7
eeg and video eeg monitoring (e	7
, for suspicion of subclinical status epilepticus	7
presence of epilepsia partialis continua	7
audiogram and brain stem auditory evoked responses as clinically indicated	7
barium swallow study as clinically indicated	7
lungs	7
, influenza and pneumococcal)	7
controls	7
recommend intravenous aat augmentation therapy for individuals with established emphysema	7
, fev1 35%-60% predicted)	7
2 months post-liver transplant and not achieving statistical significance	7
panniculitis	7
complete cessation of smoking	7
avoidance of dusty occupational exposures	7
yearly vaccination against influenza and pneumococcus	7
no such drug has yet been approved	7
drugs to enhance autophagy (e	7
human trials are under way	7
results from more recent studies are not currently available	7
overt proteinuria (urine protein-creatinine ratio >0	7
hypertensive individuals should receive appropriate management	7
male relative without hematuria	7
male relative with hematuria	7
female relative without hematuria	7
female relative with hematuria (i	7
, heterozygous female)	7
cochlear	7
hearing aids should be prescribed when appropriate	7
some individuals develop cataracts that interfere with vision	7
these should be extracted when necessary	7
diffuse leiomyomatosis	7
symptomatic leiomyomas may require surgical intervention	7
exposure to loud noise should be minimized	7
a single urinalysis is sufficient in a male	7
measurement of autoantibodies to assess for autoimmunity	7
monitoring for and treatment of lymphoproliferation and hypersplenism	7
however, sirolimus is not without side effects	7
treatment of lymphoma is according to conventional protocols	7
treatment of cytopenias and other autoimmune diseases	7
relatives who have the family-specific pathogenic variant should:	7
undergo alps-specific evaluations at initial diagnosis (e	7
, lymphoma) become apparent (see surveillance)	7
electromyography in case of als and/or lower motor signs	7
discussion of advanced care planning	7
caregiver and patient support groups are valuable	7
options include:	7
ssris	7
venlafaxine	7
clinical, neurologic, and neuropsychological follow up is necessary	7
electrophysiologic investigations	7
emg/ncv (3 extremities)	7
laboratory workup	7
radiologic	7
neuropsychologic testing (if applicable) to assess cognitive impairment	7
however, weakness and lethargy are common side effects	7
low-tech (e	7
, alphabet board) and high-tech (i	7
specialized multidisciplinary als clinic evaluations are suggested every three months	7
pt/ot evaluation	7
further investigations are needed	7
cone-rod dystrophy	7
ophthalmologic evaluation, including electroretinogram and visual field testing	7
measurement of weight and height	7
calculation of body mass index (bmi)	7
assessment of otitis media and conductive hearing loss	7
insulin resistance/type 2 diabetes mellitus	7
fasting plasma glucose, even in infancy	7
a fasting lipid profile, including triglycerides	7
endocrine abnormalities	7
measurement of pituitary hormones	7
history to document urinary difficulties	7
baseline blood pressure	7
24-hour blood pressure monitoring	7
measurement of plasma bun, creatinine, urea and electrolytes	7
if renal function testing is abnormal, ultrasound examination	7
if abnormalities, refer to a nephrologist	7
measurement of plasma alt, ast, and ggt concentration	7
liver ultrasonography to evaluate for possible hepatomegaly and portal hypertension	7
if clinically indicated, screening esophagogastroduodenoscopy for varices	7
educational evaluation for intervention and iep	7
neurologic evaluation with eeg to examine for seizures	7
no therapy exists to prevent the progressive organ involvement	7
hearing can be maximized with bilateral digital hearing aids	7
and metformin	7
hypertriglyceridemia	7
pancreatitis should be treated as in the general population	7
prevention of primary complications	7
care must be taken during sedation or operative procedures	7
audiometry should be performed yearly	7
insulin resistance/type 2 diabetes	7
patients should be monitored annually for thyroid abnormalities	7
severe dyslipidemia	7
and hyperglycemia	7
intensive multidisciplinary surveillance of any pregnancy would be mandatory	7
history (especially first symptoms, duration, progression)	7
examination (especially mental status)	7
mri, pet	7
depression and seizures should be treated with appropriate medications	7
monthly surveillance to identify and manage secondary complications is indicated	7
sudden changes in environment and over-sedation should be avoided	7
offering psychosocial support may be helpful	7
lifelong clinical follow up should include the following:	7
renal function monitoring by measurement of: blood pressure	7
body weight	7
serum concentrations of creatinine, albumin, and cholesterol	7
24-hour urinary protein	7
and creatinine clearance	7
standard measures for prevention of fetopathy should be followed	7
possible changes of medication prior to pregnancy	7
assignment of sex of rearing	7
even in cais this may not always be easy	7
cais	7
however, the issue of gonadectomy is controversial	7
pais with predominantly female genitalia (incomplete ais)	7
pais with ambiguous genitalia or predominantly male genitalia	7
gynecomastia that develops in puberty eventually requires reduction mammoplasty	7
mais	7
regular weight-bearing exercises are encouraged to maintain bone health	7
baseline brain mri and eeg	7
musculoskeletal examination for scoliosis and gait impairment (e	7
, extent of foot pronation or ankle subluxation	7
orthopedic referral as needed	7
evaluation for gastroesophageal reflux in infants and young children	7
dietary evaluation to assure optimal nutritional status	7
the customary medical treatment (i	7
sometimes fundoplication as required	7
no one drug has proven superior	7
medications used for minor motor seizures (e	7
hypermotoric behaviors are typically resistant to behavioral therapies	7
unstable or nonambulatory children may benefit from physical therapy	7
individualization and flexibility in the school are important educational strategies	7
administration of 0	7
strabismus may require surgical correction	7
these limitations place them at risk for social disruptions	7
older adults tend to become less mobile and less active	7
annual clinical examination for scoliosis	7
excessive tongue protrusion causes drooling	7
available surgical or medication treatments (e	7
the need for orthoses or other assistive devices varies individually	7
most patients remain ambulatory without assistance for decades	7
no definitive treatments for the limb-girdle muscular dystrophies exist	7
for asymptomatic persons, evaluate less frequently	7
provide palliative care for the viable newborn	7
examination of cognitive function	7
low-cholesterol diet is advised	7
assessment of cognitive function	7
physical therapy and occupational therapy assessment of strength and balance	7
educational support (e	7
a low-cholesterol diet is advised	7
routine visits to the attending neurologist are indicated	7
, behavioralists) who can provide the following:	7
gait safety devices including canes and wheel chairs	7
behavioral modification and cognitive aids as needed	7
periodic assessment of the following:	7
bladder function	7
sensation in the distal lower extremities	7
cognition (e	7
, executive function)	7
a randomized controlled trial of trihepatnoin for apbd is ongoing	7
physical examination to screen for splenomegaly	7
there are no formal management guidelines for apoe p	7
leu167del-related lipid disorders	7
in patients with fasting triglyceride levels:	7
splenectomy should be avoided as it may worsen hyperlipidemia	7
liver function abnormalities	7
persistent nausea	7
vomiting	7
yellow discoloration of the skin	7
bruising	7
any new petechial rash	7
there are no formal guidelines regarding surveillance	7
the authors suggest obtaining the following:	7
counsel patients regarding the signs of liver dysfunction	7
splenectomy as it worsens the hypertriglyceridemia	7
leu167del variant	7
if the apoe p	7
a woman with the apoe p	7
assessment of kidney involvement:	7
measure serum creatinine concentration	7
screen for albuminuria or proteinuria	7
assess kidney stone burden with ultrasound or ct examination	7
ophthalmology consultation if eye symptoms are present	7
allopurinol	7
febuxostat	7
treatment of esrd	7
no surveillance guidelines have been developed	7
monitor kidney function	7
facilitate medication compliance	7
azathioprine should be avoided by individuals taking xdh inhibitors	7
they are usually identified during family screening	7
plasma arginine concentration	7
arginine supplementation is obviously contraindicated	7
rapidly reducing plasma ammonia concentration	7
pharmacologic management to allow alternative pathway excretion of excess nitrogen	7
in early treatment, feeding 1	7
0 to 1	7
older children require and tolerate lower protein intake	7
seizures are easily treated by phenobarbital or carbamazepine	7
restriction of dietary protein through use of specialized formulas	7
administration of oral nitrogen scavenging drugs	7
0 g/m2/day in larger patients	7
particularly, elevated prothrombin time	7
arginine is the substrate for nitric oxide synthase	7
plasma quantitative amino acid analysis	7
analysis of enzymatic activity in red blood cells	7
immunizations can be provided on the usual schedule	7
multivitamin and fluoride supplementation are indicated for all affected individuals	7
appropriate use of antipyretics is indicated	7
ibuprofen is preferred over acetaminophen	7
complete neurocognitive evaluation	7
discontinuing oral protein intake	7
intravenous nitrogen scavenging therapy	7
ammonia levels usually normalize with therapy	7
nitrogen scavenging therapy needs to be continued during hemodialysis	7
diet	7
arginine base supplementation	7
oral nitrogen scavenging therapy	7
orthotopic liver transplantation (olt)	7
electrolyte (potassium) supplementation is appropriate when indicated	7
periodic evaluation of liver function tests may be necessary	7
the appropriate frequency is unknown	7
periodic evaluation of serum electrolytes is appropriate	7
the frequency unknown	7
large boluses of protein or amino acids	7
less than recommended intake of protein	7
prolonged fasting or starvation	7
intravenous steroids	7
hepatotoxic drugs in those with hepatic involvement	7
retinal examination	7
curative therapy is not available	7
skeletal radiographs depending on the clinical findings (e	7
, scoliosis)	7
clinical history studies are limited	7
aneurysms and focal stenoses are amenable to surgical intervention	7
hernias may recur after surgical repair	7
emphysema is treated symptomatically	7
, swimming) performed in moderation	7
pulmonary follow up	7
increased vigilance for emphysema is appropriate	7
, serial radiographs to evaluate for progression of scoliosis	7
all pregnancies had a good outcome	7
peripartum intensive monitoring is advised	7
medication-associated risks to the fetus	7
, a beta-blocker) prior to conception	7
audiometry for evidence of hearing loss	7
eye examination for evidence of optic atrophy	7
assessment of intellectual abilities	7
no treatment is available	7
see hereditary ataxias, management	7
an annual influenza immunization	7
routine immunizations against other common childhood infections (e	7
measles, mumps)	7
visual impairment appears to be progressive	7
thus, regular evaluation by an ophthalmologist is recommended	7
noninvasive monitoring	7
, an implantable cardioverter defibrillator)	7
beta blockers are considered first line therapy	7
management relies on personalized recommendations based on clinical assessment	7
implantable cardioverter-defibrillators (icds)	7
syncope was found to predict appropriate icd discharge	7
class ii indications (i	7
screening recommendations:	7
ecg, annually or more frequently depending on symptoms	7
echocardiogram, annually or more frequently depending on symptoms	7
holter monitoring, event monitoring, implantable loop recorder	7
exercise stress testing	7
cardiac mri, with frequency depending on symptoms and findings	7
ecg, with consideration of signal-averaged electrocardiogram	7
cardiac mri	7
nutrition and feeding assessment	7
chest x-ray and pulmonary function for baseline	7
however, individual responses to specific medications (e	7
(see also therapies under investigation	7
pulmonary and nutritional complications of dysphagia are common	7
periodic cbcs are warranted	7
research suggests the following:	7
antioxidants (e	7
a clinical trial is presently underway	7
electroretinogram (erg)	7
echocardiography and ecg to assess for cardiomyopathy	7
neurophysiologic examination	7
one of the following vitamin e preparations is used:	7
the naturally occurring form, rrr-α-tocopherol	7
, every 6 months), especially in children	7
individuals with aved should avoid:	7
occupations requiring quick responses or good balance	7
see establishing the diagnosis	7
confirmed diagnosis of thalassemia	7
facial changes	7
poor growth	7
bony fractures	7
clinically significant extramedullary hematopoiesis	7
thalassemia major	7
transfusions are usually given every two to three weeks	7
thalassemia intermedia	7
cord blood transplantation	7
transfusional iron overload	7
assessment of iron overload	7
serum ferritin concentration	7
liver biopsy	7
desferrioxamine b (dfo)	7
, hepatic iron concentration <7	7
dfo administration also increases susceptibility to yersinia infections	7
cardiac disease	7
ophthalmologic and audiologic examinations	7
bone densitometry to assess for osteoporosis in the adult	7
iron-containing preparations	7
new chelation strategies are under investigation	7
uveal melanoma (um)	7
dilated eye examination and imaging by an ocular oncologist	7
malignant mesothelioma (mme)	7
no screening modalities exist	7
clear cell renal cell carcinoma (ccrcc)	7
thus, a cure is unlikely	7
cutaneous melanoma	7
consensus management recommendations have not been established	7
no reliable early disease symptoms or screening modalities	7
cutaneous melanoma, basal cell carcinoma and atypical spitz tumors	7
clear cell renal cell carcinoma	7
arc welding	7
asbestos	7
unnecessary and prolonged sun exposure	7
ophthalmologic examination including fundoscopy	7
eeg (if brain mri is abnormal)	7
neurocognitive evaluation	7
echocardiogram for evidence of congenital heart defects	7
there is no specific treatment of bwcff syndrome	7
symptomatic management involves the following	7
ptosis may require surgical treatment	7
hearing loss may require routine care including hearing aids	7
epilepsy is treated using standard protocols	7
early detection allows specific treatment of intraocular hypertension	7
routine follow up of deafness for any evidence of progression	7
screening for malignancies	7
complete blood count and differential	7
management of heart failure	7
management of neutropenia	7
78 ± 0	7
45-12	7
8 years, with an average exposure of 7	7
educational support in school	7
antibiotic prophylaxis has been used to prevent recurrent infections	7
potassium issues:	7
increased risk for hypokalemia	7
increased risk for hyperkalemia	7
the use of rectal thermometers in those with neutropenia	7
pantothenic acid	7
carnitine	7
arginine	7
fundoscopic photographs should be filed for later comparison	7
examination of the genitalia in both sexes	7
pelvic ultrasound examination is preferred	7
baseline blood pressure assessment	7
cardiac evaluation including auscultation, ecg, and echocardiography	7
consider referral to a clinical geneticist	7
, renal or hepatic dysfunction)	7
indicators are functional interference and poorly fitting footwear	7
dental extractions are appropriate as required for dental crowding	7
insertion of grommets is commonplace	7
suggested surveillance is summarized here:	7
routine (at least annual) measurement of blood pressure	7
annual endocrinology review	7
physical examination for birth defects of clinical significance (e	7
, orofacial clefts, polydactyly)	7
evaluation by a dentist or orthodontist familiar with nbccs	7
skin examination by a dermatologist familiar with nbccs	7
manifestations should be treated by specialists (e	7
keratocysts usually require surgical excision	7
systemic treatment with retinoids (e	7
complete sunblock should be used	7
diagnostic x-rays should be used sparingly	7
excessive sun exposure increases the likelihood of developing bccs	7
joint examination for contractures	7
ullrich congenital muscular dystrophy (cmd)	7
examination of back for scoliosis	7
joint examination for contractures and hyperlaxity	7
assessment of growth and feeding	7
contractures tend to be aggressive and may require surgery	7
once scoliosis is evident, regular orthopedic follow up	7
clinical assessment of nutritional status	7
however, prenatal physiotherapy may be indicated	7
individuals with benign familial neonatal epilepsy (bfne)	7
individuals with neonatal epileptic encephalopathy (nee)	7
cognitive and behavioral neuropsychological testing	7
assessment of digestive and other non-neurologic comorbidities	7
all individuals with a kcnq2-related disorder	7
refractory seizures are uncommon in kcnq2-related bfne	7
augmentative communication techniques can be valuable for many patients	7
some children may require lifelong antiepileptic treatment	7
thorough neurologic and neuropsychiatric assessment	7
antiepileptic treatment for seizures	7
symptomatic treatment for headaches	7
thorough neurologic and neuropsychiatric assessment is indicated annually	7
neurologic evaluation by a pediatric neurologist	7
psychology evaluation for assessment of iq	7
biotin and thiamine therapy	7
symptoms typically resolve within days	7
biotin and thiamine need to be given lifelong	7
in the acute stage empiric treatment with antimicrobial/antiviral agents	7
fever control	7
antiepileptic drugs for effective control of seizures	7
symptomatic treatment of dystonia, including administration of l-dopa	7
rehabilitation, physiotherapy, occupational therapy, and speech therapy	7
educational programs adapted to individual needs	7
avoidance of triggers/stressors including trauma and surgery	7
affected women should continue biotin and thiamine therapy during pregnancy	7
testing of relatives at risk	7
detailed dermatologic examination and punch biopsy of suspected cutaneous lesion	7
therefore, renal tumors greater than 3	7
no preventive or curative treatment is available for bhds	7
renal tumor screening	7
if any suspicious lesion (<1	7
renal tumors less than 3	7
0 cm in diameter are monitor by periodic imaging	7
melanoma	7
cigarette smoking	7
high ambient pressures, which may precipitate spontaneous pneumothorax	7
fundoscopic examination	7
full-field electroretinogram (fferg) to establish a baseline	7
no treatment for bcd currently exists	7
physical examination for neurologic findings (e	7
ophthalmologic examination (for finding such as optic atrophy)	7
biotin therapy is lifelong	7
a protein-restricted diet is not necessary	7
for all children with biotinidase deficiency:	7
regularly scheduled appointments with primary care physicians or as needed	7
an optimal prenatal dose has not been determined	7
determination of plasma immunoglobulin concentrations	7
observation of urination for evidence of urethral obstruction	7
psychosocial	7
echocardiogram if there is a murmur or cardiac symptoms	7
renal ultrasonography	7
the following consultations are recommended:	7
referral to a nephrologist if renal abnormalities are identified	7
referral to an audiologist	7
monitoring for depression, attention dysregulation	7
milunsky et al [2011] provided management guidelines	7
see table iii)	7
they should not be cauterized	7
most larger skin defects require surgical excision	7
monitor for changes related to the major findings over time	7
cervical examination for fistulae	7
otologic findings	7
tests of renal function: bun and creatinine	7
urinanalysis	7
recommended treatment:	7
excise branchial cleft cysts/fistulae	7
fit with appropriate aural habilitation as indicated	7
enroll in an appropriate educational program for the hearing impaired	7
consider canaloplasty to correct an atretic canal	7
treat urologic and renal abnormalities in the standard manner	7
if renal anomalies (e	7
if esrd develops, consider renal transplantation	7
branchial arch anomalies can be surgically corrected	7
regular assessment of renal function to prevent progression to esrd	7
assessment of nutrition by a nutritionist or dietician	7
global developmental disability/intellectual disability	7
social/behavioral difficulties	7
disordered sleep	7
ophthalmologic findings	7
eye findings are treated in a routine manner	7
regular pulmonary hygiene to manage risk for pulmonary complications	7
tracheostomy as indicated when secretions are difficult to manage	7
follow-up ophthalmologic examination every one to two years	7
in uninformative families or simplex cases (i	7
eyelid surgery	7
timing of eyelid surgery is controversial	7
however, it remains controversial	7
consider prophylactic bilateral mastectomy	7
the sample size, however, was extremely small	7
ovarian cancer/fallopian tube cancer	7
salpingectomy	7
tubal ligation	7
women	7
monthly breast self-examination	7
annual mammogram beginning at age 30	7
men	7
annual clinical breast examination beginning at age 35	7
annual prostate cancer screening beginning at age 45	7
women and men	7
, pancreatic cancer)	7
the postoperative follow up was 3	7
6 years	7
4 years	7
electrophysiologic study to assess risk of sudden cardiac death	7
it is important to:	7
controversy exists regarding the treatment of asymptomatic individuals	7
febrile state	7
vagotonic agents	7
α-adrenergic agonists [miyazaki et al 1996]	7
β-adrenergic antagonists	7
tricyclic antidepressants	7
first-generation antihistamines (dimenhydrinate)	7
cocaine toxicity	7
class 1c antiarrhythmic drugs including flecainide and propafenone	7
class 1a agents including procainamide and disopyramide	7
when appropriate, clamp glucose homeostasis study	7
echocardiogram to evaluate for cardiac hypertrophy	7
renal ultrasound examination to evaluate for kidney size	7
bone age and assessment of sexual maturity rating/pubertal status	7
assessment of cognitive ability with age-appropriate scales	7
periodic screening for glycosuria as a manifestation of diabetes mellitus	7
yearly cardiac ultrasound and ekg	7
yearly or biennial liver ultrasound examination to detect fatty infiltration	7
excessive dietary fat intake should be avoided	7
pregnancy may increase the risk of diabetic decompensation	7
ophthalmology assessment for lower-eyelid coloboma for possible corneal involvement	7
examination for midline cleft palate or unilateral cleft lip/palate	7
referral to multidisciplinary cleft palate team as required	7
treatment of craniofacial manifestations (e	7
there are no reports on the use of aflibercept	7
the cnv regressed and the subretinal hemorrhage resolved	7
genetic counseling and occupational counseling should be offered	7
assessment for airway sufficiency in the presence of macroglossia	7
abdominal wall repair for omphalocele soon after birth	7
generally, this surgery is well tolerated	7
management of difficulties arising from macroglossia:	7
some children benefit from tongue reduction surgery	7
orthodontic intervention as needed in later childhood/adolescence	7
assessment of speech difficulties	7
management of cleft palate following standard protocols	7
referral to a craniofacial surgeon if facial hemihyperplasia is significant	7
treatment of neoplasias following standard pediatric oncology protocols	7
, nephrocalcinosis)	7
management of cardiac problems following standard protocols	7
monitoring for hypoglycemia, especially in the neonatal period	7
otherwise, clinical examination alone was recommended	7
developmental screening as part of routine childcare	7
when stable for monitoring, preferably fasting)	7
consideration of:	7
neurodevelopmental testing	7
during acute episodes	7
restrict protein intake if plasma ammonia is elevated	7
without carglumic acid, hyperammonemia persisted longer (i	7
, an additional 1-2 days)	7
serum lactate and glucose	7
liver parameters	7
and urine organic acids	7
for an affected mother	7
no pregnancy manaagement issues are known	7
for an affected child	7
no special management is required during pregnancy	7
physical therapy/occupational therapy assessment as needed	7
stressful emotional and physical situations (e	7
, extreme temperatures)	7
psychometrics with particular attention to executive function	7
standard brain mri (flair sequence)	7
psychiatric consultation should be considered	7
there is no treatment of proven efficacy for cadasil	7
there are no preventive measures for stroke or vascular dementia	7
there are no standard international surveillance guidelines for cadasil	7
consultation of other medical specialists (e	7
currently, no standard surveillance protocols exist	7
to assess for salt wasting	7
plasma renin activity (pra)	7
serum electrolytes	7
to assess the degree of prenatal virilization in females	7
careful physical examination of the external genitalia and its orifices	7
vaginogram to assess the anatomy of urethra and vagina	7
bone maturation assessment by bone age	7
classic 21-ohd cah	7
glucocorticoid replacement therapy	7
the use of oral hydrocortisone suspension is discouraged	7
during periods of stress (e	7
affected individuals should carry medical information regarding emergency steroid dosing	7
mineralocorticoid replacement therapy	7
sodium chloride supplementation may not be necessary after infancy	7
feminizing genitoplasty	7
the systematic evidence for this belief is lacking	7
testicular adrenal rest tumors	7
transition from adolescence to adulthood	7
women with classic cah had increased diastolic blood pressure	7
subjective health status was significantly impaired and fertility compromised	7
adrenalectomy	7
non-classic 21-ohd cah	7
salt-wasting crisis	7
evaluation may be less often thereafter	7
monitoring for testicular abnormalities in males	7
monitoring fertility and metabolic risks in adults	7
fecundity and fertility	7
weight	7
imaging studies	7
increased doses of glucocorticoids are recommended in these situations	7
pregnant females with classic 21-ohd cah	7
affected female fetus with genital ambiguity	7
treatment of short stature	7
3-q25	7
hearing screening	7
most survivors with cd require orthopedic care	7
club feet require surgical correction	7
the hips should be checked for luxation	7
bracing is usually not helpful	7
seizures may be treated with antiepileptic drugs (aeds)	7
diamox® seems to reduce intracranial pressure	7
botox® injections may be used to relieve spasticity	7
annual routine follow up is indicated	7
humans	7
three developed aav2 neutralizing antibodies	7
no children improved	7
animal models	7
these experiments were short term	7
cardiology evaluation with echocardiogram and electrocardiogram	7
skeletal survey to assess for the associated bone abnormalities	7
scoliosis may require bracing or surgical correction	7
polyhydramnios	7
the cause of polyhydramnios is unknown	7
macrosomia	7
t2* gradient echo imaging to check cerebral microbleeds	7
personality change may require antipsychotic medication	7
a wig or hairpiece may be helpful for alopecia	7
anti-platelet therapy and anti-hypertension therapy may be recommended	7
however, there is no evidence for their effectiveness	7
in males, testicular ultrasonography at the initial evaluation	7
in females, transabdominal ultrasonography during the first evaluation	7
the following interventions are routine:	7
cardiac myxoma	7
open-heart surgery	7
cutaneous and mammary myxoma	7
surgical excision	7
cushing syndrome	7
bilateral adrenalectomy	7
pituitary adenoma	7
transsphenoidal surgery	7
thyroid adenomas	7
surgery if cancerous	7
lccsct	7
pms	7
surgery to remove primary and/or metastatic lesions	7
pre-pubertal pediatric individuals	7
echocardiogram (annually	7
testicular ultrasound for boys	7
post-pubertal pediatric and adult individuals	7
testicular ultrasound (annually)	7
thyroid ultrasound (baseline examination	7
transabdominal ultrasound of the ovaries (baseline examination	7
urinary free cortisol levels (annually)	7
serum igf-1 levels (annually)	7
adrenal computed tomography	7
pituitary mri	7
three-hour oral glucose tolerance test (ogtt)	7
90-minute thyroid releasing hormone (trh) testing	7
neurologic evaluation including eeg	7
assessment of feeding	7
molecular genetic testing for the causative contiguous gene deletion	7
otologic examination and audiologic assessment	7
orthopedic examination to assess the presence of scoliosis	7
cardiac examination: 24-hour electrocardiogram and echocardiogram	7
no specific treatment is currently available for caveolinopathies	7
management should include the following:	7
periodic monitoring of the following is recommended:	7
respiratory function: spirometry	7
cardiac function: 24-hour electrocardiography and echocardiography	7
mobility and muscle function: physiatrist and physical therapist consultation	7
in an unstable patient:	7
once the patient becomes stable:	7
infants are started with daily 1	7
0 mg intramuscular or subcutaneous injections	7
acute metabolic decompensation	7
long-term management	7
these are accomplished by:	7
parenteral ohcbl	7
0 mg (~0	7
betaine	7
optimal dosing and monitoring have not been adequately established	7
folate and folinic acid	7
the adult dose of folate is 1	7
5 mg for maintenance	7
other therapeutic considerations that have not been fully validated:	7
methionine supplementation	7
pyridoxine	7
indicated for low plasma carnitine levels	7
flu prevention (i	7
clinical evaluation should include assessment of:	7
growth including weight, linear growth, and head circumference	7
feeding ability	7
laboratory evaluation should include:	7
complete blood count (cbc) to monitor for cytopenias	7
routine evaluations should include:	7
brain mri and/or eeg as clinically indicated	7
potentially exacerbating circumstances:	7
methionine restriction	7
0 mg im, folic acid 5	7
ophthalmologic examination with attention to visual acuity and visual fields	7
for adult males: evaluation of testicular function	7
supportive therapy includes the following as needed:	7
treatment of headache	7
guidance for visual impairment	7
annual evaluations including:	7
musculoskeletal examination for the presence of contractures and kyphosis/scoliosis	7
classic cca	7
this type of therapy is best instituted in childhood	7
surgical release of contractures may be necessary	7
consultation with an orthopedist is encouraged	7
severe/lethal cca	7
no general recommendations exist	7
at least annual physical examination for evidence of kyphosis/scoliosis	7
speech therapy may be required during periods of dental treatment	7
sinus and middle ear infections require aggressive and timely treatment	7
helmets may be advised for high-risk activities	7
children with ccd should be monitored for the following:	7
dental abnormalities	7
upper-airway obstruction	7
sinus and ear infections	7
visual impairment (ophthalmologic examination)	7
the treatment of cataracts is surgical	7
regular rehabilitation can prevent or postpone osteoporosis	7
in those with epilepsy:	7
electoencephalogram (eeg) and/or video-eeg	7
recurrent hemorrhage or mass effect	7
neuropsychological testing may be considered prior to any neurosurgical procedure	7
microsurgical techniques rely on intraoperative examination for precise localization	7
other medications that increase risk of hemorrhage (e	7
of the 16 women, hemorrhage occured in ten	7
6% compared with 1	7
fasudil is approved in japan for treatment of vasodilation	7
gov identifier: nct01764451)	7
gov identifier: nct02603328)	7
physical and occupational therapy assessments	7
hypotonia and weakness	7
patients may benefit from physical therapy	7
scoliosis and joint contractures	7
patients with more severe symptoms may require respiratory support	7
secondary complications can include respiratory compromise from scoliosis	7
immunization against influenza is encouraged	7
prompt treatment of respiratory infection is important	7
sleep studies especially when patients show signs of nocturnal hypoxia	7
referral to a specialized skeletal dysplasia clinic if available	7
thus far, heart valve dysplasia has not required correction	7
activities with a high impact on joints (e	7
, jogging) should be avoided	7
hemoglobin concentration and serum bilirubin concentration	7
abdominal ultrasound examination to evaluate for biliary stones	7
peginterferon-α2b has also been given once a week	7
the mechanism behind this response is unknown	7
splenectomy is of unproved value	7
recommended monitoring for iron overload:	7
avoid any preparation containing iron	7
measurement of serum albumin concentration	7
urinalysis to evaluate for proteinuria	7
echocardiogram to evaluate for pericardial effusions	7
renal ultrasound examination to evaluate for microcysts	7
they can tolerate carbohydrates, fats, and protein	7
oral motor dysfunction with persistent vomiting	7
consultation with a gastroenterologist and nutritionist is often necessary	7
"infantile catastrophic phase	7
strabismus	7
stroke-like episodes	7
coagulopathy	7
orthopedic issues—thorax shortening, scoliosis/kyphosis	7
occasionally, surgical treatment of spinal curvature is warranted	7
deep venous thrombosis (dvt)	7
independent living issues	7
periodic assessment of bleeding and clotting parameters by a hematologist	7
follow up with an orthopedist when scoliosis becomes evident	7
plotting growth parameters on cdls-specific growth charts	7
cdlsusa	7
org (girls	7
boys)	7
radiographs of the upper extremities to evaluate for radioulnar synostosis	7
echocardiogram to screen for cardiac defects	7
neurologic evaluation and eeg in all affected individuals	7
renal ultrasonography to evaluate for structural kidney anomalies	7
urologic evaluation in males with hypospadias and/or cryptorchidism	7
pelvic ultrasound to evaluate for bicornuate uterus in females	7
complete blood count, immune profile (consisting of immunoglobulins	7
antibodies to tetanus, dipetheria, and pneumococcus	7
b-cell panel	7
surgical correction of intestinal malrotation if present	7
alternative communicative methods (e	7
standard treatment for hearing loss	7
standard interventions for cardiac defects	7
appropriate treatment for seizures	7
antibiotic prophylaxis and follow up for vesicoureteral reflux	7
orchiopexy if cryptorchidism is present	7
standard intervention for bicornuate uterus, if present	7
preoperative evaluation for thrombocytopenia and cardiac disease	7
annual gastrointestinal evaluation including monitoring of growth	7
routine monitoring of existing cardiac or renal anomalies	7
no known agents exacerbate the severity of cdls	7
full skeletal survey	7
growth measures	7
assessment of upper and lower airways if stridor is present	7
polysomnography	7
brain imaging studies	7
cervical spine stenosis may require decompression	7
thoracic and lumbar spine (for scoliosis)	7
serum creatine kinase (ck) concentration	7
liver transaminases	7
pre-prandial blood glucose concentration	7
l-carnitine supplementation	7
l-carnitine supplementation has relatively few side effects:	7
hypoglycemic episodes are treated with intravenous dextrose infusion	7
cardiomyopathy requires management by specialists in cardiology	7
perform annually during childhood and less frequently in adulthood	7
plasma carnitine concentration	7
serum ck concentration and liver transaminases	7
consider measuring during acute illnesses	7
a biopsy is often taken after detection of abnormalities	7
liver ultrasound examination and measurement of liver enzymes	7
evaluation by a pulmonologist	7
cardiac evaluation for detection of possible structural heart defects	7
correction of polydactyly (optional)	7
orthopedic care as required (e	7
, for hip dysplasia)	7
dental care	7
standard treatment for renal and liver abnormalities	7
pneumonia should be treated with antibiotics	7
asthma can be treated with steroids	7
standard treatment for cardiac abnormalities	7
annual ophthalmologic examinations starting at age four years	7
baseline blood pressure if considering treatment with losartan	7
no consensus management guidelines have been developed to date	7
improving gait, exercise tolerance, and flexion contractures	7
unsuccessful steroid therapy was reported in one adult	7
less symptomatic individuals can be started on 0	7
0 mg/kg every other day	7
higher-dose steroids may help with acute pain crises	7
calcitonin	7
losartan	7
pain in the tibia resolved completely following the surgery	7
corticosteroids may delay skull hyperostosis and cranial nerve impingement	7
three underwent internal auditory canal decompression with mixed results	7
whether this is related to ced is unknown	7
the authors are unaware of any other similar cases	7
bisphosphonates	7
excess phosphate	7
celiac disease	7
a dietitian experienced in treating celiac disease should be involved	7
, 100 mg) can damage the small intestine	7
note that a slice of bread contains approximately 2	7
5 grams of gluten	7
some hidden sources of gluten:	7
non-starchy foods such as soy sauce and beer	7
, lipstick)	7
refractory sprue or celiac disease	7
a later age of onset of symptoms	7
treatment with a gluten-free diet can:	7
reduce the excess risk of mortality in symptomatic individuals	7
serum calcium and vitamin d concentrations	7
bone densitometry	7
hepatic function tests	7
cutaneous photosensitivity	7
reflectant sunscreens containing zinc oxide or titanium dioxide	7
skin trauma should be avoided	7
wound care is essential to prevent infection of opened blisters	7
laser hair removal can be used to treat facial hypertrichosis	7
topical antibiotics for corneal ulcers, scleritis, and blepharitis	7
bone manifestations	7
hemolytic anemia	7
consider blood transfusions when hemolysis is significant	7
strict avoidance of sunlight and protection from light are indicated	7
monitor the following:	7
note: individuals receiving transfusion therapy need closer monitoring	7
hepatic function every six to twelve months	7
fecal elastase	7
fecal fat content based on 72-hour stool collection	7
vitamin a, d, and e serum concentrations	7
prothrombin time and international normalized ratio (inr)	7
random glucose	7
overall clinical status / extent of disease	7
cbc with differential and cell count	7
serum electrolytes, bun, creatinine	7
liver function tests (alt, ast)	7
consultation with a genetic counselor	7
cystic fibrosis (cf)	7
inhaled dornase alfa in all individuals age ≥6 years	7
inhaled hypertonic saline in all individuals age ≥6 years	7
recommended sequence for inhaled medications:	7
an aerosolized antibiotic	7
gly551asp and other specific pathogenic variants	7
phe508del	7
lung or heart/lung transplantation	7
an option for some individuals with severe disease	7
oral pancreatic enzyme replacement with meals	7
fertility	7
congenital absence of the vas deferens (cavd)	7
prevention of primary manifestations – cystic fibrosis	7
aerosolized antibiotic	7
all routine immunizations should be given at the recommended times	7
pancreatic enzyme replacement and supplementation of fat-soluble vitamins	7
high-calorie, high-fat nutritional supplements	7
consultation with a nutritionist specializing in cf	7
surveillance – cystic fibrosis	7
culture respiratory tract secretions at least four times yearly	7
75 g/kg, or 75 g maximum	7
evaluate bone mineral density in adolescence	7
agents/circumstances to avoid – cystic fibrosis	7
respiratory irritants (e	7
, smoke, dust)	7
individuals with respiratory infections	7
deterioration during pregnancy may precipitate preterm delivery	7
mode of delivery is based on usual obstetric indications	7
cftr pathogenic variant-specific candidate drugs:	7
phe508del)	7
gene therapy is in early clinical trials	7
aeruginosa has not yet been developed	7
complete physical examination including measurement of growth parameters	7
nutrition and feeding evaluation	7
consideration of swallow study	7
psychomotor developmental evaluation	7
mri of the brain to detect any structural changes	7
cardiac evaluation including echocardiogram and electrocardiogram	7
obtain history for possible bleeding diathesis	7
increasing caloric intake may be of benefit	7
constipation affects the majority of individuals	7
seizures are treated as in the general population	7
recurrent otitis media may require placement of pe tubes	7
hyperkeratoses are treated as in the general population	7
monitor for signs of precocious puberty	7
annual evaluation of hearing is recommended	7
periodic evaluation for scoliosis during young childhood is recommended	7
over-exposure to heat	7
individuals with cfc syndrome report heat intolerance	7
palpebral fissure size measurement	7
anterior segment evaluation to detect corneal exposure	7
levator function testing	7
optional forced duction testing	7
refraction, including cycloplegic refraction in children	7
photographic documentation for future comparison	7
strongly recommended if eye muscle surgery is planned:	7
nonsurgical treatment of ophthalmologic findings:	7
correction of ptosis	7
eye muscle surgery	7
to correct or improve a compensatory head posture	7
to improve ambulation and gross motor development in young children	7
principles of surgical approach:	7
profound weakening procedures (e	7
cfeom is congenital and is believed to be non-progressive	7
weakness	7
hypotonia	7
respiratory rate	7
signs of respiratory distress	7
history of recurrent chest infections	7
ability to maintain oxygen saturation	7
evaluation should include echocardiogram and electrocardiogram	7
physical therapy and occupational therapy assessment	7
orthodontic evaluation and appropriate intervention may be necessary	7
contractures may be avoided by consistent joint movement or therapy	7
and lung function tests, including fev1 and fvc	7
poor iron absorption is common in cgd-related colitis	7
albumin	7
affected organs / manifestations of cgd on imaging	7
lungs / pneumonia [godoy et al 2008]	7
chest x-ray	7
consolidation, reticular nodular opacities, scarring	7
empyema or abscess	7
calcifications if granuloma present	7
single to multiple small or large abscesses, sharply defined	7
calcifications	7
musculoskeletal / osteomyelitis [galluzzo et al 2008]	7
genitourinary / cystitis [walther et al 1992]	7
inflammatory pseudotumors of the bladder	7
on us appear as focal wall thickening	7
obstruction	7
esophagus: strictures, diverticula, dysmotility	7
thickening of bowel wall, fistulae	7
gastric wall thickening on us, ct, or mri	7
fungal sinusitis hyperdense	7
abscesses with typical appearance on mri with ring-enhancing lesions	7
treatment of colitis in cgd can be difficult	7
corticosteroid treatment of heightened inflammatory response	7
granulocyte infusions	7
granulocyte infusions are generally well tolerated	7
males with x-linked cgd	7
, they are kell negative)	7
kell-negative blood products are rarely available	7
antibacterial prophylaxis	7
antifungal prophylaxis	7
immunomodulatory therapy	7
9 months	7
13 to 0	7
4 per patient year	7
the data for this are anecdotal and unimpressive	7
for bsa >0	7
for bsa ≤0	7
5/m2 the dose is 1	7
5 μg/kg subcutaneously 3x/week	7
allogeneic hsct is the only known cure for cgd	7
, aspergillosis)	7
exposures	7
therefore, the following should be avoided:	7
exposure to mulch	7
potting of plants or gardening	7
raking leaves or mowing lawns	7
swimming in stagnant water, brackish water, or ponds	7
transfusion considerations	7
data regarding teratogenicity of itraconazole are limited	7
one had resolution of infection with 1	7
1% of neutrophils regaining gp91phox expression	7
neuropsychological assessment to identify and address possible psychosocial complications	7
clinical genetics consultation may be considered	7
splints can be tried for foot drop	7
the following are advised:	7
prevention of falls	7
eeg approximately every third year	7
seizure-provoking circumstances (e	7
, sleep deprivation, alcohol intake)	7
anticonvulsants that may worsen involuntary movements (e	7
, carbamazepine, lamotrigine)	7
when possible, clinical testing of visual fields	7
cardiac evaluation for cardiovascular anomalies	7
ent and audiologic evaluation:	7
evaluation for cleft palate, including submucous cleft palate	7
choanal atresia	7
feeding/swallowing dysfunction	7
renal evaluation	7
renal ultrasound examination is recommended in all children	7
coloboma	7
hearing loss should be assumed until proven otherwise	7
communication	7
deaf-blind service referral	7
referral to deafblind education services (e	7
frequent rest breaks may be needed	7
myofacial release can improve posture and flexibility	7
occasionally, sleep studies show obstructive apnea	7
gi consultation is often indicated	7
obsessive-compulsive disorder	7
pervasive developmental disorder	7
sensory processing issues are likely implicated	7
attention-deficit hyperactivity disorder	7
understanding this is critical to devising appropriate interventional strategies	7
facial palsy	7
frequent clinical and radiologic dental evaluations should be performed	7
prophylaxis for retinal detachment is not appropriate	7
screening to detect depression and assess need for psychosocial support	7
general	7
mitochondrial myopathy	7
assistance with ambulation and posture	7
surgical correction of ptosis as needed	7
amyotrophic lateral sclerosis	7
(als)	7
frontotemporal dementia (ftd)	7
spinal motor neuronopathy	7
neurologic examination including assessment of memory, personality changes	7
psychiatric abnormalities	7
assessment for signs including depression and suicidal ideation	7
impaired respiratory function	7
audiologic examination including speech discrimination testing	7
the following should be noted:	7
baclofen used to treat spasticity can sometimes worsen muscle weakness	7
clinical genetics and/or child neurology consultation	7
seizures should be managed by an experienced pediatric neurologist	7
avoid flickering lights that may provoke seizures	7
history of unexplained, persistent, or recurrent fever	7
cytopenia of at least two cell lines	7
signs of liver dysfunction including hypertriglyceridemia and/or hypofibrinogenemia	7
elevated serum ferritin concentration	7
elevated soluble interleukin-2 receptor level	7
evidence of hemophagocytosis in bone marrow and/or cerebrospinal fluid	7
comprehensive neurologic examination	7
screening for a history of frequent or unusual infections	7
screening for clinical signs of lymphoma	7
hematologic and immunologic defects	7
select individuals may also receive intrathecal methotrexate and prednisilone	7
once remission occurs, prompt hsct is recommended	7
correction of refractive errors may improve visual acuity	7
skin hypopigmentation	7
skin protection varies depending on the degree of hypopigmentation	7
neurologic abnormalities	7
immunizations are generally well tolerated and should be administered	7
intravenous ddavp (0	7
2-0	7
no guidelines for surveillance of classic chs exist	7
abdominal ultrasound examination to monitor for hepatosplenomegaly	7
cbc to evaluate for cytopenias	7
measurement of serum ferritin concentration	7
soluble interleukin-2 receptor measurement	7
all nonsteroidal anti-inflammatory drugs (nsaids) (e	7
the infants were normal	7
radiologic assessment to determine facial bone involvement	7
orthodontic assessment	7
assessment of family history	7
early treatment (i	7
testing	7
complete blood count with differential cell count	7
cd3, 4, 8, 19, 16/56	7
post-vaccine titers	7
other immunologic parameters:	7
allogeneic lymphocyte cytotoxicity (alc)	7
t-cell receptor excision circles (trec) analysis	7
t-cell repertoire	7
proliferation response to pha	7
proliferation response to anti-cd3	7
consultations	7
evaluation for evidence of respiratory disease	7
gastroenterologic	7
evaluation for congenital megacolon if clinical observation is suggestive	7
orthopedic surgery may be complicated by low bone density	7
early diagnosis of relatives (i	7
completely asymptomatic individuals need not be tested	7
no issues are known	7
however, experience is limited	7
optical coherence tomography (oct)	7
nutrition and ocular health have become increasingly topical:	7
evaluation of:	7
swallowing tests and esophageal manometry	7
eeg when seizures are observed or suspected	7
preparedness for appropriate countermeasures (e	7
an apnea monitor is recommended	7
anticonvulsants may be required	7
surgical instrumentation or prolonged	7
bracing may be required to correct a progressive thoracolumbar scoliosis	7
paradoxical sweating	7
treatment should be reserved for adults and older children	7
clonidine	7
oral clonidine, at starting doses of 0	7
05 mg to 0	7
1 mg four times daily may be required	7
abrupt cessation of clonidine can lead to prominent hypertension	7
moxonidine was well tolerated in the short term	7
however, long-term observations are not yet available	7
surveillance includes monitoring for evidence of scoliosis and its progression	7
females with ciss may conceive normally	7
no complications during pregnancy have been reported to date	7
the prescription of clonidine should not be discontinued abruptly	7
assess the size of the liver and spleen	7
all phenotypes	7
the treatment with therapeutic formulas is not lifelong	7
other treatments include the following:	7
saheki et al 2010	7
yazaki et al 2010	7
ohura et al, personal communication	7
okano et al, personal communication]	7
high-carbohydrate meals and alcohol should be avoided	7
arginine administration may be effective in preventing hyperammonemic crises	7
, height, weight, and head circumference	7
plasma citrulline concentration	7
serum psti concentration	7
low-protein/high-caloric (high-carbohydrate) diet	7
infusion of sugars including glycerol, fructose, and glucose	7
ultrasonography of abdomen to evaluate for hepatosplenomegaly	7
ophthalmologic examination including veps to evaluate for optic nerve atrophy	7
otorhinolaryngologic examination to evaluate for choanal stenosis	7
eeg to detect pathologic changes associated with neurodegeneration	7
neurologic examination to evaluate development	7
orthopedic treatment is often required for fractures and arthritis	7
a schulz and u kornak, unpublished results]	7
schulz and moshous, personal communication]	7
the possible manifestations and complications of osteopetrosis require repeat investigations	7
activities with high fracture risk should be avoided	7
complete physical examination	7
for those with significant neurologic problems:	7
no specific dietary or other metabolic treatment is available	7
developmental assessment and formulation of an intervention plan	7
radiographic assessment if clinically indicated	7
developmental, age-appropriate hearing assessment	7
ophthalmologic evaluation, including refraction and fundoscopy	7
evaluation of appropriate family members for signs of the condition	7
a trial of antiepileptic drugs (aeds) (e	7
treatment of behavioral problems is standard and requires periodic reassessment	7
periodic tests of hearing and vision	7
monitoring of the spine for the development of progressive kyphoscoliosis	7
no definitive treatments exist for the congenital muscular dystrophies	7
speech therapy may be indicated	7
close attention to oral hygiene is indicated	7
stretching exercises to prevent contractures	7
neurologic/neuropediatric examination	7
assessment of strength and motor function	7
respiratory care	7
polysomnography to identify individuals with nocturnal hypoventilation	7
assessment of contractures and joint deformities by physiatrists and orthopedists	7
medical treatment	7
acetylcholineesterase (ache) inhibitors (pyridostigmine)	7
3,4-diaminopyridine (3,4-dap)	7
quinidine, fluoxetine	7
however, it may induce suicidal ideation	7
non-medical treatment	7
orthotics or a wheelchair	7
a percutaneous gastric tube	7
these individuals should receive prophylactic anticholinesterase therapy	7
routine surveillance of muscle strength and respiratory function is recommended	7
symptoms of nighttime hypoventilation should be considered	7
data on pregnancies in cms are limited	7
exercise within the affected individual's capability	7
note: (1) fatigue may improve with exercise	7
wheelchair for mobility because of gait instability	7
lower urinary tract involvement [krhut et al 2014]	7
vocal cord paresis	7
regular evaluations to determine:	7
need for change in diet to control weight	7
need to involve specialists to evaluate and treat potential complications	7
obesity because of its negative effect on gait and balance	7
ophthalmologic examination for cataract	7
treatment may include:	7
ankle/foot orthoses	7
forearm crutches or canes	7
rarely, wheelchairs	7
career and employment counseling	7
forearm crutches or canes for gait stability for some individuals	7
fewer than 5% of individuals need wheelchairs	7
many remain physically active	7
no treatment reverses or slows the natural progression of cmt	7
nerve biopsy has shown lymphocytic infiltration	7
ile99thr) [donaghy et al 2000]	7
placebo in 110 subjects with cmt1a	7
the following may be indicated:	7
wheelchairs for mobility because of gait instability	7
no similar report on cmt2a exists	7
pulmonary function testing and dynamic breathing chest x-ray	7
skeletal x-rays to document any associated skeletal dysplasia	7
clinical genetics/genetic counseling consultation	7
for treatment of findings common to all	7
trpv4-associated disorders	7
pain and depression	7
neuropathy	7
vocal cord involvement	7
respiratory therapy/support (e	7
, bipap)	7
physical therapy/exercise to maintain as much function as possible	7
orthopedic evaluation with consideration of surgical intervention (i	7
patients undergoing surgical fusion typically do well	7
ent consultation with laryngoscopy	7
dynamic breathing chest x-ray	7
annual assessment for the development of joint pain and scoliosis	7
a child reaches school age	7
surgical procedures involving general anesthesia	7
for neuromuscular disorders	7
for skeletal dysplasias	7
appropriate treatment includes:	7
prosthetic and adaptive devices for weak hands	7
ankle/foot orthoses to correct foot drop and aid walking	7
fewer than 5% of affected individuals need wheelchairs	7
no specific pregnancy management recommendations have been published	7
treatment of spinal deformities	7
physiotherapy helps to preserve flexibility	7
treatment of foot deformities	7
physiotherapy to preserve flexibility	7
treatment of pain and cramps	7
, pregabalin, gabapentin)	7
cramps can be controlled with quinine	7
some need wheelchairs	7
physical activity (e	7
scoliosis needs to be closely followed	7
monitoring four times a year is recommended	7
the symptoms of cmt can worsen during pregnancy	7
in particular: cramps, subjective sensitivity (e	7
, paresthesias), difficulty walking, and fatigue	7
see grandis & shy [2005]	7
blockers of the neuromuscular junction should be used with caution	7
clinical genetics consultation and/or pediatric neurology consultation	7
surgery to correct spine deformities	7
wheelchairs as needed because of gait instability	7
pulmonary function tests to determine whether respiratory functions are compromised	7
no specific treatment reverses the manifestations of cmt4j	7
severely affected individuals need wheelchairs	7
bipap for those with respiratory muscle weakness	7
no obvious effect has been observed	7
ncv to determine axonal, demyelinating, or mixed features	7
pure tone audiograms, auditory brain stem response test	7
evaluation of visual acuity, fundoscopic examination	7
peripheral neuropathy	7
see charcot-marie-tooth hereditary neuropathy overview, management	7
measurement of growth	7
dermatologic evaluations	7
ophthalmologic evaluations (possibly including electroretinogram)	7
audiologic evaluation (including audiogram)	7
laboratory studies to assess renal and hepatic function	7
testing for diabetes mellitus and disorders of calcium metabolism	7
skeletal x-rays to document the presence of skeletal dysplasia	7
individualized educational program for developmental delay	7
feeding gastrostomy tube placement for failure to thrive	7
management of hearing loss	7
management of cataracts and other ophthalmologic complications	7
use of sunscreens for cutaneous photosensitivity	7
use of sunglasses for lens and retina protection	7
recommended measures:	7
physical therapy to prevent joint contractures	7
aggressive dental care to minimize dental caries	7
home safety assessments to prevent falls	7
yearly reassessment for known potential complications (e	7
, hypertension	7
renal or hepatic dysfunction	7
declining vision and hearing) is appropriate	7
excessive sun exposure should be avoided	7
gastrointestinal evaluation for feeding difficulties or poor growth	7
dietary evaluation by a nutritionist as needed	7
echocardiogram to evaluate for structural cardiac defects	7
spectacle correction of refractive errors	7
psychosocial support for affected individuals and their families	7
recurrent infections should be treated per standard therapy	7
growth and weight gain should be monitored	7
brain angiographic ct scan	7
ophthalmologic examination including fundoscopic examination and slit-lamp examination	7
kidney and liver ultrasound examination or ct	7
measurement of serum ck concentration	7
evaluation for the presence of hematuria	7
electrocardiogram (ecg)	7
no specific support exists for individuals with col4a1-related disorders	7
seizures are managed using standard protocols	7
glaucoma is initially treated with topical anti-glaucoma medication	7
annual clinical evaluation is reasonable	7
smoking because it increases the global risk of stroke	7
hypertension because it increases the risk of stroke	7
anticoagulant use [gould et al 2006]	7
neurologic evaluation including brain mri	7
renal evaluation with particular attention to the presence of proteinuria	7
audiometry with particular attention to possible sensorineural hearing loss	7
coenzyme q10 supplementation	7
coq4-related coenzyme q10 deficiency	7
coq6-related coenzyme q10 deficiency	7
homozygotes for the pathogenic variants p	7
gly255arg or p	7
ala353asp responded [heeringa et al 2011]	7
coq8b-related coenzyme q10 deficiency	7
pdss2-related coenzyme q10 deficiency	7
coq8a-related coenzyme q10 deficiency	7
coq9-related coenzyme q10 deficiency	7
plotting of growth parameters, including head circumference	7
most infants require nasogastric or gastrostomy feeding	7
pyloric stenosis is treated surgically	7
anecdotally, affected children have very high caloric needs	7
kyphoscoliosis may require surgical correction	7
dental abnormalities should be addressed by a pediatric dentist	7
papillomata	7
thus, cortisol deficiency may also be considered	7
malignant tumors	7
treatment of malignant tumors follows standard protocols	7
care should be individualized	7
sedation	7
however, studies are ongoing	7
growth hormone (gh) treatment	7
unproven benefit	7
true growth hormone deficiency requires gh replacement	7
cardiac hypertrophy	7
, kerr et al [2003])	7
info and ghr	7
nlm	7
nih	7
prevention of hypoglycemia reduces the risk of related neurologic damage	7
strength testing	7
review of dietary association of symptoms	7
current treatment for long-chain fatty-acid oxidation disorders:	7
avoid known triggers	7
infusions of glucose during intercurrent infections to prevent catabolism	7
note: oral glucose cannot achieve this effect	7
frequent meals and avoidance of extended fasting	7
avoidance of prolonged exercise and other known triggers	7
extended fasting and prolonged exercise are to be avoided	7
valproic acid [kottlors et al 2001]	7
ibuprofen	7
diazepam in high doses [bonnefont et al 1999]	7
acute fatty liver of pregnancy	7
maternal liver disease	7
radiologic assessment	7
endocrinologic tests to assess bone metabolism	7
treatment consists primarily of surgical intervention	7
spinal x-rays to evaluate for vertebral anomalies	7
cytokine administration may shorten the consolidation period	7
timing of subsequent craniofacial surgeries influences their success	7
limbs	7
, hydrocephalus, cognitive impairment)	7
six of 29 persons with the fgfr3 pathogenic variant p	7
neuropsychological assessment of cognition and speech	7
video documentation of movement disorder	7
eeg, if any clinical seizures	7
ecg and echocardiogram for cardiac involvement	7
behavior therapy for behavior problems by developmental pediatrician	7
seizure management with antiepileptic drugs by epilepsy specialist	7
treatment of movement disorder by movement disorder specialist	7
gamt deficiency	7
treatment is as follows:	7
4-0	7
8g/kg/day)	7
available databases (e	7
treatment outcome of symptomatic individuals with gamt deficiency	7
in 18% of individuals seizures were eliminated	7
in 49% seizure frequency decreased	7
improvement was seen in 60% of individuals	7
treatment outcome of asymptomatic individuals with gamt deficiency	7
agat deficiency	7
treatment outcome of symptomatic individuals with agat deficiency	7
treatment outcome of asymptomatic individuals with agat deficiency	7
crtr deficiency	7
the goal of treatment is to replenish cerebral creatine levels	7
treatment has included:	7
glycine 150 mg/kg bw/day in 3 doses	7
treatment outcome of individuals with crtr deficiency	7
for patients undergoing treatment:	7
perform neuropsychological assessment of cognitive functions and speech	7
assessment of visual acuity	7
assessment of refractive error	7
measurement of corneal thickness using pachymetry	7
spectacles or contact lenses for correction of refractive errors	7
management of strabismus	7
penetrating keratoplasty	7
most grafts remain clear after penetrating keratoplasty	7
patching to prevent amblyopia in children with strabismus is appropriate	7
electroretinography	7
dark adaptation (optional)	7
urinary organic acids	7
and urinary orotic acid	7
assessment of intracranial pressure and overall neurologic status	7
see acmg-act sheet, acmg algorithm	7
acute management of hyperammonemia	7
rapidly decreasing plasma ammonia concentration	7
scavenger therapy should be continued while dialysis is being performed	7
note: exchange transfusions have no place in hyperammonemic treatment	7
0-1	7
control of intracranial pressure	7
cerebral edema and ischemia may be documented by mri	7
chronic management	7
protein restriction	7
nitrogen scavenger therapy	7
as children grow, doses change to 9	7
9-13 g/m2/day of sodium phenylbutyrate and 8	7
4 g/m2/day of arginine	7
the initial dosage for phenylbutyrate-naïve patients is 4	7
5-11	7
2 ml/m2/day (5-12	7
4 g/m2/day)	7
living related-donor liver transplantation	7
monitoring should include:	7
success has not been achieved to date	7
in individuals who are initially diagnosed at any age:	7
height and weight, plotted on age-appropriate growth charts	7
glomerular filtration rate (gfr) or creatinine clearance test	7
lipid panel	7
renal ultrasound examination for evaluation of nephrocalcinosis	7
baseline ophthalmology evaluation, including a fundoscopic examination	7
renal fanconi syndrome	7
phosphate replacement to prevent and treat rickets	7
renal glomerular disease	7
renal transplantation	7
73 m2 and azotemia and hypertension rapidly progress	7
symptoms often determine the exact time of transplantation	7
retinal involvement is irreversible	7
nutrition must be adequate for growth	7
oral l-thyroxine replacement for hypothyroidism	7
insulin for diabetes mellitus	7
speech therapy and physical therapy	7
standard treatment for benign intracranial hypertension	7
other central nervous system complications are irreversible	7
3 to 1	7
95 g/m2/day)	7
procysbi® is taken every 12 hours	7
cysteamine increases gastrin synthesis and gastric acid production	7
55% solution with benzalkonium chloride 0	7
carnitine supplementation may improve muscle strength in pre-transplant individuals	7
in advanced disease (i	7
chest ct for detection of coronary and other vascular calcification	7
dehydration, which compromises remaining renal function	7
sun exposure, which can exacerbate photophobia	7
it is appropriate to evaluate relatives at risk (e	7
cardiologic evaluation including ekg and echocardiogram	7
evaluation for osteoporosis	7
chenodeoxycholic acid (cdca)	7
normalization of nerve conduction velocities and subsequent stabilization	7
cdca treatment may be more useful when started early	7
luyckx et al 2014]	7
coenzyme q10 (coq10) treatment may improve muscle weakness	7
calcium and vitamin d supplementation improve osteoporosis	7
recommended annual surveillance includes the following:	7
neurologic and neuropsychologic evaluation	7
cholestanol plasma concentration	7
measurement of total body density (tbd)	7
treatment with chenodeoxycholic acid should not be interrupted during pregnancy	7
ortolani sign for detection of hip dislocation	7
hip ultrasound examination as needed based on clinical findings	7
assessment for inguinal hernias	7
baseline neurodevelopmental evaluation	7
evaluation for a bleeding disorder linked to coagulation factor deficiencies	7
repair of inguinal hernia(s)	7
routine management of hip dislocation	7
routine management of refractive errors	7
antiepileptic drugs (aeds): valproate	7
or a combination of aeds can be used	7
psychological help as needed for self-image issues	7
holter monitoring, as arrhythmias develop when heart rate increases	7
exercise stress test both for diagnosis and monitoring of therapy	7
echocardiogram and/or mri to evaluate for structural defects	7
flecainide	7
secondary complications are mainly related to therapy	7
beta-blockers could worsen allergic asthma	7
the reasons for this are under investigation	7
these visits should include the following:	7
echo and mri at least every two years	7
competitive sports and other strenuous exercise are always contraindicated	7
dental examination for gingival and periodontal disease	7
granulocyte colony-stimulating factor (g-csf)	7
dale, unpublished observations]	7
, 5-10 µg/kg/day)	7
observation should include the following:	7
blood counts several times a year	7
otherwise serial ancs can be evaluated	7
other findings included:	7
unrelated cord blood transplantation for neutropenia is being investigated	7
consultation with a clinical geneticist or genetic counselor	7
however, urinary ne excretion exceeds normal levels	7
fludrocortisone, at dosages of 0	7
ptosis can be corrected by surgery	7
sinus problems should be treated as needed	7
the effect of droxidopa on renal function is unknown	7
plasma magnesium and potassium should also be assessed	7
adjustment of dosage may be required	7
dose adjustment may also be required post partum	7
mean lvef increased from 36% to 53%	7
measurement of reduced sphericity indicated improved ventricular geometry	7
scoliosis treatment as needed is appropriate	7
corticosteroid therapy	7
75 mg/kg/day or 1	7
5 and 0	7
6 mg/kg/day [fenichel et al 1991]	7
follow-up studies showed that a dose of 0	7
3 mg/kg/day [fenichel et al 1991]	7
35 mg/kg/day) in both dmd and bmd	7
4 mg/kg/day	7
at lower doses of 0	7
alternate-day dosing and intermittent dosing (e	7
side effects did not negatively affect quality of life	7
initiation and length of treatment	7
75 mg/kg/day, prednisone 0	7
published guidelines	7
the optimal maintenance dose of prednisone (0	7
3 mg/kg/day	7
5 mg/kg/day	7
3 mg/kg/day after three to four months	7
deflazacort (0	7
cardiorespiratory	7
nutritional	7
assessment if:	7
dysphagia is present	7
patient is chronically constipated	7
major surgery has been planned	7
patient is malnourished	7
muscular	7
physical therapy to promote mobility and prevent contractures	7
bone health	7
magnesium and parathyroid hormone levels may be considered	7
urine (calcium, sodium, creatinine)	7
dual energy x-ray absorptiometry (dexa) scanning	7
spine radiograph	7
if back pain is present	7
to exclude vertebral compression fracture	7
to assess degree of kyphoscoliosis if present on physical examination	7
interventions:	7
intravenous bisphosphonates	7
use of oral biphosphonates for prophylaxis or treatment remains controversial	7
dmd	7
evaluations should continue at least every two years	7
confinement to a wheelchair	7
reduction in vital capacity below 80% predicted	7
age 12 years	7
manual and mechanically assisted cough techniques	7
evaluation for surgical interventions as needed	7
individuals with dmd/bmd should avoid botulinum toxin injections	7
pregnancy management for heterozygous females	7
aminoglycosides	7
in a preliminary study in which gentamicin (7	7
boys who did not lose ambulation experienced a 67	7
a phase iii multicenter study is currently in progress	7
immunosuppression with azathioprine is not beneficial	7
myoblast transfer has been inefficient	7
however, no functional improvement was noted	7
the study was not powered to look for efficacy	7
comprehensive cardiovascular evaluation	7
evaluation for conduction system disease and arrhythmia:	7
, 24-hour monitoring or event monitors)	7
evaluation for left ventricular dysfunction and dcm:	7
measurement of serum ck concentration to evaluate for skeletal myopathy	7
elements of the guidelines include the following:	7
consider therapy based on cardiac phenotype (i	7
, dcm or arrhythmia)	7
cardiac conduction system disease and arrhythmias	7
, atrial or atrioventricular node ablations)	7
lmna-related dcm	7
whether conventional medical therapy (e	7
drugs (e	7
, coronary artery disease)	7
, left ventricular enlargement but normal function	7
neurologic/neuropediatric evaluation, including eeg and cerebral mri	7
epileptic seizures require antiepileptic drugs (aeds)	7
special adaptive chairs or positioners may be required	7
monitoring of seizure activity by regular neurologic examination and eeg	7
monitoring of orthopedic complications including foot deformity and scoliosis	7
affected males	7
neurologic evaluation for dystonia and ataxia	7
formal audiologic assessment	7
speech and language evaluation for assessment of speech therapy requirements	7
ophthalmologic evaluation, including erg	7
in adults, evaluation for dementia and/or psychiatric disturbance	7
carrier females	7
neurologic evaluation for focal dystonia	7
educational	7
spectacle correction is appropriate where indicated	7
agammaglobulinemia (see x-linked agammaglobulinemia)	7
annual audiologic assessment	7
live viral vaccines should be avoided if agammaglobulinemia is present	7
2 recurrent microdeletion, the following are recommended:	7
audiologic testing	7
manifestations of the 16p11	7
early diagnosis and provision of therapies facilitate the best outcome	7
referral to other appropriate medical specialists (sue	7
neurodevelopmental disabilities including asd	7
obesity and overweight	7
maintain an active lifestyle	7
chiari i malformation or syringomyelia	7
surveillance should include the following:	7
monitoring of height, weight, and bmi	7
clinical screening for scoliosis until the age of skeletal maturity	7
some medications used to treat behavioral problems (e	7
, scoliosis, lower-limb asymmetry)	7
periodic thyroid function screening	7
the spasms are responsive to acth	7
special feeding techniques or devices, e	7
structural anomalies (e	7
hypothyroidism is treated in a standard manner	7
complete physical and dysmorphology examination	7
specialty evaluation of obesity or failure to thrive	7
echocardiogram to evaluate for congenital cardiac anomaly	7
ophthalmology evaluation for strabismus and/or refractive errors	7
audiologic assessment for possible hearing loss	7
eeg for evaluation of seizures and treatment monitoring	7
1, although screening intervals are not delineated	7
the following are also appropriate:	7
ongoing routine pediatric care	7
assessment of renal function (measured or estimated gfr	7
urine protein excretion)	7
assessment for nephrocalcinosis and kidney stones by imaging studies	7
in children, evaluation of stature using standard growth charts	7
no guidelines have been established for treatment of dent disease	7
thiazide diuretics in doses greater than 0	7
however, their effectiveness has not been clear	7
detailed clinical history to establish seizure type and frequency	7
routine eeg	7
the response to antiepileptic drugs (aeds) is variable	7
ophthalmology evaluation for strabismus and hypermetropia	7
routine ophthalmologic management of strabismus, if present	7
ophthalmology evaluation for myopia and other ocular comorbidities	7
routine correction of refractive error	7
ent and audiology evaluations at least yearly	7
regular speech and language evaluation to monitor language development	7
individuals with hearing loss should avoid the following:	7
known environmental factors for hearing loss (e	7
, loud noises)	7
ototoxic medications	7
audiometry, including bone conduction testing	7
evaluations may include:	7
ophthalmologic evaluation for refractive errors	7
annual examination by a physician familiar with hereditary hearing impairment	7
see hereditary deafness and hearing loss overview for details	7
hearing habilitation	7
for those with nonsyndromic bilateral congenital hearing loss	7
hearing aids should be fitted as soon as possible	7
educational programs designed for individuals with hearing impairment are appropriate	7
for individuals with ts-nsan:	7
prevent febrile episodes	7
for individuals with nonsyndromic bilateral congenital hearing loss:	7
individuals with ts-nsan	7
avoid excessive body temperatures when possible	7
pure tone audiograms, auditory brain stem response testing	7
assessment of the vestibular function	7
see deafness and hereditary hearing loss overview	7
for both neonatal multisystem diseases and isolated hepatic disease	7
hepatic sonography and afp to screen for hepatocellular carcinoma	7
additional evaluation for neonatal multisystem diseases	7
measurement of plasma lactate and fasting blood sugar	7
neuroimaging may be considered	7
additional evaluation for isolated hepatic disease	7
management of neurologic manifestations in neonatal multisystem disease	7
hypotonia may be significant	7
the one-year survival rate was 64%	7
five of the 14 survived longer than five years	7
neonatal multisystem disease:	7
isolated hepatic disease	7
evidence of renal disease (proteinuria and aminoaciduria)	7
evaluation by a hematologist	7
ultrasound examination of the kidney and urinary tract	7
evaluation by a nephrologist and a urologist, as appropriate	7
evaluation by a cardiologist including echocardiography	7
corticosteroid administration	7
corticosteroids may be slowly tapered to the minimal effective dose	7
the recommended maximum maintenance dose is ≤0	7
red blood cell transfusion	7
7% ±10	7
1% ±11	7
survival was the best (92	7
cancer treatment	7
treatment of malignancies should be coordinated by an oncologist	7
mri for assessing iron loading in the liver and heart	7
deferasirox is recommended in individuals age two years or older	7
the recommended initial dose is 40 mg/kg/day	7
the maximum dose is 50-60 mg/kg/day	7
complete blood counts several times a year	7
monitoring of blood pressure in individuals who are steroid dependent	7
evaluation by an endocrinologist	7
cancer surveillance includes the following:	7
consideration of other testing (e	7
during pregnancy the maternal hemoglobin level must be monitored	7
intrauterine growth retardation	7
preeclampsia	7
retroplacental hematoma	7
in utero fetal death	7
, for clubfeet)	7
physical therapy may prevent early joint contractures	7
suggested studies to consider include:	7
thorough skin and nail examination	7
growth and development evaluation	7
ophthalmic	7
otolaryngology	7
gastrointestinal and hepatic	7
history of potential swallowing difficulties and/or enteropathy	7
baseline liver function tests	7
for males, assessment for urethral stenosis	7
consideration of baseline bone mineral density scan	7
history of any joint problems	7
if early-onset neurologic findings (e	7
consideration of bubble echocardiography to evaluate for pulmonary arteriovenous malformations	7
increased risk of cancer	7
comprehensive coordinated care among specialties is required	7
bone marrow failure (bmf)	7
, aggression, mood swings)	7
the suggested starting dose of oxymetholone is 0	7
hematopoietic growth factors may be useful in bmf	7
this risk has not been quantitated	7
studies are ongoing	7
individuals with dc should not smoke cigarettes or drink alcohol	7
bone marrow failure	7
individuals on androgen therapy for bone marrow failure	7
perform liver ultrasound examination semiannually for adenomas	7
annual cancer screening by an otolaryngologist	7
annual gynecologic examination	7
annual skin cancer screening by a dermatologist	7
oral and dental surveillance	7
schedule routine screening and dental hygiene visits every six months	7
maintain good oral hygiene	7
all blood products should be leukodepleted and irradiated	7
radiation	7
androgens and growth factors	7
cancer prevention	7
telomere length testing	7
they should be followed closely by a perinatologist	7
danazol may have fewer side effects than oxymetholone	7
in the acute setting, measurement/evaluation of:	7
blood acid-base status	7
plasma/serum concentration of lactate, glucose, and ammonia	7
plasma total and free carnitine	7
liver function and transaminases (alt/ast)	7
liver size via physical examination and/or ultrasonography	7
cardiac size via echocardiography	7
after metabolic stability has been achieved:	7
clinical assessment of physical growth and development status	7
formal ophthalmologic evaluation if concern for vision loss	7
dld pathogenic variants cause variable deficiency in three enzymatic pathways	7
branched chain alpha-ketoacid dehydrogenase (bckdh) complex	7
α-ketoglutarate dehydrogenase (αkgdh) complex	7
pyruvate dehydrogenase (pdh) complex	7
early-onset neurologic presentation	7
review of treatment strategies	7
protein/bcaa-restriction	7
ketogenic/high-fat diet	7
five had no clinical or biochemical benefit	7
two improved clinically	7
carbohydrate tolerance	7
dichloroacetate (dca)	7
additional therapies used with limited success include:	7
lipoic acid	7
biotin	7
empiric recommendations	7
for acute management (based on the above review)	7
this is typically achieved by the following:	7
promotion of an anabolic state:	7
maintain serum glucose concentration in the normal range	7
protein should then be reintroduced gradually	7
hepatic presentation	7
correction of metabolic acidosis with sodium bicarbonate	7
correction of any coagulopathy with fresh frozen plasma	7
avoidance of liver-toxic medications	7
episodes of catabolic stress (e	7
as such, empiric recommendations include the following:	7
supplement with levocarnitine if deficient	7
avoid liver-toxic medications	7
catabolic stressors	7
liver-toxic medications	7
initial treatment	7
long-term medical management	7
caution:	7
high doses are usually required (0	7
4-1	7
0 mg/kg/day of glibenclamide)	7
transfer protocols are available at www	7
diabetesgenes	7
high caloric intake should be maintained to achieve weight gain	7
glycemic targets for children younger than age six years:	7
90-130 mg/dl before meals	7
90-150 mg/dl at bedtime/overnight	7
hemoglobin a1c value < 7	7
urinalysis for microalbuminuria	7
ophthalmologic examination to screen for retinopathy	7
neurologic examination and developmental assessment	7
brain mri scan if evidence of developmental delay or hypotonia	7
serum glucose concentration	7
c peptide measurement	7
pancreatic beta cell autoantibody measurements	7
liver function and thyroid function tests	7
a pediatric endocrinology consultation for follow up of diabetes	7
insulin can be discontinued when blood glucose concentrations stabilize	7
, some residual endogenous insulin remains)	7
note: macroglossia could potentially cause airway obstruction	7
, at least every six months)	7
developmental assessment to identify any special educational needs is appropriate	7
general factors that predispose to late-onset diabetes (e	7
recommendations vary by underlying genetic mechanism:	7
past medical history to determine extent of autonomic involvement	7
currently no effective treatment exists for any type of hsan	7
sensory impairment	7
dementia	7
perform annual routine clinical testing for dementia:	7
observation of behavior	7
perform annual audiogram	7
neuroimaging (preferably mri scan)	7
detailed ophthalmologic examination including glaucoma screening	7
quantitative urine protein determination	7
eeg if symptoms suggest a seizure disorder	7
provision of corrective lenses for myopia	7
treatment of retinal detachments or glaucoma	7
antiepileptic drugs for seizures	7
frequent and serial monitoring is needed	7
the schedule should be determined by the findings present	7
treatments (e	7
neurologic examination to assess the severity of motor disturbances	7
gradual increase to higher doses is recommended	7
discontinuation of levodopa treatment usually results in return of symptoms	7
two women reported mild deterioration of dystonia	7
an increase in dose was required in one	7
eeg in the presence of seizures	7
head mri to monitor progression of the disease	7
neuropsychological testing for evidence of dementia and psychiatric disturbance	7
consultation with a rehabilitation therapist	7
for affected children, adaptation of educational programming to abilities	7
surveillance is individualized based on disease progression	7
see mothertobaby	7
org for further information on medication use during pregnancy	7
baseline cbc to evaluate for thrombocytopenia and/or leukocytosis	7
duane anomaly	7
severe strabismus may require eye surgery	7
radial ray malformations	7
hearing deficits	7
hearing aids may be required	7
in those with cardiac malformations or conduction defects:	7
in those with renal anomalies:	7
the frequency depends on the clinical situation	7
certain medications may be contraindicated in individuals with arrhythmias	7
evaluation for aberrant movements	7
the following may be considered:	7
nonsurgical treatment of ophthalmologic findings	7
surgical treatment of ophthalmologic findings (extraocular muscle surgery)	7
to correct or improve compensatory head posture	7
to improve upshoot or downshoot	7
principles of surgical approach as reviewed in	7
kekunnaya et al [2015]	7
type 1 and type 3	7
type 2	7
approach for non-treatment	7
approach for treatment	7
the galactose challenge	7
for example:	7
, after the introduction of solid foods)	7
assessment of possible feeding difficulties associated with hypotonia	7
neurologic examination including assessment for seizure activity and baseline eeg	7
supportive care may include the following:	7
occupational and physical therapy	7
alternative and augmentative communication	7
behavioral therapy (e	7
, applied behavioral analysis therapy)	7
psychotropic medications for behavioral manifestations	7
many of these are preventable	7
ongoing pediatric care with regular immunizations is indicated	7
periodic neurodevelopmental and/or developmental/behavioral assessments	7
seizure triggers (e	7
2-q13	7
currently, no clinical trials for dup15q exist	7
seizures should be managed by a neurologist using standard practice	7
plotting of growth parameters	7
evaluation by a cardiologist	7
genitourinary system evaluation	7
ultrasound examination of the kidneys	7
physical examination of males for cryptorchidism	7
baseline ophthalmologic evaluation	7
occupational therapy (including assessment for sensory integration difficulties)	7
social skills	7
intellectual abilities	7
adaptive behavior	7
vocational skills	7
attention problems	7
oppositional behavior/aggression	7
autism spectrum disorder screening	7
childhood apraxia of speech	7
anxiety/selective mutism	7
autism spectrum disorder (asd)	7
attention deficit hyperactivity disorder (adhd)	7
aggression	7
applied behavior analysis intervention is recommended	7
oppositionality	7
specific medical problems are treated in the following ways:	7
hydrocephalus as needed with ventriculo-peritoneal shunting	7
aortic dilation with beta blocker therapy in some affected individuals	7
strabismus in the usual manner	7
recurrent otitis media in the usual manner	7
poor feeding in infants	7
feeding therapy	7
human growth hormone replacement therapy	7
club feet	7
casting	7
interval/age	7
infancy	7
every 3 years	7
assessment of intellectual abilities & academic achievement	7
adolescents/adults	7
2 duplication, the following are recommended:	7
educational program should be tailored to individual needs	7
sleep history and sleep evaluation if necessary	7
musculoskeletal examination for signs of hypertonia and spine curvature anomalies	7
orthopedic referral if needed	7
physical therapy evaluation regarding interventions needed to achieve optimal ambulation	7
the following baseline evaluations:	7
educational programs to address the specific needs identified	7
speech therapy directed at improving communication skills	7
therapeutic management of sleep disturbances if necessary	7
early intervention with occupational therapy for feeding problems	7
consideration of tube feeding for severe persisting feeding problems	7
monitoring and guidance as needed for educational and behavior problems	7
regular lifelong dietary evaluation to assure optimal nutritional status	7
regular lifelong evaluations of the following:	7
heart: based on the type of congenital anomaly	7
thorough history, including family history	7
consideration of occupational and/or physical therapy evaluation	7
anticholinergics (e	7
, trihexyphenidyl)	7
if medications fail	7
, prior to sufficient medication trials)	7
detailed medical history of the individual	7
acetazolamide	7
sulthiame 50-200 mg daily may reduce the attack rate	7
known triggers of attacks should be avoided	7
neurologic examination for signs of interictal ataxia and nystagmus	7
this medication is generally well tolerated	7
acetazolamide could stabilize channels that fail to properly inactivate	7
phenytoin has been reported to exacerbate symptoms	7
surgical intervention is required to correct pyloric atresia	7
many children need medical treatment for gastroesophageal reflux disease	7
use of soft and properly fitted clothing and footwear	7
selenium and carnitine replacement for possible prevention of dilated cardiomyopathy	7
see junctional epidermolysis bullosa: management, therapies under investigation	7
primary layers may include any the following:	7
ordinary band-aids®	7
non-stick products (e	7
, telfa® or n-terface®)	7
, mepitel® or mepilex®)	7
other nutritional deficiencies must also be addressed:	7
calcium and vitamin d supplementation for osteopenia and osteoporosis	7
selenium and carnitine replacement to help prevent dilated cardiomyopathy	7
zinc replacement to enhance wound healing	7
occupational therapy may be helpful in preventing progressive hand contractures	7
psychosocial support including social services and psychological counseling is essential	7
aureus (mrsa) and pseudomonas	7
aeruginosa	7
allogenic transplantation of fibroblasts [fritsch et al 2008]	7
a lane, stanford university, personal communication]	7
woodley et al 2013]	7
bone marrow transplantation:	7
evaluation for existing osteopenia through skeletal radiographs or dexa scan	7
ordinaryband-aids®	7
silicone-based products provide a good substitute for tape	7
dressings usually involve three layers:	7
some individuals with ebs can use ordinary bandages	7
foam dressings and/or rolls of gauze (e	7
, one-layer) dressing	7
infection is the most common secondary complication	7
surveillance for infection and proper wound healing is indicated	7
excessive heat may exacerbate blistering and infection in ebs	7
avoiding activities that traumatize the skin (e	7
no clinical trials have been carried out	7
no rigorous clinical trials have been undertaken	7
dystrophic nails	7
in many cases, wigs are helpful	7
palmoplantar hyperkeratosis	7
skin emollients may help relieve palmoplantar hyperkeratosis	7
elicitation of pain history	7
assessment of joint mobility	7
radiographs to determine the extent and severity of joint involvement	7
however, pain can be difficult to control	7
obesity, which increases stress on joints	7
exercise that causes repetitive strain on affected joints	7
height measurement	7
career counseling is recommended	7
radiographic surveillance by an orthopedist is appropriate	7
sports involving joint overload are to be avoided	7
note: electrophysiologic study is often advisable in edmd	7
more advanced and invasive cardiac assessment may be required	7
monitoring of respiratory function	7
caesarean section delivery may be required	7
evaluation of joint mobility with use of the beighton score	7
evaluation for hypotonia and motor development in infants and children	7
evaluation of clotting factors if severe easy bruising is present	7
deep stitches should be applied generously	7
anti-inflammatory drugs may help with joint pain	7
cardiovascular problems should be treated in a standard manner	7
however, there is no limitation	7
acetylsalicylate (aspirin)	7
modalities must be tailored to the individual	7
assistive devices	7
braces are useful to improve joint stability	7
pain medication	7
adjustments may be necessary for other populations	7
nsaids (nonsteroidal anti-inflammatory drugs) (e	7
cox-2 inhibitors (e	7
they are also sometimes helpful in treating neuropathic pain	7
all require gradual titration before reaching therapeutic levels	7
topiramate and lamotrigine have also been used successfully	7
nausea is the most common side effect	7
routine use of benzodiazepines is not recommended	7
medication precautions	7
abrupt cessation of anti-seizure medications can precipitate a seizure	7
when discontinuing, they should be tapered gradually	7
severity can range from mild to life threatening	7
surgery and other procedures	7
anesthetic nerve blocks can provide temporary relief of neuropathic pain	7
for severe bleeding (e	7
other treatable causes, such as h	7
pylori infection, should be investigated	7
rarely, severe enlargement (>4	7
5-5	7
0 cm) requires surgical evaluation	7
periodontal disease should be identified and treated	7
temporomandibular joint laxity and dysfunction are difficult to treat	7
there are no specific interventions of proven benefit	7
intra-oral devices are sometimes helpful	7
antidepressants are also of great benefit	7
consumer support groups are available and can be very beneficial	7
joint hyperextension may not need to be avoided	7
resistance exercise can exacerbate joint instability and pain	7
labor and delivery may progress very rapidly	7
there is no clear advantage to vaginal vs	7
cesarean delivery	7
, the uterus in pregnancy)	7
trauma	7
arteriography	7
furthermore, injection pressure may lead to arterial aneurysms	7
routine colonoscopy	7
elective surgery	7
evaluation for kyphoscoliosis	7
bracing may be required to support unstable joints	7
swimming is recommended	7
vascular surgery is fraught with danger	7
routine examination for inguinal hernia and surgical referral as necessary	7
vigilant observation of blood pressure	7
delivery should be performed in a medical center	7
, dystonia)	7
feeding evaluation & nutrition assessment	7
referral to appropriate feeding therapist and/or nutritionist as indicated	7
assessment for chronic diarrhea	7
referral to gastroenterologist as needed	7
referral to orthopedist as needed	7
miscellaneous /other	7
antispastic medications	7
muscle relaxants	7
severe diarrhea	7
maintain hydration & caloric intake	7
tube feeding often necessary	7
poor energy metabolism & oxidative stress	7
enrollment in developmental disabilities administration (dda) is recommended	7
, feeding, grooming, dressing, writing)	7
all affected individuals should receive routine immunizations	7
as well as annual immunizations for influenza	7
surveillance should be individualized based on symptoms and organs affected	7
evaluation/action	7
frequency	7
assess growth and monitor for failure to thrive	7
at each visit	7
monitor for epileptic crisis	7
modify therapy according to clinical presentation and eeg findings	7
3d-ct scan	7
lung function test	7
mr angiography (mra) from head to pelvis	7
routine repair is appropriate	7
pulmonary emphysema is treated symptomatically	7
no definitive treatment is available	7
based on experience in other related disorders (e	7
aortic aneurysm replacement has been performed successfully	7
joint hypermobility can be supported by muscle reinforcing physical therapy	7
annual mra from head to pelvis	7
cigarette smoking, which can worsen emphysema	7
sun tanning, which can damage skin	7
palatal evaluation for cleft palate	7
cardiac evaluation with an echocardiogram to screen for cardiac defects	7
renal ultrasound examination to evaluate for structural kidney anomalies	7
feeding and swallowing assessment	7
urologic evaluation in males with cryptorchidism and/or micropenis	7
standard management of gastroesophageal reflux	7
standard interventions for:	7
cardiac defects	7
hip dysplasia and other skeletal complications	7
cryptorchidism and/or micropenis	7
refractive errors, strabismus, or other ophthalmologic issues	7
seizures, if present	7
hemoglobin concentration and reticulocyte count to evaluate severity of disease	7
serum bilirubin concentration	7
transfusion history	7
serum ferritin concentration to evaluate iron load status	7
abdominal ultrasound examination to evaluate:	7
for evidence of cholelithiasis when symptoms are present	7
then 1 mg 1x daily thereafter)	7
prevnar-13® and h	7
the incidence of post-splenectomy sepsis varies among studies	7
cholecystectomy	7
note: when indicated, splenectomy is curative	7
contact sports are not advisable in those with splenomegaly	7
valproic acid is the first drug of choice	7
it diminishes myoclonus and the frequency of generalized seizures	7
the phototoxic pain is not responsive to narcotic analgesics	7
tanning products	7
β-carotene	7
hepatic complications may be accompanied by motor neuropathy	7
pregnancy is not complicated by epp	7
the pain is not responsive to narcotic analgesics	7
sun creams containing a physical reflecting agent (e	7
there is no information on pregnancy management in xlp	7
reports on treatments in a series involve heterogeneous populations	7
cooling the extremities reduces pain in a symptomatic person	7
01) [mork et al 2004]	7
experts have reported typically mild to moderate pain relief	7
remissions (i	7
carbamazepine	7
oxcarbazepine use in treating em has not been reported	7
topical application of 1	7
0% amitriptyline hydrochloride and 0	7
calcium antagonists	7
magnesium	7
cyclosporine was successful in one person with erythromelalgia	7
sympathetic block, surgical sympathectomy, and epidural infusion	7
amputation has occasionally been necessary to treat these complications	7
in some individuals, exercise can trigger symptoms	7
small molecule inhibitors of the scn9a encoded sodium channel nav1	7
7 have been developed	7
orthopedic evaluation to assess joint contractures and scoliosis	7
electroencephalography in those with suspected liability of seizures	7
the main problems to manage are:	7
adaptation of education to the level of cognitive handicap	7
epilepsy, which is amendable to standard treatments	7
regular examinations to address:	7
joint contractures and scoliosis	7
development or management of epileptic seizures	7
detailed history of symptoms from osteochondromas	7
osteochondromas require no therapy in the absence of clinical problems	7
leg-length inequalities greater than 2	7
surgical resection is the treatment for sarcomatous degeneration	7
encroaching lesions and those causing symptoms may merit excision	7
ultrasound examination of the kidneys and urinary tract	7
formal hearing evaluation	7
evaluation by a clinical geneticist and genetic counseling	7
3% (±5	7
9%) [mehta et al 2017]	7
mds/aml treatment remains challenging	7
solid tumors	7
annual evaluation with a multidisciplinary team including an endocrinologist	7
individuals receiving androgen therapy	7
liver function tests every three to six months	7
annual gynecologic assessment for genital lesions beginning at age 13	7
suspicious genital tract lesions should be biopsied	7
unsafe sex practices increase the risk for hpv-associated malignancy	7
examination of the skin for angiokeratomas	7
formal audiology assessment	7
acroparesthesia	7
diphenylhydantoin	7
a potential side effect of diphenylhydantoin is gingival hypertrophy	7
carbamazepine has similar effects	7
chronic hemodialysis and/or renal transplantation have become lifesaving procedures	7
therefore, successful renal transplantation corrects renal function	7
2 mg/kg every 2 weeks)	7
06) [banikazemi et al 2007]	7
the largest comparative study is the canadian fabry disease initiative	7
3 g/kg every other week	7
and compliance should be closely monitored	7
blood pressure control optimized	7
at age 12-13 years in asymptomatic boys	7
annual or more frequent renal function studies	7
annual cardiology evaluation	7
annual audiology evaluation	7
biennial brain mri/mra	7
therefore, affected individuals should be discouraged from smoking	7
measure α-gal a enzyme activity	7
dgj	7
migalastat amicus therapeutics, nj, usa)	7
alternative enzyme therapy	7
substrate reduction therapy for fabry disease has a biochemical rationale	7
evaluation in high-risk individuals (i	7
thrombosis	7
5 (therapeutic range 2	7
prophylactic anticoagulation	7
however, the indications for family testing are unresolved	7
pharmacologic and surgical interventions have focused on palliation of symptoms	7
weighted gloves can sometimes be used to assist with dysmetria	7
ablative pallidotomy or thalamotomy	7
assessment of ambulation, speech, and swallowing	7
regular review of communication needs and environmental adaptations	7
no serious treatment-related adverse events occurred	7
currently, consensus management guidelines for gapps are unavailable	7
colonic polyps	7
types of colectomy include the following:	7
total colectomy with ileorectal anastomosis (ira)	7
this is a single-stage procedure	7
total proctocolectomy with permanent ileostomy	7
the choice of procedure depends on the clinical circumstances	7
small-bowel polyps	7
osteomas may be removed for cosmetic reasons	7
desmoid tumors	7
nsaids	7
in individuals known to have fap	7
colonoscopy, once polyps are detected	7
spigelman staging criteria can help determine the frequency	7
non-fundic gland polyps should be removed endoscopically	7
thyroid cancer	7
annual abdominal palpation for desmoids	7
small-bowel polyps and cancer	7
screening for hepatoblastoma	7
efficacy in individuals with fap is unclear	7
in individuals who have undergone colectomy	7
in individuals known to have attenuated fap	7
colectomy	7
in individuals known to have gapps	7
surgery and desmoid risk	7
individuals at high risk for desmoids (women	7
those with apc pathogenic variants in codons 1395-1493	7
surgery and fecundity	7
recommended genetic testing for at-risk family members	7
pregnancy/fertility/hormone use	7
trials with similar agents are being planned	7
curcumin is the main component in the spice turmeric	7
kidney ultrasound examination	7
if clinically indicated:	7
barium enema	7
voiding cystouretrogram (vcug)	7
appropriate treatment for:	7
routine repair	7
cutis laxa	7
pulmonary emphysema	7
no treatment available	7
attention to respiratory function prior to surgery	7
prophylactic antibiotics (cotrimoxazole) in case of vesicoureteral reflux	7
smoking is contraindicated	7
ent	7
cardiac evaluation w/electrocardiogram & echocardiography	7
consider referral to cardiology if results are abnormal	7
swallowing assessment for feeding difficulties	7
neurology consultation including comprehensive neurologic examination	7
brain mri to evaluate extent of the disease	7
electroencephalogram	7
if there is a history of seizures	7
complete blood count to evaluate for neutropenia	7
no definite treatment is available to date	7
inadequate nutrition	7
standard treatment w/antiepileptic drugs	7
immobility/wheelchair dependence	7
, wheelchair	7
cardiomyopathy and arrhythmia	7
standard treatment per cardiology recommendations	7
consider granulocyte colony stimulating factor 2	7
significant acidosis	7
consider bicarbonate therapy	7
cataract and/or strabismus	7
surgical treatment if indicated	7
hearing aids	7
regular immunization to prevent life-threatening infections is indicated	7
no surveillance guidelines have been published	7
table 6	7
continued assessment of nutrition and growth	7
regular neurologic evaluations & developmental assessments	7
neurologic evaluation, including eeg and brain mri	7
physical therapy evaluation of joint range of motion	7
assessment of caloric intake and nutritional status	7
there is no definite treatment for fcmd	7
monitoring for orthopedic complications such as foot deformity and scoliosis	7
prompt treatment of acute respiratory tract infections	7
antiepileptic drugs (aeds) when indicated	7
surgical treatment for gastroesophageal reflux when indicated	7
gastrostomy when indicated to assure adequate caloric intake	7
routine therapy of cardiomyopathy	7
monitoring for foot deformities and scoliosis	7
standardized intelligence tests	7
frequently demonstrate better verbal than motor performance	7
electroencephalography	7
magnetic resonance imaging (mri)	7
feeding problems	7
maintain adequate nutrition and avoid aspiration	7
gastroesophageal reflux	7
orthostatic hypotension	7
counter-maneuvers (e	7
squatting had the greatest effect	7
kidney and bladder	7
bradyarrhythmia	7
soft contact lenses can promote corneal healing	7
corneal transplantation has had limited success	7
spinal fusion may be necessary	7
many adults use walkers or wheelchairs when outside the home	7
sialorrhea is a common	7
use of general anesthetics requires adequate hydration	7
exercise can help correct or prevent secondary contractures	7
routine assessment of growth in children	7
follow-up frequency depends on findings	7
screening for sleep-disordered breathing with polysomnography	7
periodic assessment of psychomotor development and behavior in children	7
symptoms tend to be worse in hot or humid weather	7
environmental situations associated with hypobaric hypoxia (e	7
visceral pain related to contractions during labor is perceived normally	7
therefor, analgesia should be provided	7
kinetin	7
5 mg/kg/d for 28 days	7
002)	7
long-term clinical trials are warranted	7
induced pluripotent stem cells (ipscs)	7
tocotrienols	7
pregabalin	7
phosphatidylserine (ps)	7
digoxin	7
cardiac investigation (echocardiogram)	7
renal ultrasound to evaluate for structural abnormalities	7
audiometry for the possibility of hearing loss	7
neuropsychological evaluation if there are concerns about psychomotor development	7
analysis of the family pedigree for other possible affected individuals	7
surgical treatment of gastrointestinal atresia when present	7
follow up and treatment of possible cardiac and renal anomalies	7
treatment for significant hearing loss	7
developmental or educational intervention for children with learning difficulties	7
ophthalmologic examination, including indirect ophthalmoscopy and scleral depression	7
retinal avascularity per se often requires no treatment	7
however, retinal traction continued to progress	7
developmental and behavioral assessment	7
neurologic history and examination for evidence of seizures and hypotonia	7
evaluation for evidence of spasticity in individuals with fgs1	7
examination for evidence of anal anomalies in individuals with fgs1	7
examination for evidence of genitourinary anomalies	7
cardiology evaluation with echocardiogram	7
audiology evaluation in individuals with xlos	7
individualized management of behavior problems	7
neurologic management of seizures	7
standard management of chronic constipation for individuals with fgs1	7
annual audiology evaluation for evidence of hearing loss in xlos	7
regular dental evaluations for individuals with xlos and ls	7
renal ultrasound examination and blood pressure assessment	7
assessment for cryptorchidism in males	7
orthopedic assessment of hip dysplasia and clavicular anomalies	7
communication rehabilitation with sign languages or alternative means of communication	7
standard treatment for any of the following if identified:	7
refractive errors and strabismus	7
investigation for celiac disease if indicated by clinical features	7
blood pressure measurement and assessment of renal function	7
standard monitoring for renal anomalies	7
spondylocarpotarsal synostosis (sct) syndrome	7
ophthalmologic examination for retinal anomalies	7
audiometry to assess for sensorineural hearing loss	7
cervical spine films to evaluate for cervical dysplasia	7
larsen syndrome	7
audiometry to assess hearing	7
assessment of the hips for dislocation	7
large joint dislocations	7
scoliosis is treated medically	7
no effective surgical intervention has been described	7
club feet are managed in a routine manner	7
vertebral anomalies can lead to progressive scoliosis	7
orthopedic monitoring is therefore indicated	7
physical examination to assess joint problems	7
urinalysis for the presence of protein	7
febrile and inflammatory episodes are usually treated with nsaids	7
colchicine	7
homozygotes/compound heterozygotes	7
individuals who are homozygous for the pathogenic variant p	7
met694val or compound heterozygous for p	7
children may need 0	7
5-1 mg/day according to age and weight	7
affected individuals should receive colchicine for life	7
individuals who do not have the p	7
glu148gln	7
heterozygotes	7
treatment of affected individuals who are unresponsive to colchicine	7
some individuals appear to be unresponsive to colchicine treatment	7
weekly intravenous colchicine (1	7
this is not a long-term solution	7
the possibility of interferon alpha side effects (e	7
, chills and fatigue) should also be considered	7
sulphasalazine	7
she was homozygous for the pathogenic variant p	7
treatment with colchicine 1	7
met694val pathogenic variant	7
cisplatin	7
met694ile [sasaki et al 2009]	7
this is especially important when the p	7
ectodermal manifestations	7
limb and skeletal manifestations	7
eye findings	7
oral and dental findings	7
evaluation by a cleft palate team if relevant	7
gastrointestinal and nutrition	7
consideration of abdominal ultrasound examination to evaluate for diaphragmatic hernia	7
renal and urogenital	7
evaluation by a pediatric gynecologist prior to puberty	7
cognitive and psychological	7
camptodactyly often improves with physical and occupational therapy	7
consultation with:	7
the papillomas may be friable and prone to bleeding	7
regular examinations	7
assessment by a pediatric neurologist to determine baseline neurologic status	7
baseline (and follow-up) formal cognitive testing	7
initial evaluation and follow up by a metabolic genetic specialist	7
folate formulations	7
leucovorin is available in oral and parenteral formulations	7
neither drug is available for parenteral administration	7
deplin® is available as a 15-mg tablet	7
folate dosing	7
with intramuscular injections of approximately 1	7
serum and csf folate concentrations	7
serum and csf homocysteine concentrations	7
poncz & cohen 1996	7
min et al 2008	7
goldman, personal communication to author]	7
family history of speech disorder	7
assessment of oral motor function including:	7
examination for evidence of oral motor dyspraxia (e	7
, ‘kiss and blow’	7
social skills assessment for the presence of autistic features	7
additional evaluations:	7
speech and language deficits	7
no single recommended treatment exists	7
dysarthria [pennington et al 2009]	7
language deficits [law et al 2003]	7
literacy impairments [snowling & hulme 2012]	7
cognitive deficits	7
fine and gross motor deficits	7
routine care by a general pediatrician	7
cardiac auscultation for mitral valve prolapse	7
assessment for hypertension	7
history for possible seizure activity	7
ophthalmologic evaluation for possible strabismus	7
behavioral and psychological assessment	7
neuroradiologic evaluation	7
therapy must be individualized and closely monitored	7
speech and swallowing assessment	7
assessment for significant scoliosis	7
assessment by an orthopedic surgeon, as needed	7
ecg and echocardiogram for evidence of cardiomyopathy	7
assessment by a cardiologist if abnormal	7
random blood glucose concentration for evidence of diabetes mellitus	7
ophthalmologic assessment if ophthalmologic symptoms are present	7
hearing assessment and referral for amplification apparatus if required	7
psychological assessment	7
there is little objective evidence regarding management of frda	7
speech therapy to maximize communication skills	7
treatment of sleep apnea by continuous positive airway pressure	7
measures include the following:	7
curefa	7
org]	7
the following are appropriate	7
annual fasting blood sugar to monitor for diabetes mellitus	7
alcohol can exacerbate ataxia and should be consumed in moderation	7
, rough surfaces) should be avoided	7
a summary of therapies under investigation can be found online	7
coenzyme q10 and vitamin e	7
idebenone has shown promise as a treatment for frda:	7
results from this study have not yet been published	7
nonspecific iron chelators (e	7
a clinical trial was terminated for lack of efficacy	7
neurologic benefit was suggested	7
increasing frataxin levels	7
a placebo-controlled study is to commence shortly	7
chest and abdominal radiographs	7
cranial ultrasound examination	7
in fryns syndrome, additional anomalies may dictate further consultations	7
see also congenital diaphragmatic hernia overview	7
there are no specific surveillance guidelines for fryns syndrome	7
physical examination to assess strength and functional limitations	7
evaluation for physical therapy and need for assistive devices	7
assessment of hearing if the individual has symptomatic hearing loss	7
ophthalmologic evaluation for the presence of retinal telangiectasias	7
physical therapy and rehabilitation	7
consultation with a physical therapist is indicated	7
exercise in fshd	7
orthopedic intervention	7
no additional audiometry screening of asymptomatic individuals is necessary	7
annual dilated ophthalmoscopy in childhood is indicated	7
the injections were fairly well tolerated	7
medium dose: 2	7
2% increase	7
high dose: 5	7
3% increase in size)	7
a general medical history and family history	7
there is no consensus treatment guideline for ftd3	7
detailed general, neurologic, and family history	7
physical, neurologic, and cognitive examination	7
individuals with seizures are treated with antiepileptic drugs	7
evaluation by a pediatric neurologist	7
this evaluation will likely include a brain mri study	7
feeding assessment and evaluation of nutritional status	7
nutritional intervention (e	7
wheelchairs can be useful for some individuals	7
, intermittent thrombocytopenia and/or lymphopenia)	7
consultation with a cardiologist to evaluate for congenital heart disease	7
renal and pelvic ultrasound examination to look for urogenital malformations	7
growth parameters in children and pubertal development in adolescents	7
, growth hormone, gonadotropins, thyroid hormone)	7
biochemical investigations to look for abnormalities in the lipid profile	7
5x109/l can vary greatly among patients	7
fevers and infections require prompt treatment with antibiotics	7
routine management of hormone deficiencies	7
chemotherapy and hematopoietic stem cell transplantation for acute myelogeneous leukemia	7
, absolute neutrophil counts above 0	7
5x109/l)	7
monitoring of growth in children and pubertal development in adolescents	7
biochemical profile including lipid profile	7
monitoring for development of varicose veins, especially in adults	7
monitoring for osteopenia/osteoporosis	7
, evidence of autosomal recessive hypophosphatemic rickets)	7
pediatric cardiology consultation including:	7
include cervical films to evaluate for cervical spine fusion	7
audiologic assessment for conductive or sensorineural hearing loss	7
pediatric nephrology consultation in the setting of refractory hypertension	7
treatment of arterial calcification	7
bisphosphonate therapy	7
026, log-rank test)	7
the dose of pamidronate has varied from 0	7
cardiovascular treatment	7
anti-hypertensive therapy	7
017-0	7
068 μg/kg/min [ciana et al 1997]	7
prevention of coronary thrombosis	7
treatment of hearing loss	7
no specific guidelines address the issue of surveillance	7
nutrition and feeding assessments	7
ophthalmology consult to evaluate for cataracts	7
generalized epimerase deficiency galactosemia	7
, some fruits and vegetables, organ meats)	7
, hepatic cirrhosis or mature cataracts)	7
peripheral epimerase deficiency galactosemia	7
intermediate epimerase deficiency galactosemia	7
however, insufficient data exist to make firm recommendations	7
furthermore, such tests may not be available	7
5 mg/100 ml in red blood cells	7
follow growth	7
monitor developmental milestones	7
propose supportive intervention as needed	7
diagnostic evaluations can include:	7
appropriate ophthalmologic treatment (e	7
the following should be monitored in persons with gan:	7
intellectual development/deterioration	7
the frequency of the monitoring should depend on disease progression	7
annual or more frequent evaluation is recommended	7
detailed history of age at which hematologic disease was manifest	7
individuals with gata1-related cytopenia are treated supportively	7
, ibuprofen)	7
molecular genetic testing for the familial gata1 pathogenic variant	7
, enzyme dose and frequency of infusion)	7
mode of ascertainment (e	7
, family screening vs disease signs and symptoms)	7
presence/absence of primary neurologic involvement	7
transfusion of blood products for severe anemia and bleeding	7
analgesics for bone pain	7
, improved joint range of motion)	7
supplemental treatment	7
, combined ert and bmt)	7
it is likely that end-stage histologic changes (e	7
ert is well tolerated	7
adverse effects (e	7
, brain, bones, and lungs)	7
substrate reduction therapy (srt)	7
6 to -0	7
parenchymal abnormalities can be identified as well	7
screening for pulmonary hypertension	7
assessment of disease severity	7
chaperone-mediated enzyme enhancement therapy	7
treatment of manifestations *	7
surveillance *	7
author, unpublished observations])	7
cognitive neuropsychological evaluation	7
behavioral neuropsychological evaluation	7
clinical genetics evaluation [pal et al 2010]	7
care is best provided by a physician (e	7
clobazam (0	7
topiramate [coppola et al 2002]	7
ethosuximide	7
can be effective for absence seizures	7
levetiracetam (20-80 mg/kg/day)	7
potassium bromide	7
phenobarbital	7
sleep deprivation and illness can exacerbate scn1a-related seizures	7
routine seizure and personal safety counseling is indicated	7
seizures are not always responsive to conventional aeds	7
ethosuximide and high-dose piracetam for myoclonic seizures	7
placement of an indwelling venous access device	7
creating a portable microenvironment	7
having a written emergency department protocol	7
establishing emergency routines for the family	7
creating personal time to decrease parent stress	7
finding respite care	7
contacting an internet support group	7
, naproxen)	7
acetaminophen, which is hepatotoxic in overdose	7
effect of anticonvulsants on hormonal methods of birth control	7
effects of anticonvulsants on conception	7
effect of pregnancy on anticonvulsant metabolism	7
effect of pregnancy on maternal seizure control	7
lacosamide has not been studied in scn1a-related seizure disorders	7
however, it has not been formally studied	7
clinical history for evidence of tracheal stenosis and respiratory compromise	7
liver size by clinical assessment and/or ultrasound examination	7
eye examination for to evaluate for evidence of glaucoma	7
joint manifestations: regular physiotherapy to prevent joint limitation	7
heart: valve replacement	7
tracheal stenosis: tracheostomy when severe	7
annual multidisciplinary examination to assess:	7
trachea for evidence of stenosis and respiratory compromise	7
liver size for evidence of hepatomegaly	7
the examination includes the following:	7
measurement of corneal diameter	7
examination of the anterior segment	7
direct gonioscopy to rule out secondary glaucoma	7
dilated fundus examination to evaluate for optic nerve damage	7
surgical treatment	7
pcg is almost always managed surgically	7
beta-blockers (e	7
, timolol), parasympathomimetics (e	7
, pilocarpine), sympathomimetics (e	7
treatment of refractive errors	7
eeg (pre-prandial and post-prandial tracings)	7
brain imaging, including fdg-pet in selected individuals	7
affected individuals develop a mild compensated metabolic acidosis when ketotic	7
phenobarbital and valproic acid can inhibit glut1 transport	7
valproic acid may partially inhibit beta-oxidation of fatty acids	7
these agents also can cause kidney stones	7
response has been modest at best	7
for those who are treated with the ketogenic diet:	7
l-carnitine supplementation to avoid carnitine deficiency	7
additionally, valproic acid may inhibit glucose transport	7
blood measurement of ketone concentration is the preferred method	7
barbiturates	7
methylxanthines (e	7
, anaplerosis)	7
the primary efficacy objective is reduction in seizure frequency	7
physical examination for evidence of hepatosplenomegaly	7
skeletal survey to determine the extent of skeletal involvement	7
electroencephalogram to assess for seizure disorder, if indicated	7
clinical genetics consultation with genetic counseling	7
maintenance of adequate hydration and adequate calories for growth	7
aggressive seizure control	7
medical management of cardiac involvement	7
tomatsu et al 2011	7
author, unpublished observations]	7
assessment of quality of life by a physiotherapist	7
yearly and before/after major medical events	7
monitoring of hip joint stability re risk of hip dislocation	7
yearly evaluation by a neurologist	7
assessment of quality of life by a physiotherapist:	7
yearly: track progress and optimize ambulation	7
neurologic examination every six months	7
mri neutral position: whole spine every year	7
these guidelines can be modified as appropriate	7
polysomnography if any clinical suspicion exists	7
slit lamp examination of cornea	7
examination of the posterior segment	7
evaluation every six months	7
yearly audiogram	7
no fda-approved treatments for glb1-related disorders exist	7
see animal model	7
tsh level	7
complete blood cell count with differential	7
renal ultrasound examination to evaluate for structural renal defects	7
consideration of ophthalmology evaluation	7
chest x-ray to evaluate for thoracic vertebral anomalies	7
assessment for possible feeding problems including significant gastroesophageal reflux	7
vomiting and constipation	7
as needed:	7
later, educational and behavioral therapy are often warranted	7
, oral polio, mmr)	7
antibody studies to assess results of immunizations are warranted	7
consider the following:	7
possible effects on speech prior to adenoidectomy	7
pre- and postoperative sleep studies when performing pharyngeal procedures	7
assessment of platelet volume and function prior to surgical procedures	7
thyroid studies annually	7
reevaluation of immunologic status between age nine and 12 months	7
annual complete blood count and differential	7
repeat audiology evaluation in infancy and prior to school enrollment	7
routine surveillance for the development of scoliosis	7
carbonated drinks and alcohol consumption may exacerbate hypocalcemia	7
caffeine intake may contribute to or worsen anxiety	7
skeletal differences such as club foot and craniosynostosis	7
and umbilical and inguinal hernia	7
a complete physical and neurologic examination	7
comprehensive speech/language evaluation including an audiologic examination	7
oral-motor therapy to alleviate chewing and swallowing problems	7
routine protocols to alleviate sleep apnea	7
tympanostomy tube placement for recurrent ear infections	7
surgical removal of ingrown toenails to prevent infection	7
walkers or other assistive walking devices	7
intravenous fluids to prevent dehydration in individuals with recurrent vomiting	7
monitoring for symptoms (e	7
routine monitoring of cardiac abnormalities	7
in severe cases, monitoring by a vascular surgeon	7
3 deletion have reduced perspiration and tend to overheat easily	7
intranasal insulin (init)	7
risperidone	7
assessment of joint mobility by physical examination	7
surgical bone lengthening may be an option for some	7
adaptive aids for people with short stature are appropriate	7
consultation with a speech and language pathologist	7
hearing testing	7
speech/language deficits	7
aeds are associated with possible adverse reactions (e	7
developmental surveillance should be conducted in all affected children	7
gly188arg pathogenic variant in g6pc	7
evaluation of nutritional status	7
liver imaging to evaluate for hepatomegaly	7
kidney imaging to evaluate for renomegaly	7
kidney function tests	7
platelet function assay to evaluate platelet function	7
measurement of bone density (after the first decade)	7
screening to detect systemic and pulmonary hypertension	7
metabolic specialist consultation	7
metabolic specialist familiar with the multisystem nature of gsdi	7
medical nutrition therapy goals	7
maintain	7
normal glucose levels and prevent hypoglycemia:	7
frequent daytime feedings	7
note: recommendations for uncooked cornstarch dosing are: 1	7
provide	7
optimal nutrition for growth and development:	7
, protein low in fat)	7
treatment of other manifestations	7
sodium levels should also be monitored	7
kidney transplantation can be performed for esrd	7
liver transplantation can be considered when other interventions have failed	7
g-csf should be administered subcutaneously starting at 1	7
0 μg/kg given daily or every other day	7
0 x 109/l is reached	7
surveillance of the liver may include the following:	7
when hepatic adenoma is detected	7
any imaging performed for liver surveillance (e	7
cardiovascular surveillance	7
maintain a low-sucrose, low-fructose diet	7
limit galactose and lactose intake to one serving per day	7
baseline ultrasound of liver and kidneys prior to pregnancy	7
consideration of referral to high-risk obstetrician	7
metabolic control should be followed closely throughout the pregnancy	7
abdominal ultrasound should be performed every six to 12 weeks	7
see kishnani et al 2006b]	7
chest radiography	7
electrocardiography (ecg)	7
in later stages, dilated cardiomyopathy may be seen	7
most infants have varying degrees of respiratory insufficiency	7
formal pulmonary function tests show pulmonary insufficiency	7
assessment of growth (i	7
all infants should be evaluated for gastroesophageal reflux disease	7
assessment of nutritional status as baseline is recommended	7
audiologic –	7
baseline hearing evaluation including tympanometry is appropriate	7
disability inventory –	7
iopd and lopd	7
assessment of risk for falls is recommended	7
arteriopathy	7
conduction disturbances	7
muscle weakness	7
respiratory insufficiency	7
respiratory support including cpap and bipap may be required	7
crim status	7
age restrictions on lumizyme were removed in 2014	7
many individuals are now treated with the higher dose	7
complications of ert	7
infusion-associated reactions	7
prognosis	7
the major morbidities are motor disability and respiratory insufficiency	7
infections need to be aggressively managed	7
immunizations need to be kept current	7
patients and household members should receive annual influenza vaccinations	7
close follow up is indicated	7
chest x-rays at regular intervals	7
yearly or more frequently as indicated	7
this may include assessment for scoliosis and bone densitometry	7
regular nutritional and feeding assessment	7
periodic echocardiography	7
hypotension and volume depletion should be avoided	7
exposure to infectious agents is to be avoided	7
baseline electrocardiogram and echocardiogram	7
consultation with a biochemical geneticist	7
special formulas are not required	7
3 mmol/l)	7
emergency protocol	7
5 normal saline administered at 1	7
osteoporosis may occur in adults with gsd iii	7
bone mineralization is adversely affected in acidic environments	7
the following are appropriate annually:	7
measurement of height and weight to monitor growth	7
laboratory studies: lfts, ck, lipid profile	7
echocardiogram to monitor for cardiomyopathy	7
bone density measurements are recommended after growth is complete	7
long-term steroid usage itself can cause muscle weakness	7
use the following with caution:	7
statins for control of hyperlipidemia	7
beta blockers as they can induce hypoglycemia	7
abdominal ultrasound examination to assess liver size and texture	7
neurodevelopmental evaluation	7
medical or biochemical genetics consultation	7
hepatic manifestations	7
selecting appropriate candidates for liver transplantation can be complex	7
nutritional deficiencies (e	7
bleeding due to coagulopathy can occur especially with surgical procedures	7
physical examination with emphasis on muscle strength/weakness	7
basal serum ck activity	7
aerobic training (on a regular diet)	7
95% confidence intervals 20	7
3 to 2496	7
7) after controlling for age	7
7 metabolic equivalents (mets, with 1met equaling 3	7
5 ml o2/kg/min) necessary for independent living	7
5mets higher than in those who were not active	7
avoid a totally sedentary life, which induces deconditioning	7
pharmacologic and nutritional treatments	7
the authors' conclusions:	7
this treatment does not influence sustained or unexpected exercise	7
a carbohydrate-rich diet was of benefit	7
pharmacologic treatments	7
nutritional treatments	7
see treatment of manifestations and agents/circumstances to avoid	7
annual routine physical examination	7
annual review of diet	7
static muscle contractions (e	7
, handgrip exercises)	7
, weightlifting)	7
dynamic exercises at a high-intensity level (e	7
, competitive ball games)	7
, jumps)	7
very intense dynamic aerobic exercise (e	7
general anesthetics	7
lipid-lowering drugs	7
arg50ter, p	7
branched-chain amino acids (bca)	7
height and weight should be measured annually to monitor growth	7
bone density determinations are recommended after growth is complete	7
elevated blood ketones (beta-hydroxybutyrate >1	7
liver imaging, if not performed in the past year	7
prothrombin time	7
lipid panel (cholesterol and triglyceride concentrations)	7
physical therapy evaluation	7
serum creatine kinase measurement	7
the dose of cornstarch can range from 0	7
5 g/kg every six hours based on clinical symptoms	7
for signs of	7
some individuals may require cornstarch only before bedtime	7
requirements for cornstarch tend to lessen with age	7
however, regular moderate aerobic exercise may be beneficial	7
abrupt discontinuation of fluids could result in hypoglycemia	7
lipid-lowering drugs (e	7
liver imaging	7
follow-up echocardiogram	7
no guidelines established	7
affected individuals with should avoid the following:	7
prolonged fasting	7
the final decision is based on clinician judgment	7
alcohol, as this may predispose to hypoglycemia	7
affected individuals should avoid the following:	7
vigorous exercise	7
medications that can cause rhabdomyolysis (e	7
, succinylcholine)	7
assess development including evidence of spasticity	7
evaluate suspicious activity for evidence of seizures	7
surgery may be required	7
hypothalamic involvement	7
central diabetes insipidus may require treatment with desmopressin	7
temperature dysregulation can be managed by modifying the environment	7
surgery of hand and foot defects can improve dexterity	7
tethered cord may require surgical intervention	7
some children may require a gastrostomy and/or tracheostomy	7
inquiry into possibility of seizures	7
measurement of serum sodium concentration	7
acute attacks	7
in an individual presenting with acute abdominal symptoms:	7
discontinue all nonessential medications	7
provide glucose-containing iv solution to reverse the fasting state	7
treat seizures with a short-acting benzodiazepine (e	7
not yet approved in the us)	7
some individuals recover with a glucose infusion only	7
200 mg once daily is appropriate for most individuals	7
the following responses to hematin infusion can be expected:	7
chronic (cutaneous) manifestations	7
grey or smoke colored filters provide only partial protection	7
involves the following:	7
selection of appropriate contraception for females	7
a copper-eluting iud is theoretically the safest in porphyria	7
however, little information exists	7
suppression of menses using a gnrh agonist	7
, propofol, ketamine, short-acting benzodiazepines)	7
does not	7
involve the following:	7
use of glucose	7
extreme diets (e	7
extreme caloric deprivation (i	7
, total fasting, gastric bypass surgery)	7
female reproductive hormones	7
birth-control pills are risky and not recommended	7
some drugs are clearly unsafe for cpox heterozygotes	7
porphyriafoundation	7
com and www	7
porphyria-europe	7
the effect of pregnancy on inducing acute attacks is unpredictable	7
in general, serious problems during pregnancy are unusual	7
efforts to accomplish this are under way	7
pharmacologic agents may suppress abnormal movements	7
tremor in one individual was suppressed with clonazepam	7
no known treatment stops or slows the progression of hdl2	7
nutrition and swallowing should be monitored	7
any agents that increase ataxia should be used with caution	7
psychological and psychiatric assessments	7
eeg or video eeg if a seizure disorder is suspected	7
evaluation of the need for antiepileptic drugs	7
no specific therapy is currently available for alsp	7
other:	7
onset of seizures and need for antiepileptic therapy	7
need for physical therapy to minimize contractures and maintain locomotion	7
treatment should be coordinated through a hemophilia treatment center	7
(individuals in the usa see national hemophilia foundation	7
immunizations should be administered preferably subcutaneously	7
ddavp®	7
(desmopressin acetate)	7
immune tolerance therapy	7
5 to three years	7
if the female is symptomatic (i	7
others are in clinical trials	7
these result in half-life extension by approximately 1	7
5 fold	7
products with greater half-life extension are under development	7
elsewhere worldwide: see world federation of hæmophilia)	7
immunizations should be administered subcutaneously	7
inhibitors	7
, in individuals with atherosclerotic cardiovascular disease)	7
range: 15%-50%)	7
recombinant factor ix (fix) proteins with prolonged survival	7
gene therapy for hemophilia b	7
for p	7
cys282tyr homozygotes:	7
clinical	7
biochemical	7
clinical hfe-hh	7
this may be accompanied with measurement of alpha fetoprotein	7
01 kpa [friedrich-rust et al 2008]	7
biochemical hfe-hh	7
alcohol consumption in those with hepatic involvement	7
the following strategy is appropriate:	7
perform iron studies (i	7
no guidelines exist	7
common practice is to withhold phlebotomy during pregnancy	7
the following measures are recommended:	7
avoidance of drugs and agents that induce the hepatic p450	7
persons of all ages should avoid exposure to sunlight	7
older individuals should avoid the known precipitating factors (e	7
variceal bleeding	7
transjugular intrahepatic portosystemic shunts (tips) are widely available	7
hypersplenism	7
hypersplenism usually does not result in clinically significant sequelae	7
abnormalities of the biliary tree	7
cholangitis is best treated with rapid institution of appropriate antibiotics	7
biliary stones	7
cholangiocarcinoma and hepatocellular carcinoma	7
these should be managed by a multidisciplinary team	7
patient education	7
general health should be closely followed	7
imaging allows:	7
assessment of spleen size to indirectly follow ph	7
visualization of bile duct abnormalities (e	7
malnutrition	7
infection with human immunodeficiency virus (hiv)	7
immunosuppression (e	7
, after renal transplantation)	7
hepatotoxic medicines should be avoided	7
examination for upj obstruction	7
urologic referral is indicated	7
gynecologic referral is indicated	7
hymenectomy may be necessary for tight constriction ring	7
gynecologic examination prior to menstruation for small hymenal opening	7
biochemical geneticist or pediatrician with an interest in metabolic disorders	7
dietician with experience in managing inherited metabolic diseases	7
hepatologist	7
nephrologist	7
clinical geneticist and/or genetic counselor	7
food category	7
foods permitted	7
foods prohibited	7
dairy	7
any milk, cheese, eggs	7
meat	7
beef, veal, lamb, pork	7
ham, bacon, hot dogs, processed meats	7
any other meat where sugar is used in processing	7
fish	7
all fish	7
poultry	7
chicken, turkey	7
cereal	7
sweetened/sugar-coated cereals	7
fruit	7
vegetables	7
all other vegetables, including sweet potatoes	7
bread	7
soda crackers & saltines	7
any breads or crackers prepared w/fructose/sucrose/sugar/sorbitol	7
fat sources	7
desserts and sweeteners	7
dietetic jello, dietetic ice cream, dietetic puddings	7
natural yogurt	7
sugar, sucrose, sorbitol, fructose	7
miscellaneous	7
some sugar substitutes	7
some dietetic beverages	7
pasta	7
rice	7
cinnamon, garlic, poppy seeds	7
peanut butter if prepared w/added sugars	7
chewing gum w/sorbitol	7
the following are recommendations:	7
medicines	7
not be given to neonates known to have hfi	7
coli sepsis and pulmonary edema	7
blood tests:	7
liver function: sgot, sgpt, alp, ggt	7
fecal elastase level if steatorrhea is present	7
ophthalmologic examination to evaluate for cataracts or other abnormalities	7
however, no data on its use are available	7
lymphedema management (manual lymphatic drainage, compression)	7
muscle	7
physical therapy and exercise to promote mobility and prevent contractures	7
noninvasive ventilation if needed	7
treatment of pancreatic exocrine insufficiency with pancreatic enzyme supplementation	7
treatment of cholestasis with ursodeoxycholic acid	7
enteral feeding as needed	7
surgical removal of visually significant cataracts	7
physical therapy assessment for muscle weakness or contractures	7
blood test:	7
excessive sun exposure, which may exacerbate the rash	7
exposure to heat because of heat intolerance secondary to hypohidrosis	7
evaluation of cdh1 heterozygotes for h	7
breast examination/mammography in females	7
the primary curative treatment of gastric cancer is surgical resection	7
biopsy-proven diffuse-type gastric carcinoma	7
heterozygotes for a germline cdh1 pathogenic variant	7
however, the morbidity from prophylactic gastrectomy is high	7
the age-specific risks of gastric cancer	7
gastric cancer	7
several screening modalities have been tested:	7
endoscopy	7
endoscopy permits direct inspection and biopsy of suspicious areas	7
the submucosal lesions are difficult to identify	7
further research is needed to evaluate this possibility	7
69 of 99 (70%) endoscopies were normal	7
lobular breast cancer (lbc)	7
lehman 2006	7
schelfout, personal communication]	7
testing of populations at risk	7
baseline electrocardiogram (ecg) and echocardiogram	7
baseline mri/mra of the brain and neck	7
standard goniometry to assess joint mobility	7
physical therapy and occupational therapy assessments	7
audiologic, ophthalmologic, and dental examinations	7
frequent small meals tend to maximize caloric intake	7
stiffened peripheral vasculature may be less tolerant to dehydration	7
therefore maintaining optimal hydration orally is recommended	7
infections are generally handled as for unaffected children	7
anesthetics should be used with particular caution	7
nitroglycerin is frequently of benefit if angina develops	7
statins are recommended for their putative effect on farnesylation inhibition	7
injuries	7
wound healing is normal	7
fracture rate is equivalent to the general pediatric population	7
hips	7
teeth	7
, finger) joints	7
eye care	7
hearing aids can be used, when clinically necessary	7
aspirin	7
vitamin supplementation	7
standard amounts of ordinary multiple vitamin tablets are appropriate	7
fluoride supplements are recommended in areas where needed	7
immunizations are generally handled as for unaffected children	7
annually:	7
lipid profiles	7
dental examination, x-ray, and cleaning	7
complete ophthalmologic examination with special attention to possible exposure keratopathy	7
physical activity should be self-limited	7
search hgps or progeria within clinicaltrials	7
gov for access to information on clinical trials for hgps	7
lonafarnib is an investigational farnesyltransferase inhibitor	7
pravastatin inhibits hmg-coa reductase	7
zoledronate is a bisphosphonate that inhibits farnesyl pyrophosphate synthase	7
three clinical trials have been conducted: lonafarnib monotherapy	7
lonafarnib in combination with pravastatin and zoledronate	7
and pravastatin and zoledronate administered as combination therapy:	7
trial results for pravastatin and zoledronate are not yet known	7
neurocognitive evaluation of the affected individual including brain imaging	7
evaluation of school performance with attention to possible learning disabilities	7
treatment of acute hyperammonemic episodes	7
, as part of nitrogen scavenging therapy)	7
this approach also stops all protein intake	7
infusion 1	7
infants and children	7
10% arginine hcl	7
210 mg/kg/day	7
drug	7
action	7
glucose	7
arginine 1	7
sodium benzoate 3	7
sodium phenylacetate 3	7
hemodialysis	7
dialysis may be prolonged if the catabolic state persists	7
note: non-essential amino acids (i	7
citrulline supplementation at 0	7
17 g/kg/day or 3	7
lysine supplementation is indicated when plasma lysine concentrations are low	7
liver transplantation is not indicated for persons with hhh syndrome	7
excess dietary protein intake	7
prolonged fasting during an illness or weight loss	7
use of intravenous steroids	7
valproic acid, which exacerbates hyperammonemia in urea cycle disorders	7
exposure to communicable diseases	7
polycythemia raises suspicion for pulmonary arteriovenous malformations	7
nosebleeds	7
oral drug therapy	7
topical drug therapy	7
, timolol 0	7
gastrointestinal bleeding	7
pulmonary avms	7
hepatic avms	7
cerebral avms	7
cerebral avms greater than 1	7
intestinal polyps	7
reevaluation for cerebral avm	7
childhood	7
dermatologic examination	7
chest imaging	7
dental examination for possible retention of primary teeth	7
if structural damage to the lungs (e	7
, pseudomonas) or fungi (e	7
, aspergillus)	7
adequate skin lubrication is needed with frequent bleach baths	7
osteoporosis and minimal trauma fractures are frequent findings	7
, pneumatocoeles) have formed	7
cessation of prophylactic antimicrobials is often advised during pregnancy	7
hlh-1994	7
hlh-2004	7
in general, treatment involves the following:	7
after achievement of clinical remission in simplex cases (i	7
, a single occurrence in a family)	7
the following are recommended annually after hct:	7
neuropsychological evaluation	7
live vaccinations	7
exposure to infections	7
cutaneous lesions	7
cutaneous leiomyomas should be examined by a dermatologist	7
treatment of cutaneous leiomyomas is difficult:	7
surgical excision may be performed for a solitary painful lesion	7
lesions can be treated by cryoablation and/or lasers	7
uterine fibroids should be evaluated by a gynecologist	7
hysterectomy should be performed only when necessary	7
renal tumors	7
early detection of kidney tumor in hlrcc is important	7
uterus	7
caution: ultrasound examination alone is never sufficient	7
consultation with a hepatologist is advised	7
establishment of whole blood manganese levels	7
chelation therapy with disodium calcium edetate	7
short term	7
, >3 hours)	7
long term	7
chelation therapy should be continued lifelong	7
iron therapy	7
iron is a competitive inhibitor of intestinal manganese uptake	7
dystonia can result in physical deformities and pain	7
calcium, magnesium, and phosphate concentrations	7
and iron status	7
trace metal supplements are provided as needed	7
white blood count <3	7
5x10^9/l	7
neutrophils <2	7
0x10^9/l	7
platelets <150x10^9/l	7
toxicity of iron supplementation	7
foods very high in manganese (cloves	7
physiotherapy consultation to assess lower limb function and general mobility	7
at present no disease-modifying therapy exists	7
comprehensive neuromuscular evaluation	7
bmj	7
pain management is the primary goal of therapy:	7
cleft palate is best managed by a local craniofacial team	7
methylprednisolone, intravenous 30 mg/kg (or 1	7
intravenous immune globulin, 0	7
management of colon cancer in a person with lynch syndrome	7
endometrial cancer	7
ovarian cancer	7
gastric and duodenal cancers	7
distal small bowel	7
other cancers	7
ideally cancer screening exams would be planned around a pregnancy	7
chromoendoscopy and intensive colonoscopy	7
chemoprevention research studies	7
history of focal nerve symptoms	7
electromyography / nerve conduction velocity (emg/ncv)	7
complications should be managed appropriately (e	7
betaine therapy is usually added to the therapeutic regimen	7
details about each aspect of treatment follow	7
vitamin b6 (pyridoxine) therapy	7
dietary treatment	7
this diet should be continued indefinitely	7
folate and vitamin b12 supplementation	7
betaine treatment	7
side effects of betaine are few	7
complications should be promptly addressed with appropriate therapy	7
vitamin b12 and folate levels should be monitored	7
5 n saline at 1	7
if fluids at 1	7
serum concentration of calcium, phosphorus, magnesium	7
baseline dental evaluation	7
baseline orthopedic evaluation	7
multidisciplinary management at various ages may include:	7
endocrinology to optimize bone homeostasis and avoid exacerbating treatments	7
nephrology to monitor calcium homeostasis and examine for nephrocalcinosis	7
neurology to prophylactically or prospectively treat seizures and manage myopathy	7
neurosurgery or craniofacial team to manage pseudocraniosynostosis	7
orthopedics to manage primary and secondary skeletal manifestations	7
pain management	7
pediatric and adult dentistry to manage tooth loss	7
perinatal/infantile hpp study outcomes	7
survival	7
bone findings	7
juvenile-onset hpp study outcomes	7
age at treatment onset was six to 12 years	7
perinatal types	7
infantile type	7
in the absence of ert, supportive management remains	7
calcium homeostasis	7
craniosynostosis in those with the infantile phenotype is variable	7
childhood (juvenile) and adult hypophosphatasia	7
osteoarthritis may respond to nsaids	7
pseudofractures and stress fractures are difficult to manage	7
biphosphonates are relatively contraindicated in hypophosphatasia	7
it is contraindicated in children with hypophosphatasia	7
limb involvement is determined by physical examination	7
ecg is recommended for the detection of cardiac conduction disease	7
cleft lip and/or palate	7
hydrocephalus and/or features of hpe or other cortical anomalies	7
growth deficiency	7
pituitary dysfunction	7
oral feeding and swallowing	7
early surgical repair may improve feeding	7
, illness, surgery)	7
during an acute paralytic attack:	7
measurement of serum potassium concentration	7
assessment for swallowing difficulty	7
between attacks or in a currently asymptomatic individual:	7
neurologic examination to assess muscle strength in the legs	7
plasma thyroid-stimulating hormone (tsh)	7
free thyroxine (ft4)	7
free triiodothyronine (ft3)	7
the principles of treatment are summarized in table 7	7
goal	7
means	7
practical details	7
to avoid triggering or aggravating factors for paralytic attacks	7
strenuous effortprolonged immobilitycarbohydrate-rich diet	7
treatment of paralytic attack:	7
shorten/prevent aggravation of the weakness episodenormalize kalemia	7
preventive treatment for paralytic attacks	7
daily k+ supplementation	7
slow-release forms of potassium may be used	7
diamox (acetazolamide)	7
k+-sparing diuretics	7
preventive treatment for late-onset myopathy	7
diamox (acetazolamide)?	7
medical precautions	7
other elements of management	7
strenuous effort	7
carbohydrate-rich diet	7
provide dietary review/counseling	7
shorten/prevent aggravation of the weakness episode	7
normalize kalemia	7
avoid glucose intake	7
do not use slow-release forms of potassium	7
oral potassium: initially, 1 meq/kg	7
3 meq/kg after 30 minutes if no improvement	7
iv potassium: 0	7
avoid corticosteroids if possible	7
kinesitherapy in case of permanent pelvic deficit	7
paralytic crisis	7
mild to moderate paralytic episodes	7
aqueous potassium contained in vials may act more rapidly	7
, 4	7
3 meq/kg can be administered (20 meq	7
, 1	7
severe paralytic episodes	7
note the following critical points:	7
3 meq/kg/h of potassium (i	7
some individuals exhibit serious arrhythmias with only mild hypokalemia	7
they are associated with a risk for cardiac arrest	7
attempting to abort paralytic attacks when they begin	7
acetazolamide treatment:	7
is beneficial in approximately 50% of individuals with hokpp	7
has no effect in 30% of affected individuals	7
alternatives to acetazolamide	7
pinacidil [ligtenberg et al 1996]	7
and bumetanide [wu et al 2013]	7
pre- or postoperative paralysis	7
general guidelines for perioperative care include the following:	7
strict control of serum potassium concentration	7
avoidance of large glucose and salt loads	7
low-carbohydrate diet	7
maintenance of body temperature and acid-base balance	7
late-onset myopathy with fixed muscle weakness	7
renal ultrasound should be performed annually	7
unusually strenuous effort	7
excess of carbohydrate-rich meals	7
sweets	7
complete ophthalmologic evaluation	7
correction of these refractive errors can improve visual acuity	7
the surgery is not always successful	7
humidifiers may reduce the frequency of nosebleeds	7
oral contraceptives can limit the duration of menstrual periods	7
the authors know of several additional successful lung transplantations	7
pulmonary function testing should be performed annually in adults	7
colonoscopy is used to confirm the diagnosis	7
evaluation for renal lesions: renal ultrasound examination preferred	7
ct and/or mri as clinically indicated	7
consultation with a medical genetics professional (e	7
, medical geneticist, genetic counselor): recommended	7
primary hyperparathyroidism	7
minimally invasive parathyroidectomy requires the use of:	7
preoperative imaging (e	7
jaw tumors	7
uterine tumors	7
, elevated serum alkaline phosphatase concentration)	7
uterine tumors have only been reported in adults	7
surveillance can begin at reproductive age	7
a diabetic clinic is a good source of advice	7
appropriate shoes and socks are recommended	7
it is best to prevent callous formation in neuropathic skin	7
hyperthermia or hypothermia	7
hypothermia responds to warming by a blanket as necessary	7
of note, longstanding infections require wide surgical debridement	7
bone and joint deformities can be managed by corrective osteotomy	7
joint dislocations are best treated conservatively	7
the oral self-mutilation (i	7
6-0	7
dental care includes the following:	7
inadequate sedation	7
hyper- or hypothermia	7
heating blankets should not be used	7
hot or cold environments	7
hot or cold foods	7
hot showers or baths	7
jumping or high-impact activities and sports	7
hyperpyrexia and its potential complications, including febrile seizures	7
, first 28 days of life)	7
joints for evidence of charcot joints	7
strength	7
loss of sweating and compensatory patchy hyperhydrosis	7
see warren & nade [1999]	7
charcot joints may require arthrodesis	7
opiates are contraindicated as hsn1a is a chronic disorder	7
foot ulcers are frequently caused by breakdown of callus	7
, during cooking)	7
opiates are contraindicated as this is a chronic disorder	7
sleep study if sleep apnea is a potential concern	7
see prevention of secondary complications	7
note: many of these assessments are age dependent	7
commonly required interventions include the following:	7
shunting for hydrocephalus	7
tonsillectomy and adenoidectomy	7
positive pressure ventilation (cpap or tracheostomy)	7
carpal tunnel release	7
cardiac valve replacement	7
inguinal hernia repair	7
hip replacement	7
developmental, occupational, and physical therapy are often necessary	7
5 mg/kg	7
more recently, in a 3	7
long-term use of ert was safe	7
, infliximab)	7
itching	7
rash	7
flushing	7
and headache	7
risks associated with general anesthesia include the following:	7
nasopharyngeal intubation is often necessary	7
the risk of airway complications may continue following successful surgery	7
cardiology visit with echocardiogram	7
pulmonary clinic visit with pulmonary function testing	7
audiogram	7
sleep study for obstructive sleep apnea	7
ncv study for evidence of carpal tunnel syndrome	7
head/neck mri to document ventricular size and cervicomedullary narrowing	7
opening pressure on lumbar puncture	7
orthopedic evaluation to monitor hip disease	7
significant secondary complications of hd include the following:	7
the side effects associated with various pharmacologic treatments	7
l-dopa-containing compounds may increase chorea	7
alcohol and smoking are discouraged	7
huntington-study-group	7
for the most up-to-date information see hddrugworks	7
creatinine clearance (i	7
, glomerular filtration rate [gfr])	7
serum concentration of creatinine resources	7
hematologic status	7
erythrocyte count	7
search for schistocytes in the blood smear	7
leukocyte count	7
serum ldh concentration	7
haptoglobin	7
serum c3 and c4 concentrations	7
plasma concentrations of bb and sc5b-9	7
measure serum concentrations of cfh and cfi	7
assessment of cd46 expression on leukocytes	7
for further information about eculizumab, click here	7
typically, plasma exchange is undertaken daily initially	7
cfb	7
cfh autoantibodies	7
cfi	7
, persistent severe thrombocytopenia and hemolytic anemia)	7
molecular genetic testing can help to define graft prognosis	7
c3, cfb, and cfi	7
four individuals with isolated	7
importantly, there were no ahus recurrences after transplantation	7
individuals with known ahus	7
note: individuals with esrd usually do not relapse	7
fresh frozen plasma should be avoided (i	7
some chemotherapeutic agents (e	7
no monitoring is needed for:	7
8%) and preeclampsia (7	7
7%)	7
for ahus associated with cfh pathogenic variants:	7
plasma-resistant/plasma-dependent disease	7
some individuals with ahus are plasma resistant (i	7
scd risk factors include:	7
family history of scd	7
extreme lvh (>30mm)	7
hypotensive blood pressure response to exercise	7
nonsustained ventricular tachycardia (vt) on ambulatory monitoring	7
unexplained syncope	7
echocardiogram to measure the degree of lvh	7
exercise testing to assess blood pressure response to exercise	7
ambulatory monitoring for significant ventricular ectopy	7
l-type calcium channel blockers	7
note: direct vasodilators (e	7
for relatives at risk for hcm	7
because penetrance of diagnostic features (i	7
screening guideline	7
<12 yrs	7
optional unless any of the following are present:	7
12-18 yrs	7
repeat evaluation every 12-18 months	7
>18-21 yrs	7
competitive athlete in intense training program	7
other clinical findings that suggest early lvh	7
avoid exercise in extreme environmental conditions and maintain adequate hydration	7
use jacuzzis, steam rooms, saunas with caution	7
and avoid the following:	7
medications that decrease afterload (e	7
, ace inhibitors	7
medications for erectile dysfunction (e	7
, sildenafil, tadalafil)	7
hemoglobin concentration to document the level of anemia	7
dose is based on response to therapy	7
gout typically responds well to prednisone or colchicine	7
prednisone is the preferable alternative	7
fludrocortisone treatment (0	7
mineralocorticoid replacement	7
kidney transplantation cures adtkd-ren	7
treatment of hyperuricemia with allopurinol can prevent development of gout	7
the use of other analgesics/antipyretics should be considered	7
exertion under extreme conditions (e	7
children because of their increased risk for anemia	7
determine neurologic status	7
edema should be extruded with long-term diuretics	7
treatment for hyperpp is symptomatic and not curative	7
, 2 g glucose per kg body weight)	7
1 mg salbutamol	7
calcium gluconate (0	7
diet/environment	7
potassium-rich medications and foods (e	7
, fruits, fruit juices)	7
strenuous work	7
exposure to cold	7
diuretics	7
intubation and mechanical ventilation may be impaired	7
permanent weakness requires continuous medication, eg	7
the value should be between 3	7
0 and 3	7
5 mmol/l	7
annual monitoring of thyroid function is appropriate	7
see prevention of primary manifestations and prevention of secondary complications	7
for results, see clinicaltrials	7
adults with fh	7
risk factors (e	7
4 mmol/l])	7
risk factors:	7
clinically evident cad or other atherosclerotic cardiovascular disease	7
8 mmol/l)	7
diabetes mellitus or metabolic syndrome	7
women age <55 years)	7
current smoking	7
3 mmol/l] using an isoform insensitive assay)	7
class	7
ldl-lowering response	7
statins	7
↑ ldlr activity (1o)	7
>35% 1, 2	7
cholesterol absorption inhibitors (ezetimibe)	7
mipomersen (apob antisense) 4	7
blocks apob production in the liver	7
mtp inhibitor(lomitapide) 4	7
pcsk9 inhibitors(alirocumab, evolocumab)	7
↓ ldl-receptor degradation	7
50% 6	7
bile acid sequestrants(cholestyramine, colesevelam)	7
stanol esters	7
10% 1, 3	7
children with fh	7
9 mmol/l)	7
consultation or referral to a lipid specialist is recommended	7
statins are the preferred initial pharmacologic treatment in children	7
4 mmol/l)	7
children and adults with homozygous fh (hofh)	7
nla guidelines for homozygous fh (full text):	7
referral to a lipid specialist is indicated	7
early initiation of therapy and monitoring are recommended	7
multiple drug therapy is usually needed	7
many states do not have an apheresis center	7
preventive measures include the following:	7
statin-based therapy with addition of other medications as needed	7
reduced intake of saturated fat	7
increased intake of soluble fiber to 10-20 g/day	7
increased physical activity	7
not smoking	7
1 mmol/l) is relatively specific for fh	7
during treatment, individuals of any age with:	7
fh should have lipid levels monitored as recommended	7
high intake of saturated and trans unsaturated fat	7
excessive intake of cholesterol	7
sedentary lifestyle	7
measurement of ldl-c level	7
degree of relatedness to an affected individual	7
first degree 1	7
second degree 2	7
third degree 3	7
cholesterol levels	7
total cholesterol (ldl cholesterol) in mg/dl	7
<20	7
220 (155)	7
230 (165)	7
20-29	7
250 (180)	7
260 (185)	7
30-39	7
270 (190)	7
280 (200)	7
290 (210)	7
40+	7
290 (205)	7
300 (215)	7
310 (225)	7
statins are contraindicated during pregnancy	7
statins are contraindicated in pregnancy due to concerns for teratogenicity	7
nursing mothers should not take statins	7
ldl apheresis is also occasionally used	7
regarding other agents:	7
pcsk9 inhibitors	7
use during pregnancy has not been well studied	7
use during human pregnancy has not been well studied	7
niacin	7
higher doses have been associated with toxicity	7
cad outcome trials of pcsk9 inhibitors are currently underway	7
evaluation for the head retraction reflex	7
in adults the initial dose is 0	7
5 mg twice a day	7
the dose can be increased up to 2	7
0 mg three times a day	7
see treatment of manifestations, clonazepam	7
antiepileptic drugs if epileptic seizures are present	7
a multidisciplinary approach is advisable to prevent:	7
spasticity: pharmacologic agents, physical therapy	7
ataxia: rehabilitation	7
seizures: anticonvulsants	7
feeding: swallowing surveillance and gastrostomy if needed	7
surveillance includes periodic:	7
neurologic evaluation to identify neurologic complications	7
screening developmental assessment	7
speech evaluation at diagnosis or by age two years	7
the usual neurosurgical approach to spinal stenosis is laminectomy	7
the l2-3 level most commonly required decompression	7
seizure disorders should be treated in the standard manner	7
standard management of frequent middle ear infections	7
social adjustment should be monitored	7
growth hormone therapy	7
, those with fgfr3 mutations and those without)	7
0+/-3	7
their mean height increased 1	7
32+/-1	7
asn540lys substitution, mean age 2	7
6+/-0	7
their mean height sds increased by 1	7
management of blisters in a standard manner (i	7
, not opening them, avoiding trauma)	7
topical treatment (e	7
, medications, oatmeal baths) to relieve discomfort	7
significant skin involvement may benefit from dermatology management	7
treatment of infections as for any other cellulitis	7
standard treatment for retinal detachment	7
head trauma may precipitate retinal detachment	7
monthly until age three to four months	7
every three months between ages four months and one year	7
every six months between ages one and three years	7
annually after age three years	7
ongoing evaluation by a pedodontist or dentist is appropriate	7
detailed dietary and feeding assessment as needed	7
orthopedic and rehabilitation assessment as needed	7
physical and occupational therapy to promote mobility and independence	7
aids for mobility and limb function	7
routine monitoring:	7
treatment is symptomatic only:	7
annual routine follow-up with the multidisciplinary team is recommended	7
several oral exogenous forms of sialic acid (e	7
gov for details)	7
assessment of muscle strength, muscle wasting and tendon reflexes	7
emg and/or muscle biopsy may be necessary	7
baseline pulmonary function studies	7
cardiac evaluation by echocardiogram and ecg	7
baseline neuropsychological studies of behavior and mental status	7
management should be tailored to the individual	7
paget disease of bone	7
actonel®/risedronate	7
fosamax®/alendronate	7
aredia®/pamidronate	7
at periodic intervals:	7
echocardiogram and ekg to monitor for evidence of cardiomyopathy	7
monitoring of behavior and mental status	7
brain mri during a quiescent period	7
rehabilitation/ot/pt consultation	7
tnfα antagonists have also been used	7
in intervals between ane events neurologic function is stable	7
serum and urine concentration of electrolytes	7
serum concentration of glucose and acth	7
assessment of arterial blood gases	7
consultation with an endocrinologist	7
growth hormone (gh) therapy	7
risks during delivery include cephalopelvic disproportion	7
thorough ophthalmologic examination to assess for optic atrophy	7
eeg for the possibility of unrecognized seizure activity	7
treatment by a psychiatrist for neuropsychiatric symptoms is indicated	7
manju kurian, personal communication]	7
paul kotzbauer, personal communication]	7
full text)	7
thyrotropinoma (hyperthyroidism with non-suppressed tsh)	7
measurement of parental heights	7
visual field evaluation	7
basal pituitary function including: spot gh, igf-1	7
prolactin	7
lh, fsh, testosterone/estradiol	7
tsh, ft4	7
9 a	7
cortisol	7
assess acth reserve if necessary	7
consultation with specialists in endocrinology	7
dopamine agonist therapy has been tried in some cases	7
repeat pituitary mri	7
persons with acromegaly	7
persons with hypogonadism	7
follow established guidelines	7
recommendations follow	7
more data are needed to develop appropriate future guidelines	7
baseline	7
thereafter	7
perform annual clinical assessment and pituitary function tests	7
yearly beginning at age four years	7
measure height and weight with calculation of height velocity	7
document pubertal development, tanner stages	7
perform pituitary function tests (as for adults)	7
perform baseline pituitary mri at about age ten years	7
complete blood count and differential, coombs test	7
regulatory t cell numbers	7
serum albumin and pre-albumin	7
monitor fluid intake to assure adequate intravascular volume	7
bmt is currently the only cure for ipex syndrome	7
prevent disease	7
complete neurologic assessment by a pediatric neurologist	7
eeg/video eeg to monitor seizures	7
assessment of feeding and nutrition and appropriate intervention	7
appropriate medications for management of seizures and spasticity	7
chest physiotherapy to prevent respiratory complications	7
sleep studies to assess nocturnal hypoventilation and institute appropriate interventions	7
assessment for scoliosis	7
dietary	7
medical	7
degree of spasticity and related complications, including scoliosis	7
periodic sleep studies	7
biochemical genetics or neurogenetics consultation	7
management focuses on rehabilitation to optimize mobility and communication	7
treatment of seizures follows standard management principles	7
serum iron status	7
pituitary-gonadal axis	7
pituitary mri may be considered in some cases	7
affected joints	7
radiographic evaluation	7
dual photon absorptiometry of the lumbar spine	7
ecg, transthoracic echocardiogram	7
liver histology to determine the extent of liver damage	7
treatment of iron overload	7
it is simple, safe, and effective	7
the hematocrit should be monitored prior to phlebotomy	7
usually four to six phlebotomies annually are sufficient	7
treatment of secondary complications	7
transdermal preparations (i	7
arthropathy is not modified by treatment	7
cirrhosis is thought to be irreversible despite iron removal	7
diabetes mellitus may require insulin administration	7
treatment by phlebotomy in presymptomatic stages can prevent organ damage	7
hrt prevents the development of osteoporosis	7
iron-containing preparations and supplemental vitamin c	7
formal audiology evaluation for extent of hearing loss	7
cardiac examination including calculation of qtc	7
complete blood count to screen for anemia	7
cardiac issues	7
even with additional therapies (e	7
qtc interval >550 msec	7
syncope before age five years	7
left cardiac sympathetic denervation has been effective for some individuals	7
iron deficiency anemia	7
crediblemeds	7
triggers for intense or sudden emotion	7
competitive sports	7
amusement park rides	7
frightening movies	7
jumping into cold water	7
affected individuals should wear an id bracelet explaining their diagnosis	7
developmental assessment with age-appropriate tools	7
, loss of corticomedullary differentiation)	7
hypotonia and therapeutic interventions	7
periodic neuropsychologic and developmental testing at appropriate ages	7
other cns malformations	7
posterior fossa cysts and fluid collections rarely require intervention	7
encephalocele may require primary surgical closure	7
corrective lenses for refractive errors	7
consultation with a nephrologist is indicated	7
hepatic fibrosis	7
consultation with a gastroenterologist is indicated	7
some individuals have needed orthotopic liver transplantation	7
surgical treatment for polydactyly	7
appropriate medical management by an orthopedic specialist for scoliosis	7
orofacial clefting is treated by standard surgical interventions	7
neuropsychological and developmental evaluation and testing, as appropriate	7
individuals with liver impairment should avoid hepatotoxic medications	7
evaluate the degree of response to treatment	7
assess for cognitive or behavioral problems	7
consider clinical genetics consultation	7
no specific guidelines are currently available	7
pregnancy in women with parkinson disease is a rare event	7
jps	7
jps/hht	7
treat manifestations of hht as needed	7
see hereditary hemorrhagic telangiectasia	7
these symptoms may warrant additional screening	7
if negative, screening should be repeated in three years	7
population	7
see hereditary hemorrhagic telangiectasia, pregnancy management	7
no known chemoprevention options are effective for juvenile polyps	7
comprehensive management guidelines are also available online (pdf)	7
monitoring for nocturnal lagophthalmos by parents or caregivers is recommended	7
if present, evaluation by an ophthalmologist is indicated	7
, dental work) that could lead to bacteremia	7
the following are recommended for individuals with ks:	7
evaluation of developmental milestones at each well child visit	7
referral for formal developmental evaluation if delays are identified	7
annual monitoring of vision	7
expectant monitoring for otitis media in children	7
gps and sbbyss	7
evaluation by developmental specialist	7
feeding evaluation	7
baseline hearing evaluation	7
gps	7
hip radiographs to evaluate for femoral head dislocation	7
renal ultrasound examination for hydronephrosis and cysts	7
sbbyss	7
skeletal features	7
early referral to physical therapy to help increase joint mobility	7
orchiopexy in males with undescended testes	7
anal anomalies	7
referral to an urologist or nephrologist as indicated	7
facial features	7
hearing aids as needed for hearing loss	7
the following should be assessed annually:	7
thyroid function	7
cardiac function if malformations are present	7
renal function if hydronephrosis or multiple renal cysts are present	7
oropharynx	7
feeding & swallowing evaluation	7
polysomnogram if obstructive apnea is suspected	7
evaluation for skeletal manifestations (i	7
joint contractures, scoliosis)	7
consider referral to an orthopedist, if indicated	7
neurological	7
assessment of strength & motor skills	7
assessment for hypoglycemia during neonatal period & infancy	7
misc/other	7
no specific management guidelines have been developed	7
management is mostly supportive	7
lacrimal duct obstruction	7
tear duct massage	7
consider lacrimal duct stent placement	7
cleft palate, bifid uvula, or velopharyngeal insufficiency	7
management by a cleft/craniofacial team	7
cpap or bipap	7
ent evaluation for tonsillectomy/adenoidectomy	7
pulmonary consultation	7
feeding difficulties or signs of aspiration	7
use of a special nipple or bottle with cleft palate	7
short-term nasogastric feeding tube	7
consideration of gastrostomy tube	7
gastroesophageal reflux disease	7
standard positioning & pharmacologic treatment	7
musculoskeletal findings (i	7
, contractures, scoliosis)	7
ankle-foot orthoses or other assistive devices	7
physical therapy and/or occupational therapy evaluation	7
consultation w/an orthopedist	7
seizure disorder	7
evaluation of blood sugar & electrolytes	7
standard treatment for seizures	7
consider eeg and referral to a neurologist	7
unexplained hypoglycemia or suspected hyperinsulinism	7
consideration of diazoxide therapy	7
consider referral to an endocrinologist	7
consider referral to a neurodevelopmental specialist and/or neuropsychiatric testing	7
evaluation of nutritional status & growth	7
evaluation of feeding difficulties	7
sleep study (if history of sleep disturbance)	7
evaluate for scoliosis	7
every 6 months until age 2 years	7
1 or task3)	7
the reduced outward current through abnormal p	7
benign familial neonatal epilepsy (bfne)	7
all but three had family histories of neonatal seizures	7
pathogenic variants in kcnq3 were present in two	7
earlier initiation of cbz was associated with shorter hospitalization	7
no side effects of cbz were reported	7
8 years)	7
benign familial infantile epilepsy (bfie)	7
bfne	7
bfie	7
the eeg at 36 months should be normal	7
see mothertobaby for more information on medication use during pregnancy	7
ezogabine has been commercially withdrawn as of june 2017	7
assessment of/for:	7
attention to distal muscle strength and deep tendon reflexes	7
swallowing	7
appropriate measures include:	7
strength testing (annually)	7
pulmonary function tests (annually in advanced cases)	7
high-dose testosterone	7
anti-androgen therapy	7
creatine supplementation	7
this remains to be tested	7
experimental therapies in animal models	7
reverses changes in muscle gene expression	7
and extends the life span of mutant males	7
renal ultrasound examination to evaluate for possible renal/urologic anomalies	7
speech/language evaluation including audiologic examination	7
physical and/or occupational therapy assessment	7
no well-controlled treatment trials have been reported	7
cardiac and renal/urologic abnormalities should be monitored as needed	7
males with igd age ≥18 years	7
hormone replacement therapy for males not desiring fertility	7
doses do vary with newer testosterone preparations	7
if testosterone levels fall, therapy should be reinitiated	7
human chorionic gonadotropin (hcg)	7
male infants/adolescents with suspicion of igd	7
if igd is clinically suspected (e	7
fsh is added at doses ranging from 37	7
5 to 75 iu as either hmg or recombinant formulation	7
pulsatile gnrh stimulation vs	7
females with igd	7
hormone replacement therapy for females not desiring fertility	7
many formulations of estrogens are available	7
a suggested oral regimen is using premarin 0	7
25 mg daily	7
in vitro fertilization	7
bone age determinations	7
growth assessment, including assessment of feeding and nutrition	7
ophthalmologic evaluation for microcornea, cataract, ptosis, coloboma	7
hearing evaluation for sensorineural or mixed sensorineural/conductive hearing impairment	7
renal ultrasound examination for structural renal abnormalities and vesicoureteral reflux	7
hip ultrasound examination to evaluate for femoral head dislocation	7
evaluation of thyroid function	7
other hormone levels if clinically indicated	7
the following treatment recommendations are appropriate:	7
educational intervention and speech therapy beginning in infancy	7
cataract and ptosis surgery if indicated	7
hearing aids or cochlear implant if needed	7
cardiac function assessment and treatment if needed	7
orchidopexy in males with undescended testes	7
treatment of vesicoureteral reflux if indicated	7
other facial	7
cleft palate repair if present	7
the following should be assessed at least annually:	7
vision, hearing	7
brain mri and mrs	7
treated individuals show improved and preserved cognitive function	7
complete hematologic and gastroenterologic evaluations for pearson syndrome in infants	7
placement of eyelid slings for severe ptosis	7
cochlear implants and hearing aids for neurosensory hearing loss	7
hormone replacement for endocrinopathies	7
dilation of the upper esophageal sphincter to alleviate cricopharyngeal achalasia	7
replacement of pancreatic enzymes in pearson syndrome	7
treatment of depression	7
ventilatory support for respiratory abnormalities in leigh syndrome	7
yearly audiometry and endocrinologic evaluation	7
medications to avoid:	7
head imaging study	7
surgical treatment should be performed as needed	7
developmental progress should be monitored and stimulated	7
adducted thumbs	7
surgical intervention is not generally indicated	7
a splint may help reduce the degree of adduction	7
neurologic features should be monitored	7
follow up and treatment is nonspecific	7
physiotherapy is recommended	7
evaluation by a child neurologist at regular intervals is appropriate	7
psychological evaluation and neuropsychological assessment	7
assessment by rehabilitation specialists including equipment needs	7
evaluation of swallowing function and communication	7
gastroenterology evaluation for bowel dysfunction	7
consultation with clinical geneticist and/or genetic counselor	7
autonomic dysfunction	7
neurogenic bladder:	7
urinary urgency may require spasmolytics (e	7
, solifenacine succinate)	7
, docusate) or a laxative is needed	7
sexual dysfunction can be alleviated with sildenafil	7
anhidrosis is managed by avoiding overheating	7
cognitive dysfunction can affect social interactions and financial management	7
yearly influenza immunizations	7
valproic acid is the traditional antiepileptic treatment for ld	7
carbamazepine [nanba & maegaki 1999]	7
oxcarbazepine [kaddurah & holmes 2006]	7
wolman disease	7
malabsorption and malnutrition	7
hepatomegaly and liver disease	7
adrenal cortical insufficiency	7
consider discussion of comfort care options	7
cesd	7
lipophilic vitamin supplementation may also be beneficial	7
special attention should be paid to growth and nutritional status	7
chronic diarrhea or failure to thrive could indicate malabsorption	7
special attention should be paid to nutritional status	7
chronic diarrhea or weight loss could indicate malabsorption	7
both children and adults	7
consensus on optimal screening protocols has not been published	7
brain and spinal cord mri	7
if possible, proton mrs of abnormal cerebral white matter	7
the following as needed:	7
lbsl is very slowly progressive in most cases	7
annual clinical evaluations suffice	7
rarely, vision appears to improve beyond expectations	7
in such cases, a repeat erg is indicated	7
recurrence is possible even with more definitive treatment	7
surgery for ptosis if clinically indicated (e	7
, obscured vision, cosmetic appearance)	7
prophylactic antibiotics (e	7
edema may be exacerbated during pregnancy	7
diuretics are not effective in the treatment of lymphedema	7
cosmetic surgery is often associated with disappointing results	7
age-appropriate developmental assessment	7
detailed dermatologic evaluation for supportive findings	7
individualized education plans for learning disorders and school performance issues	7
consideration of hearing evaluation during infancy if:	7
early intervention with special education maximizes cognitive development	7
referral to services for the visually impaired is recommended	7
no special preventative care is recommended	7
urinalysis if urinary tract abnormalities are identified	7
treatment of hearing loss may include the following:	7
if the ptpn11, raf1,	7
orthopedic examination when gait is severely impaired	7
baseline cardiac evaluation including echocardiogram	7
avoidance of prolonged immobility is recommended	7
while the specific mechanism whereby cholesterol-lowering agents (e	7
measurement of best corrected visual acuity	7
assessment of visual fields with static or kinetic perimetry	7
idebenone	7
3460g>a, m	7
11778g>a, and m	7
hormone therapy	7
mitochondrial replacement	7
examination for evidence of infection	7
evaluation for problems relating to prematurity	7
evaluation by a dermatologist familiar with congenital ichthyosis	7
assessment of transepidermal water loss and hydration status	7
assessment of corneal hydration in babies with ectropion	7
assessment of feeding and nutrition status	7
prevention of dehydration	7
maintenance of body temperature	7
prevention of overheating	7
prevention of corneal drying	7
high caloric diet	7
frequency depends on the severity	7
skin irritants and overheating should be avoided	7
the following is recommended:	7
the following is suggested:	7
consultation with a dermatologist (or pediatric dermatologist)	7
evaluation for evidence of seizures if clinical findings are suggestive	7
evaluation for neuropsychiatric manifestations	7
there is no curative therapy for lp	7
treatments of unproven efficacy	7
click here (pdf) for further details	7
monitoring of the airway and vocal cords by an otolaryngologist	7
neurocognitive assessment	7
assessment by general surgery for abdominal hernia repair	7
assessment by orthopedic surgery for symptomatic skeletal deformities	7
visualization of the aortic arch by echocardiogram or mri	7
urologic assessment for cryptorchidism if present	7
feeding assessment	7
specific treatment for lms does not currently exist	7
lateral spinal meningoceles	7
symptomatic treatment of neurologic sequelae (e	7
physiotherapy to reduce risk for joint subluxation and dislocation	7
routine management of the following:	7
congenital cardiac defects	7
no surveillance guidelines for lms have been published	7
complete blood count to evaluate for megaloblastic anemia	7
chemistry screen for uric acid concentration	7
developmental/behavioral assessments	7
hyperuricemia	7
allopurinol therapy results in the accumulation of hypoxanthine and xanthine	7
xanthine may also form stones	7
hypoxanthine is soluble	7
neurologic dysfunction	7
virtually any reduction of hyperuricemia will prevent urate nephropathy	7
monitor plasma uric acid concentration and urinary excretion of oxypurines	7
monitor affected individuals for early signs of self-injury	7
some carrier females develop gout in later years	7
deep brain stimulation must be considered experimental at present	7
partial exchange transfusion in two individuals	7
, severe aortic dilatation)	7
, severe scoliosis, cervical spine instability)	7
craniofacial examination for evidence of cleft palate and craniosynostosis	7
specific assessment for retinal detachment and blue sclerae	7
two important considerations when managing cardiovascular features of lds:	7
vascular disease is not limited to the aortic root	7
0 cm and the excellent response to prophylactic surgery	7
clubfeet require surgical correction by an orthopedic surgeon	7
surgical intervention for protusio acetabulae is rarely indicated	7
treatment focuses on pain control	7
orthotics are only indicated for severe pes planus	7
some individuals prefer use of arch supports	7
others find them irritating	7
surgical intervention is rarely indicated or successful	7
if the causal tgfbr1,	7
pregnancy can be dangerous for women with lds	7
plasma carnitinine may be measured to evaluate for carnintine deficiency	7
developmental and behavioral evaluations should be completed	7
cataract surgeons and glaucoma specialists may also be needed	7
others require surgery	7
most seizure disorders can be controlled with anticonvulsant therapy	7
early childhood and preschool intervention programs, e	7
kidney	7
, with surgical procedures	7
most undescended testes descend with time into the scrotum	7
some require hormone therapy and/or surgical correction	7
no formal guidelines exist	7
corneal contact lenses	7
artificial lens implants	7
neurologic evaluation to detect secondary neurologic damage	7
evaluation and follow-up of growth parameters	7
hematologic evaluation (bone marrow aspirate may be required)	7
renal function studies	7
bone density evaluation	7
treatment of acute hyperammonemic crises	7
pharmacologic management	7
therapy with ondansetron can be started to decrease vomiting	7
dietary protein restriction and citrulline supplementation	7
current treatment consists of dietary protein restriction (0	7
8-1	7
5 g/kg/day in children and 0	7
lysine supplementation	7
carnitine supplemetation	7
treatment of late complications	7
however, relapses may require serial lavage	7
monitoring should include the following:	7
fasting and postprandial blood ammonia concentrations	7
urinary orotic acid excretion	7
attention to early clinical signs of lung involvement	7
serum concentrations of ldh and ferritin	7
no specific guidelines have been proposed	7
large boluses of protein or amino acids should be avoided	7
alendronate	7
medical nutrition therapy	7
recurrent or persistent eruptive xanthomas indicate inadequate therapy	7
fat malabsorption is very rare	7
it is appropriate to evaluate at-risk sibs during infancy	7
measurement of plasma triglyceride concentration	7
1:p	7
ser474ter (nm_000237	7
2:c	7
1421c>g)	7
tremor	7
rigidity	7
bradykinesia	7
mental status	7
a number of inhibitors are being developed	7
chest x-ray or high-resolution ct scan	7
ultrasound examination of the genitourinary tract	7
bladder ultrasound examination to diagnose multiple bladder diverticula	7
physiotherapeutic evaluation (hypotonia, hyperlaxity)	7
on clinical indication:	7
bronchoscopy	7
visualization of the gastrointestinal tract by gastrographin ingestion or enema	7
intravenous pyelogram may be an alternative	7
treatment is largely symptomatic	7
oxygen supplementation if necessary	7
education on complete bladder emptying when voiding	7
medical treatment of pulmonary hypertension (e	7
, by sildenafil)	7
surgical treatment of congenital diaphragmatic hernia or severe hiatal hernia	7
physical therapy for muscle strength and joint stability	7
psychosocial support	7
repeat imaging of:	7
gastrointestinal tract	7
cardiovascular system	7
positive pressure ventilation unless needed to treat life-threatening conditions	7
people with respiratory infections	7
affected mother	7
affected fetus	7
height, arm span, and sitting height	7
madelung deformity	7
body mass index that is frequently above the mean	7
mainly because of shortening of the legs	7
painful bilateral madelung deformity (uncommon)	7
upper airway obstruction	7
clinical feeding and nutrition evaluation	7
cervical spine films	7
, torticollis)	7
audiologist	7
dietitian	7
clinical geneticist and genetic counselor	7
nurse coordinator	7
oral and maxillofacial surgeon	7
orthodontist	7
orthopedist	7
otolaryngologist	7
pediatric dentist	7
pediatrician	7
plastic and reconstructive surgeon	7
psychosocial professionals (psychologist, social worker)	7
speech pathologist	7
referral to a craniofacial center or otolaryngologist is recommended	7
face	7
jaw and teeth	7
good oral hygiene is especially important for children with cfm	7
children should have consistent primary preventative dental care	7
early referral to an otolaryngologist is recommended	7
this surgery typically occurs after age five years	7
ears	7
options for management of microtia include the following:	7
no action	7
prosthetic management, either adhesive or implant-retained	7
family and social support	7
individuals with any degree of hearing loss	7
avoid exposure to ototoxic drugs	7
individuals with cervical spine anomalies	7
individuals with a single kidney	7
manage diabetes mellitus to maintain good control and avoid hyperglycemia	7
skeletal radiographs, if not already performed	7
cbc, if not already performed	7
bone marrow biopsy if significant anemia is present	7
examination of the skin	7
crmo is treated as follows:	7
thus, their efficacy in this disorder is unknown	7
physical therapy to avoid disuse atrophy of muscles or contractures	7
physical therapy can help to prevent contractures	7
regular pediatric care	7
colonoscopy and review of pathology	7
upper endoscopy and review of pathology	7
colon polyps and colon cancer	7
colonoscopy is effective surveillance for colon cancer	7
duodenal polyps	7
management of polyps is similar to individuals with fap	7
individuals with biallelic germline	7
in europe:	7
registration or institutional access required):	7
pan colonoscopy beginning at age 18-20 years	7
individuals heterozygous for a germline	7
specific assessment for glaucoma and cataract	7
, severe scoliosis)	7
click here	7
protusio acetabulae can be associated with pain or functional limitations	7
surgical intervention is rarely indicated	7
orthotics are indicated only in severe cases	7
surgical intervention is rarely indicated or fully successful	7
pneumothorax can be a recurrent problem	7
, prolonged lethargy, depression)	7
caffeine can aggravate a tendency for arrhythmia	7
agents that cause vasoconstriction, including triptans	7
lasik correction of visual deficits	7
at a root dimension <5	7
0cm) before becoming pregnant	7
speech evaluation including feeding evaluation and nutrition consultation as needed	7
behavioral assessment	7
school-age children benefit from an individualized educational program	7
no information is available on response to specific aeds	7
plasma acylcarnitine analysis	7
plasma free and total carnitine measurement	7
urine acylglycine analysis	7
urine organic acid analysis	7
mcad activity assay in leukocytes (where available)	7
blood glucose concentration	7
blood gas analysis	7
ammonia	7
lactic acid	7
blood cultures (in case of fever)	7
up to ten hours during the second year of life	7
up to 12 hours after age two years	7
to avoid excessive fasting:	7
infants require frequent feedings	7
a relatively low-fat diet (e	7
alcohol consumption, in particular acute alcohol intoxication (e	7
pregnant women who have mcad deficiency must avoid catabolism	7
the authors recommend the following studies:	7
skeleton	7
fd evaluation	7
see fibrous dysplasia evaluation (pdf)	7
see gonadal evaluation in girls (pdf)	7
see gonadal evaluation in boys (pdf)	7
growth hormone excess evaluation (pdf)	7
see thyroid evaluation (pdf)	7
adrenal evaluation (pdf)	7
less common manifestations	7
see gastrointestinal evaluation (pdf)	7
the primary elements of management include the following	7
see fibrous dysplasia management (pdf):	7
see precocious puberty management in girls (pdf)	7
see gonadal involvement management in boys (pdf)	7
, letrozole) [boyce et al 2012]	7
thyroid disease	7
see hyperthyroidism management (pdf)	7
methimazole is effective for management of hyperthyroidism	7
the risk may potentially be enhanced by radiation exposure	7
growth hormone (gh) excess	7
see gh excess: management (pdf)	7
medical therapy is the preferred first-line treatment	7
see hypercortisolism management (pdf)	7
definitive treatment includes surgical removal of the diseased adrenal glands	7
see gonadal involvement management in boys	7
growth hormone excess	7
see growth hormone excess evaluation:	7
all children should be monitored for growth acceleration	7
routine biochemical surveillance is not indicated	7
see gastrointestinal management (pdf)	7
while a strong association between gsp mutations (i	7
, radiation exposure) and encourage vigilance and monitoring	7
referral to a nephrologist for further evaluation	7
care by a nephrologist is recommended	7
hemoglobin concentration	7
serum concentrations of uric acid and creatinine	7
for the purpose of early diagnosis and treatment	7
for the purpose of kidney donation	7
measurement of serum uric acid concentration	7
gout prevention with allopurinol or probenecid should be considered	7
kidney disease	7
measurement of serum uric acid concentration at least annually	7
drugs known to be nephrotoxic should be avoided	7
however, patients should avoid chronic daily use	7
no pregnancy issues are particular to adtkd-umod	7
neurologic and neuropsychological examination	7
serum ck concentration and liver function tests	7
cerebral mri and electroencephalography	7
treatment of psychiatric problems according to the clinical presentation	7
antiepileptic drugs (aeds) for treatment of seizures	7
carrier females with the mcleod blood group phenotype	7
one individual with mls developed life-threatening rhabdomyolysis	7
thus, no particular recommendations can be made	7
no prenatal or perinatal neurologic manifestations of mls are known	7
physical therapy assessment of muscle strength and joint mobility	7
neuropsychological testing if learning or behavioral deficiencies are identified	7
evaluation by a cardiologist including electrocardiogram and echocardiogram	7
evaluation of respite care services for caregivers	7
early-onset	7
nutrition/weight	7
weight needs to increase annually by small increments	7
gastroesophageal reflux is treated as needed	7
respiratory function testing	7
assistance with coughing	7
noninvasive ventilation support is indicated in the setting of:	7
daytime hypercapnea and/or nocturnal hypoventilation	7
toddlers often fight the masks	7
non-ambulant children require standing frames for postural support	7
late-onset	7
antiepileptic drugs should be used to treat seizures	7
early-onset lama2 md	7
annual measurement of fvc to allow trending of fvc	7
at least annual evaluation of the spine by an orthopedist	7
cardiac monitoring:	7
late-onset lama2 md	7
monitor for respiratory insufficiency with serial pulmonary function tests	7
monitor to detect and treat seizures	7
cognitive assessment including speech assessment	7
eeg and neurologic examination if epilepsy is suspected	7
cardiac ultrasound evaluation	7
additional management in healthy adults who have the 15q13	7
, schizophrenia)	7
about 10% of the individuals with the 15q13	7
3 microdeletion develop schizophrenia	7
using genomic testing that will detect the 15q13	7
formal audiology evaluation to assess for sensorineural hearing loss	7
brain imaging in individuals with microcephaly and/or neurologic findings	7
examination for genitourinary abnormalities (e	7
, hypospadias or cryptorchidism in males)	7
discussion of results with a clinical geneticist or genetic counselor	7
routine treatment of ophthalmologic, cardiac, neurologic findings	7
speech, occupational, and physical therapies	7
routine developmental assessments	7
monitoring of specific identified medical issues	7
close monitoring for intrauterine growth retardation is warranted	7
2 microdeletion, the following evaluations are recommended:	7
broad review of all organ systems	7
developmental assessment with cognitive and behavioral testing	7
to consider:	7
evaluation and echocardiogram by a cardiologist	7
because manifestations of 16p12	7
early diagnosis and treatment facilitate the best outcome	7
developmental and cognitive delays	7
initiate developmental therapies promptly when indicated	7
individuals with 16p12	7
psychiatric and/or behavior problems	7
standard treatment should be provided for hearing loss	7
other malformations	7
periodic:	7
urine magnesium and creatinine	7
and consultation with a nephrologist	7
liver function tests (ast, alt, ggtp)	7
clinical assessment for congenital heart defects	7
consultation with a cardiologist and echocardiography if warranted	7
neurology consultation if seizure activity is suspected	7
neurodevelopmental/neuropsychiatric disorders	7
renal structure/function	7
periodic monitoring of renal function	7
serum concentration of magnesium, potassium, uric acid	7
hgba1c annually	7
routine monitoring through early childhood	7
audiologic and ophthalmological evaluations on a regular basis	7
multidisciplinary developmental evaluation, including feeding assessment	7
comprehensive speech/language evaluation including audiologic examination	7
a renal ultrasound examination	7
brain imaging studies in individuals with microcephaly and/or seizures	7
involvement of a clinical geneticist following the initial diagnosis	7
routine medical care by a pediatrician or other primary physician	7
speech therapy directed at improving verbal and nonverbal communication skills	7
the seizures usually are easy to control with medication	7
treatment for cryptorchidism if indicated	7
ongoing pediatric care	7
monitoring for spine deformities	7
monitoring as needed of cardiac and renal/urologic abnormalities	7
ophthalmologic examination if there are concerns about vision	7
psychiatric evaluation if evidence of mental illness is present	7
routine treatment of ophthalmologic, cardiac, and neurologic findings	7
speech, occupational, and physical therapies, as appropriate	7
routine developmental and learning assessments	7
monitoring of any specific medical issues that are identified	7
using genomic testing that will detect the 1q21	7
assessment for feeding problems and nutrition	7
consultation with pediatric feeding specialists as needed	7
early consultation with a pediatric dentist	7
evaluation in infancy for evidence of congenital heart disease	7
early speech and language therapy to address speech delays	7
individualized education program (iep) for school-age children	7
applied behavioral analysis or other treatment for manifestations of asd	7
continued assessment of:	7
developmental milestones	7
possible psychiatric manifestations	7
brain imaging (not using ct) and neurologic evaluation	7
familial genetic counseling	7
3 microdeletion until disproven otherwise	7
3 microdeletion	7
evaluation of school performance and emotional status	7
ataxia may require assistive devices or eventually wheelchair	7
consultation with a speech pathologist may be helpful	7
valproate levels are affected by a number of drugs	7
phenytoin [eldridge et al 1983]	7
complete neurologic evaluation and eeg	7
complete neuropsychological evaluation of intellectual level and behavioral problems	7
assessment of feeding for swallowing difficulties in infants	7
cognitive impairment	7
developmental stimulation including speech therapy is appropriate	7
treatment is nonspecific	7
predisposition to infections	7
all vaccines should be given	7
gastrointestinal dysfunction	7
respiratory problems require early intervention	7
the following should be monitored from early childhood:	7
onset and frequency of seizures and response to antiepileptic medications	7
number and type of infections	7
autistic-like features	7
gastrointestinal symptoms	7
complete neurologic examination, including brain mri	7
developmental assessment, iq testing	7
for (progressive) spasticity	7
for excessive drooling	7
patients experienced great improvement (e	7
for failure to thrive	7
medications known to impair mitochondrial function (e	7
, valproic acid) should be avoided	7
no therapy is available for peo or retinopathy	7
physical therapy should be implemented in individuals after strokes	7
seizures respond to traditional anticonvulsant therapy	7
standard analgesics can be used for migraine headaches	7
cardiac manifestations can benefit from standard pharmacologic therapy	7
no specific treatment for melas exists	7
infertility may preclude pregnancy in some affected individuals	7
double-blind studies are needed to confirm these data	7
multiglandular parathyroid disease	7
prolactinoma	7
gastrinoma and other entero-pancreatic neuroendocrine tumors	7
phpt	7
subtotal parathyroidectomy (i	7
removal of ≤3	7
prl-secreting tumors (prolactinomas)	7
growth hormone-secreting tumors	7
acth-secreting tumors	7
non-secreting pituitary adenomas	7
gastrinoma	7
pancreatic tumors	7
the optimal therapy of gastrinoma is controversial	7
occult metastatic disease (i	7
carcinoid tumors	7
adrenocortical tumors	7
postoperative hypoparathyroidism	7
intraoperative hypertensive crisis	7
men1 minimal surveillance program	7
fasting serum gastrin concentration from age 20 years 2	7
every three to five years beginning at the specified age	7
head mri from age five years 2	7
abdominal ct or mri from age 20 years 2	7
notes:	7
serum concentration of prolactin from age five years	7
primary hyperparathyroidism (phpt)	7
a dose of 30 mg daily was well tolerated	7
hypercalcemia and hypercalciuria normalized in 75% and 62	7
5%, respectively	7
these two studies mainly included individuals without men1	7
biochemical evaluations	7
plasma calcitonin	7
plasma catecholamines and metanephrines	7
serum calcium and parathyroid hormone	7
workup to evaluate for metastatic disease in individuals with mtc	7
ct with contrast for chest and abdomen	7
medullary thyroid carcinoma (mtc)	7
prophylactic thyroidectomy is safe for all age groups	7
ata 1 risk level	7
pathogenic variants 2, 3	7
age of prophylactic surgery	7
age to begin screening	7
for pheo	7
for hpt 4	7
level d(highest risk)	7
ala883phep	7
met918thrp	7
glu805lys 5p	7
tyr806cys 5p	7
ser904cys 5	7
as soon as possible in 1st year of life	7
level c	7
cys634arg/gly/phe/ser/trp/tyr	7
<5 yrs	7
level b	7
cys609phe/arg/gly/ser/tyrp	7
cys611arg/gly/phe/ser/trp/tyrp	7
cys618arg/gly/phe/ser/tyrp	7
cys620arg/gly/phe/ser/trp/tyrp	7
cys630arg/phe/ser/tyrp	7
asp631tyrp	7
633/9 bp dupp	7
634/12 bp dupp	7
val778ile 5	7
consider <5 yrs	7
may delay if criteria met 5	7
level a	7
arg321glyp	7
531/9 bp dupp	7
532 dupp	7
cys515serp	7
gly533cysp	7
arg600glnp	7
lys603glup	7
tyr606cysp	7
635/insert elcr	7
thr636prop	7
lys666glup	7
glu768aspp	7
asn777serp	7
leu790phep	7
val804leu/metp	7
gly819lysp	7
arg833cysp	7
arg844glnp	7
arg866trpp	7
ser891alap	7
arg912pro	7
may delay beyond age 5 yrs if criteria met 6	7
six months for children with men 2b	7
mtc	7
hypoparathyroidism	7
parathyroid adenoma or hyperplasia	7
dopamine d2 receptor antagonists (e	7
other medications including monoamine oxidase inhibitors, sympathomimetics (e	7
albumin-corrected calcium or ionized calcium for hyperparathyroidism	7
evaluation of feeding and nutrition	7
assessment of bladder function	7
bladder diverticula	7
vascular tortuosity	7
dysautonomia (chronic diarrhea, orthostatic hypotension)	7
mild cognitive deficits	7
emg with nerve conduction studies	7
surgery for bladder diverticula that occur in classic menkes disease	7
developmental intervention	7
atp7a-related dmn	7
physical therapy (strength and stretching exercises)	7
occupational therapy	7
ankle foot orthotics	7
occipital horn syndrome	7
antibiotic prophylaxis may be necessary to prevent bladder infection	7
therapies proven to be ineffective include vitamin c	7
medical genetics consultation including genetic counseling	7
the seizure disorder can be treated with conventional anticonvulsant therapy	7
clonazepam can also reduce myoclonus	7
physical therapy is helpful for any impaired motor abilities	7
standard pharmacologic therapy is used to treat cardiac symptoms	7
, skeletal x-ray for scoliosis)	7
mandibulofacial dysostosis	7
see esophageal atresia/tracheoesophageal fistula overview	7
thumb anomalies	7
other thumb anomalies are not generally functionally significant	7
short stature is managed expectantly	7
, cardiac and renal defects)	7
routine ecg to identify arrhythmias and cardiac conduction defects	7
holter monitoring if symptoms suggest an intermittent arrhythmia	7
echocardiogram if cardiac symptoms are present	7
respiratory function tests if respiratory symptoms are present	7
treatment of scoliosis by spinal fusion is appropriate	7
orthoses are indicated for treatment of foot drop	7
electrocardiogram and/or echocardiogram yearly for early detection of cardiomyopathy	7
pulmonary function tests for individuals with exertional or nocturnal dyspnea	7
the role of strengthening exercises has not been defined	7
developmental/educational assessment	7
tobacco and alcohol use	7
medications known to impair mitochondrial function	7
arterial blood gas analysis	7
serum concentration of electrolytes, lactate, and ck	7
coagulation studies	7
continuous core temperature monitoring until the syndrome has resolved	7
measurement of serum ck concentrations until normalized	7
family history of anesthetic complications	7
discontinue use of potent inhalation agents and succinylcholine	7
increase minute ventilation to lower end-tidal co2	7
get help	7
prepare and administer dantrolene: 2	7
5 mg/kg initial dose	7
tachycardia, hypercarbia, and muscle rigidity respond rapidly	7
multiple doses of dantrolene may be needed	7
the suggested upper limit is 10 mg/kg	7
however, more may be given as needed	7
continue dantrolene at 1	7
dantrolene may aggravate previously existing muscle weakness	7
begin cooling measures	7
stop cooling measures at core body temperature of 38	7
5° c	7
treat cardiac arrhythmias as needed	7
do not use calcium channel blockers	7
check values every six to 12 hours	7
the earliest sign of rhabdomyolysis is myoglobinuria/myoglobinemia	7
serum ck levels may not rise for several hours	7
ensure urine output of 2	7
evaluate need for invasive monitoring and continued mechanical ventilation	7
myoglobinuria	7
medicalert	7
fetal monitoring should follow standard guidelines	7
continuous epidural analgesia is highly recommended for labor and delivery	7
therapies under investigations	7
, physiotherapy, occupational therapy, communication assistance)	7
pediatric neurology evaluation	7
baseline echocardiogram and abdominal ultrasound examination	7
pediatric palliative care consultation and psychosocial support for family	7
physical habilitation	7
standard care for other medical issues (e	7
regular follow up with a child neurologist for seizure management	7
age-adapted psychomotor or neuropsychological evaluation	7
therapy is supportive and involves the following:	7
special education programs tailored to the needs of the individual	7
speech and language therapy	7
behavioral therapy as needed	7
occupational therapy as needed	7
community services that provide support for families	7
ritalin® may be helpful to treat marked hyperkinesia	7
objective efficiency of gh therapy has not been evaluated	7
monitoring of head circumference and stature using standard growth charts	7
dermatologic evaluation to look for skin lesions	7
use of a prosthesis in severe microphthalmia and anophthalmia	7
referral to a lymphedema therapist	7
lymphoscintigraphy	7
, fitting stockings, massage) is important	7
secondary cellulitis is prevented through the following measures:	7
prompt treatment for early cellulitis with appropriate antibiotics	7
prophylactic antibiotics in recurrent cases (e	7
, penicillin v 500 mg daily)	7
, on a long airplane flight)	7
treatment with diuretics is of no proven benefit	7
a clinical genetics consultation may also be proposed	7
adaptation of the school environment (e	7
especially calf muscle	7
if needed, measurement of serum ck concentration	7
no definitive treatments exist for the limb-girdle muscular dystrophies	7
stretching exercises to prevent contractures are indicated	7
the following surveillance is appropriate:	7
control weight to avoid obesity	7
muscle strength improved after the study drug was discontinued	7
skeletal radiographs to detect osseous polydactyly and syndactyly	7
ecg and echocardiogram, to detect congenital heart defects	7
standard treatment is indicated for the following:	7
polydactyly and syndactyly	7
anal anomalies and hirschsprung disease (surgical treatment)	7
surveillance as appropriate for each individual is recommended	7
pulmonary radiographs	7
joint	7
intellectual impairment in ml ii is rarely severe	7
severe gingival thickening can compromise routine dental cleaning	7
otic	7
extubation may also be challenging in ml ii	7
ultrasound abnormalities are not present in all affected pregnancies	7
the recommended dose is 1 mg/kg monthly	7
bone density needs to be monitored closely	7
the long-term effect(s) are unknown	7
not all affected individuals benefit from bisphosphonate treatment	7
the prevalence decreases with age	7
however, such treatment is still considered investigational	7
basic assessment	7
pain assessment	7
orthopedic and functional assessments	7
skeletal survey	7
medical genetics consultation for genetic counseling and reproductive decision making	7
psychosocial support of patients and families is recommended	7
management of pain in the hips is required	7
jaw and neck movement can be limited	7
annual ophthalmologic assessment should address possible ophthalmologic changes	7
ophthalmic examination	7
iron studies	7
neurologic evaluation, including eeg	7
surgical correction of strabismus	7
physical therapy and rehabilitation can help prevent permanent joint contractures	7
annual follow up with a generalist is appropriate	7
assessment of cognitive dysfunction (neuropsychological testing)	7
speech therapy as needed	7
examination of the peripheral nervous system	7
guidelines	7
pulmonary function and vision may also need attention	7
they reflect evolving pretreatment conditioning and improved donor matching	7
hsct failures continue	7
nevertheless, some improvement has been seen	7
piguet et al [2009] investigate intracerebral aavrh	7
10 as a possible gene therapy vector for mld	7
mouse model of mld	7
other studies	7
capotondo et al [2007] evaluated overexpression of arsa	7
arterial or venous blood gas	7
plasma ammonium and lactic acid concentration	7
formal urinalysis and ketone measurement	7
quantitative plasma amino acids	7
biochemical genetics consultation	7
stabilization of critically ill individuals	7
volume replacement with isotonic solutions	7
adequate kcals must be delivered	7
after stabilization, nutritional management is critical	7
a propiogenic amino acid-deficient formula (e	7
isolated valine or isoleucine supplementation should be avoided	7
hydroxocobalamin injections	7
antibiotics	7
rotating antibiotic regimens may be considered in some persons	7
a second patient developed progressive neurologic symptoms	7
and two others developed metabolic decompensations post transplant	7
plasma and urine mma levels	7
serum acylcarnitines and free and total carnitine levels	7
liver, kidney, and bone health	7
bone marrow indices	7
stress	7
increased dietary protein	7
spinal x-rays to evaluate for presence of scoliosis	7
physical examination for joint contractures	7
cardiac evaluation for cardiomyopathy/cardiac involvement secondary to respiratory complications	7
orthodontic evaluation for palatal anomalies	7
annual influenza and other respiratory infection-related immunizations are advised	7
aggressive treatment of lower respiratory infections is critical	7
monitoring of respiratory function should include the following:	7
lung function tests (fev1 and fvc)	7
assessment of the need for intermittent or permanent ventilation	7
growth should be assessed regularly	7
regular neuromuscular evaluation to assess disease progress is indicated	7
risk for malignant hyperthermia	7
depolarizing muscle relaxants (e	7
, succinylcholine) and inhalational agents (e	7
abnormal presentation of an affected fetus may complicate delivery	7
cardiac evaluation, including echocardiogram	7
osteopenia and osteolysis	7
at present no specific therapy can alleviate the progressive osteopenia	7
nonsteroidal anti-inflammatory drugs may not provide sufficient relief	7
provide medical or surgical interventions as appropriate	7
annual assessment of joints by a rheumatologist or orthopedic surgeon	7
avoid physical trauma to reduce the risk of fractures	7
no information on pregnancy management and outcomes is available	7
monosomy 7 in children with de	7
novo aml (i	7
plastic surgery evaluation	7
eye anomalies	7
notched or bifid nose	7
rhinoplasty may be performed for cosmetic purposes	7
anal stenosis is generally managed by serial dilatations	7
electromyography/nerve conduction studies	7
the cardiomyopathy may respond to ace inhibitors or other medication	7
cardiac consultation is recommended	7
kyphoscoliosis may be treated with surgical stabilization of the spine	7
there is no treatment for spinal rigidity	7
additional recommendations include:	7
repeat electrocardiogram and echocardiogram if symptoms of cardiac insufficiency occur	7
screen cfh for pathogenic variants using bidirectional sequencing	7
these agents are not widely used in children	7
renal allografts	7
001)	7
005)	7
allograft survival appears to be age-dependent in ddd	7
penetrance rates, however, are not known	7
the following treatment modalities are of unproven value:	7
plasmapheresis to remove or suppress serum c3nef activity:	7
calcineurin inhibitors	7
bevacizumab	7
an improvement in vision was noted	7
echocardiogram (to evaluate for structural cardiac defects)	7
neurosurgical complications (hydrocephalus and cerebellar tonsillar ectopia)	7
epilepsy may require long-term antiepileptic treatment	7
developmental delays	7
however, recommended surveillance includes the following:	7
brain mri to detect hydrocephalus and/or cerebellar tonsillar ectopia	7
cardiac evaluation with echocardiography to assess ventricular size and function	7
consideration of sleep study	7
assessment of spinal cord and peripheral nerve involvement	7
joint replacement and atlanto-occipital stabilization may be necessary	7
repeated surgery may be required	7
cardiac valve replacement should be considered early	7
hearing aids should also be considered	7
ent (otolaryngologic)	7
gastrointestinal system	7
hydrocephaly	7
early surgical intervention may prevent severe complications	7
adults have not undergone hsct	7
all published reports indicate that ert is well tolerated	7
hepatic volume normalized in 92%	7
respiratory function either improved slightly or remained constant	7
timed walk measurements remained largely constant	7
growth resumed in approximately 70%	7
the most common reactions were of an immune nature	7
other studies have shown:	7
5-4	7
the following are important considerations:	7
intubation may require fiber-optic laryngoscopy	7
cardiac assessment including annual echocardiogram	7
developmental assessment in all patients	7
combined ert and hsct	7
delivery of enzyme to the cns	7
stabilization of mutated enzyme with substrate analogs	7
substrate deprivation	7
gene- and cell-based therapy	7
plain radiographs	7
baseline ap and lateral radiographs of the entire spine	7
baseline ap and frog leg lateral radiographs of the pelvis	7
baseline ap standing radiographs of the lower extremities	7
evaluation by:	7
a physiatrist (i	7
electrocardiogram and echocardiogram	7
ophthalmology evaluation to assess visual acuity and intraocular pressure	7
slit lamp examination and posterior segment examination for retinopathy	7
pain assessment and quality of life questionnaires	7
physical therapist to optimize mobility	7
occupational therapist to optimize autonomy	7
psychological support to optimize coping skills and quality of life	7
educational professions to optimize learning in a medically fragile individual	7
home care for affected individuals with multiple medical equipment needs	7
hospice for end-of-life care	7
the recommendation dose is 2 mg/kg/week intravenous	7
upper extremities	7
knee and ankle valgus	7
however, no absolute indications for intervention exist	7
hip dysplasia	7
affected individuals undergoing surgical fusion typically do well	7
lumbar spine malalignment	7
when kyphosis exceeds 45 degrees, progression is likely	7
progressive thoracolumbar kyphosis greater than 70 degrees	7
uncontrolled back pain	7
neurologic changes related to spinal stenosis	7
thus tachycardia treatment with beta blockers should be avoided	7
restrictive lung disease is managed by supportive treatment	7
learning environment	7
cataract surgery may benefit those with cataracts	7
orthodontic management to correct malocclusion may be necessary	7
see treatment of manifestations for information regarding ert	7
cardiac evaluation, including electrocardiogram and echocardiography	7
evaluation of respiratory function (spirometry and polysomnography)	7
postoperative narcotic management should be judicious	7
individuals on ert	7
physical and neurologic evaluation at least every six months	7
optimize ambulation	7
pain severity assessment every six months	7
age-appropriate quality of life questionnaires every year	7
upper and lower extremities	7
, functional dexterity test) of the upper extremities	7
, extremity weakness	7
clumsiness	7
unsteady, changing gait	7
evaluate heart rate annually	7
polysomnography every three years	7
monitor for vision and ocular abnormalities at every visit	7
refer to an ophthalmologist as needed	7
evaluate every six to 12 months	7
perform yearly audiogram	7
hypersensitivity reactions occurred in 18	7
7% of participants	7
alpha fetoprotein (afp) to screen for hepatocellular carcinoma	7
hepatology/liver transplantation consultation	7
neurologic consultation and comprehensive neurologic examination	7
brain mri to assess white matter and other abnormalities	7
nerve conduction velocity (ncv) to assess peripheral neuropathy	7
plasma lactate and glucose concentration	7
urinalysis and amino acids to assess for renal tubulopathy	7
gastrointestinal consultation if gastrointestinal dysmotility is present	7
prevention of hypoglycemia requires frequent feeds and avoidance of fasting	7
hepatocellular carcinoma	7
serum alpha fetoprotein (afp) concentration	7
urinalysis and urine amino acids to assess for renal tubulopathy	7
prolonged fasting can lead to hypoglycemia and should be avoided	7
assessment of speech and feeding	7
treatment of muscular manifestations is symptomatic	7
cataracts are removed surgically during the first decade of life	7
hypergonadotropic hypogonadism (i	7
86 and -0	7
62, respectively	7
p<0	7
0001	7
home therapy	7
acute decompensation	7
indication for hospitalization	7
number	7
vomiting and viral gastroenteritis	7
viral bronchiolitis	7
sinusitis	7
neonatal encephalopathy	7
urinary tract infection	7
cellulitis	7
influenza	7
viral meningitis	7
bacterial pharyngitis	7
esophageal candidiasis	7
appendicitis	7
the primary goals of in-hospital therapy	7
25 mosm/l per hour	7
minimize exposure to hypotonic fluid sources	7
the most commonly encountered are hypokalemia and hypophosphatemia	7
methods of achieving these goals	7
identify and treat precipitating conditions (e	7
, infection, inflammation, and fever)	7
administer antiemetics (e	7
, odansetron 0	7
15 mg/kg/dose) to control nausea and vomiting	7
provide at least 1	7
10 units/kg/hour and titrated to maintain euglycemia	7
5 g/kg/day	7
provide specific amino acid supplements during metabolic crisis:	7
isoleucine and valine	7
20-120 mg/kg/day each	7
glutamine and alanine	7
tyrosine	7
strauss & morton, unpublished observation]	7
nutrient	7
age in months (# of persons)	7
0-2 (31)	7
3-5 (18)	7
6-8 (21)	7
9-12 (18)	7
13-18 (21)	7
19-24 (18)	7
25-36 (32)	7
leucine (mg)	7
72(64-84)	7
58(47-68)	7
44(37-51)	7
35(30-41)	7
33(26-39)	7
27(22-28)	7
21(20-25)	7
energy (kcal)	7
111(103-119)	7
99(94-107)	7
89(82-99)	7
78(71-87)	7
67(55-77)	7
57(49-71)	7
38(39-51)	7
total protein (g)	7
1-2	7
5(1	7
isoleucine supplement (mg)	7
4(0-7)	7
3(0-3	7
7(0-3	7
6(0-3	7
8(2	7
1-5	7
7(1	7
5(3	7
valine supplement (mg)	7
5(9	7
8-14	7
4(9	7
0-13	7
0(9	7
5-12	7
1(6	7
8(5	7
4-10	7
2(2	7
8(4	7
9-8	7
alanine intake (mg)	7
233(200-262)	7
209(197-234)	7
206(193-225)	7
189(168-218)	7
178(159-199)	7
159(140-192)	7
117(114-149)	7
glutamine intake (mg)	7
416(361-471)	7
363(337-405)	7
358(332-400)	7
320(288-371)	7
294(252-337)	7
256(221-318)	7
184(181-235)	7
iron (mg)	7
1(2	7
6-2	7
8(1	7
zinc (mg)	7
6(3	7
1-4	7
4-4	7
9-4	7
6(2	7
6-3	7
selenium (µg)	7
0(5	7
7-6	7
7(4	7
8-6	7
7(5	7
3-6	7
3(4	7
4-6	7
0(4	7
0-4	7
378(307-401)	7
330(307-378)	7
330(307-354)	7
307(260-354)	7
307(283-330)	7
283(236-330)	7
212(212-260)	7
leucine / energy ratio (mg/kcal)	7
65(0	7
57-0	7
72)	7
58(0	7
48-0	7
66)	7
56)	7
46(0	7
37-0	7
53)	7
48(0	7
38-0	7
54(0	7
44-0	7
55)	7
control of brain edema	7
measure head circumference and fontanel size in neonates	7
papilledema	7
disorientation, combativeness	7
depressed level of consciousness	7
refractory vomiting	7
extremity hyperreflexia	7
bradycardic hypertension	7
hyperactive gag	7
pupillary asymmetry	7
ophthalmoplegia	7
decorticate posturing	7
methods to minimize the possibility of brain swelling:	7
elevate the individual's head	7
note: give furosemide (0	7
methods to manage brain swelling:	7
furosemide: 0	7
0 mg/kg, followed by	7
mannitol: 0	7
0 g/kg over 60 minutes, followed by	7
hypertonic (3%-5%) saline: 2	7
5 meq/kg over 60 minutes	7
hemodialysis/hemofiltration	7
other potential complications in hospitalized persons with msud:	7
monitor for and promptly treat hospital-acquired infections	7
superficial and invasive candida infections are common	7
normal weight gain, linear growth, and head growth	7
home formula supplies include bcaa-free powder	7
normal age- and weight-adjusted energy intake	7
appropriate leucine tolerance	7
goals of laboratory monitoring:	7
plasma isoleucine concentration approximately equal to plasma leucine concentration	7
plasma valine concentration at least twofold plasma leucine concentration	7
thiamine treatment	7
9-20	7
the post-partum period is dangerous for the mother	7
plain skull radiography	7
3d ct scan of the head with bone windows	7
brain imaging using ct or mri scanning, if appropriate	7
the management of enlarged parietal foramina is generally conservative	7
associated headaches or seizures should be treated symptomatically	7
examination of the skin for evidence of keratoderma	7
appropriate rehabilitation, e	7
enrollment in educational programs appropriate for the hearing impaired	7
for mild keratoderma, use of lotions and emollients	7
for severe keratoderma, dermatologic evaluation	7
mt-rnr1-related aminoglycoside-induced ototoxicity	7
the following assessments are indicated:	7
, palmoplantar keratosis)	7
1555a>g	7
mt-rnr1 pathogenic variant	7
ophthalmologic examination to assess for optic atrophy	7
treatment by a psychiatrist for those with significant neuropsychiatric symptoms	7
tracheostomy as indicated for difficulty managing secretions	7
annual ophthalmologic examination is recommended	7
annual ophthalmologic exams for ophthalmoplegia, ptosis, and myopia	7
potential screening tests include the following:	7
annual blood counts [herman et al 1999]	7
assessment for hydrocephalus with brain ct or mri	7
ophthalmologic assessment including screening for strabismus and vision	7
other disciplines are involved as needed	7
this procedure is usually transcranial (i	7
severe initial clinical presentation requiring a staged repair	7
postoperative increased icp	7
recurrent deformity requiring a second transcranial repair:	7
seven (24	7
1%) of 29 individuals with the p	7
3%) of 47 without the pathogenic variant	7
048) [thomas et al 2005]	7
15 were expected to undergo extracranial contouring	7
note that none had increased icp	7
hearing loss is often sensorineural	7
strabismus surgery/correction is indicated to prevent amblyopia	7
, behavioral changes)	7
regular developmental assessments of affected children	7
periodic repeat audiograms	7
periodic assessment for strabismus	7
evaluation includes targeted molecular genetic testing for the fgfr3 c	7
749c>g pathogenic variant	7
baseline echocardiogram	7
baseline dental evaluation in early childhood	7
baseline ophthalmology evaluation	7
review history for evidence of chronic constipation	7
review history for evidence of seizures	7
renal ultrasound examination to assess for structural renal anomalies	7
genitourinary evaluation, particularly for hypospadias and cryptorchidism in males	7
physical examination for pectus anomalies and foot/ankle malpositioning	7
evaluation for hscr and ultrashort hscr	7
referral to a urologist or nephrologist as indicated	7
monitoring for the development of otitis media (om)	7
regular developmental assessments to plan and refine educational interventions	7
suturing for treatment of accidental or surgical wounds	7
mouthwash with tranexamic acid may control gingival bleeding	7
eltrombopag	7
antifibrinolytic agents	7
ten of them benefited from cochlear implants	7
glomerular nephropathy	7
dialysis or kidney transplantation is required in individuals with esrd	7
cataracts	7
cataract surgery remedies clouding of the lens	7
elevation of liver enzymes does not require any specific treatment	7
thrombocytopenia cannot be prevented	7
oral contraceptives are often effective in preventing or controlling menorrhagia	7
every six months	7
every year	7
measurement of serum concentration of creatinine	7
every three years	7
measurement of serum ast, alt and ggt	7
drugs that inhibit platelet function or blood coagulation:	7
other substances that interfere with platelet function including some antibiotics	7
cardiovascular, psychotropic, and oncologic drugs	7
drugs that affect platelet camp	7
some anesthetics	7
antihistamines	7
ototoxic drugs (e	7
exposure to hazardous noise	7
, earplugs, headphones) to attenuate intense sound	7
nephropathy	7
elevation of liver enzymes	7
upper- and lower-extremity blood pressure measurements	7
two-dimensional echocardiography with doppler	7
treatment is largely symptomatic and may include the following	7
elective tracheal surgery/intubation should be avoided	7
symptomatic treatment of restrictive lung disease	7
oxygen supplementation as necessary	7
noninvasive 3d imaging may be preferred	7
global developmental disability/intellectual disability educational issues	7
persistent middle ear effusions	7
myringotomy tubes as needed	7
routine treatment of strabismus and refractive errors	7
evaluation for upper airway stenosis (e	7
annual ophthalmologic and audiology evaluations	7
monitoring of physical skill development and joint mobility	7
patients should be aggressively counseled not to smoke	7
all experienced substantial improvement of both myoclonus (61	7
5%) and dystonia (48	7
2%)	7
no adverse effects on cognition or affect were noted	7
the results of case studies are summarized below:	7
no specific therapy currently exists for this disorder	7
avoid sustained fatiguing physical exertion	7
exercise temporarily alleviates myotonia (the warm-up effect)	7
the effect has not been systematically studied	7
a trial with lamotrigine is ongoing (nct01939561)	7
assessment of thyroid function	7
assessment of strength [whittaker et al 2006]	7
fasting blood glucose determination	7
assessment of motor skills	7
baseline cardiac evaluation	7
baseline endocrine evaluation	7
special education evaluation is indicated for children with dm1	7
statins)	7
pain management can be an important part of dm1 treatment	7
avoid using succinylcholine	7
propofol-induced pain can induce myotonia	7
sevoflurane has been used uneventfully	7
gagnon et al [2010] provide guidelines for surveillance	7
annual ecg to detect asymptomatic cardiac conduction defects	7
ophthalmologic examination every two years to evaluate for cataract formation	7
the overall frequency of complications was 8	7
2% (18 of 219)	7
evaluation for placenta previa	7
routine clinical evaluation of muscle strength and functional status	7
initial cardiac evaluation including at minimum:	7
ecg to establish a baseline record for future comparison	7
thyroid studies	7
treatment guidelines for dm2 have been published	7
no one medication has been consistently effective	7
anesthetic risk may be increased in those with dm2	7
history and physical examination to detect orthopedic problems	7
history to identify gastrointestinal, neurologic, or vasomotor abnormalities	7
history and examination to detect dental anomalies	7
treatment as in the general population for:	7
glaucoma	7
annual measurement of the following is appropriate:	7
urine albumin:creatinine ratio on a first-morning urine	7
dental examination is indicated at least every six months	7
otherwise, monitor renal findings (i	7
consider consultation with a movement disorders specialist	7
treatments for nbia are palliative	7
botulinum toxin for those with focal dystonia	7
l-dopa treatment, which is beneficial in rare cases	7
some will develop prominent dyskinesias early in the treatment	7
assessment of ambulation and speech abilities	7
dental evaluation if dental eruption is delayed	7
ophthalmologic examination, including visual acuity and dilated fundus examination	7
evaluation for cryptorchidism in males	7
spectacles as needed to correct refractive errors	7
orchiopexy as needed	7
developmental/cognitive and educational assessment	7
trihexyphenydil improves dystonia and sialorrhea	7
this may include clinical surveillance for the following:	7
swallowing difficulties and recurrent aspiration	7
x-ray surveillance of hip joints and spine	7
lamotrigine may exacerbate seizures and myoclonus especially in cln2 disease	7
czp is a sedative and can cause behavior disturbances	7
the research is ongoing	7
trials in humans have not yet started	7
general management	7
thiazide diuretics (i	7
emergency treatment for dehydration	7
5% dextrose in water is the preferred solution	7
if administration of iv fluids is required, 2	7
special situations	7
hydronephrosis, hydroureter, and megacystis	7
treatment and monitoring may then start immediately	7
monitoring of growth and development in infants and children	7
water intake must not be restricted	7
physical examination to evaluate for joint contractures	7
orthodontic evaluation if palatal anomalies are present	7
aggressive treatment of lower respiratory tract infections	7
standard treatment of gastroesophageal reflux, if present	7
physical therapy for maintenance/improvement of function and joint mobility	7
speech therapy if dysarthria and/or hypernasal speech is present	7
anesthetics are generally well tolerated in individuals with nm	7
none developed malignant hyperthermia	7
routine assessment for scoliosis and joint contractures	7
l-tyrosine has been proposed as a potential therapy	7
human data are lacking	7
tests to evaluate the kidneys:	7
complete blood count (cbc) to evaluate for anemia	7
skeletal radiographs	7
assessment of psychomotor development and/or behavior	7
endocrine assessment	7
currently no cure for nephronophthisis exists	7
treatment of anemia, hypertension, and proteinuria if present	7
dialysis or renal transplantation when patients reach esrd	7
annual influenza vaccination is indicated for patients with ckd	7
other vaccinations (e	7
evaluations are recommended at least annually	7
monitoring of blood pressure, growth parameters, and development	7
urinalysis to monitor proteinuria	7
nephrotoxic agents, e	7
individuals with liver function impairment should avoid hepatotoxic medication	7
psychometric assessment	7
physiotherapy assessment	7
speech therapy assessment	7
botulinum toxin is helpful for painful focal dystonia	7
dietary assessment is helpful	7
affected individuals should maintain caloric intake	7
physiotherapy helps to maintain mobility and prevent contractures	7
current treatments under evaluation:	7
venesection	7
iron chelation with deferiprone	7
coenzyme q10 (ubiquinone)	7
personal medical history with particular attention to features of nf1	7
ophthalmologic evaluation including slit lamp examination of the irides	7
further studies are in progress	7
regular developmental assessment by screening questionnaire (in childhood)	7
regular blood pressure monitoring	7
other studies (e	7
no limitations are necessary for most individuals with nf1	7
note:	7
nih clinicaltrials	7
gov has a list of current clinical trials for nf1	7
hearing evaluation, including baer	7
cutaneous examination	7
for nf specialists see www	7
ctf	7
for nf2 service centers in uk see www	7
nfauk	7
vestibular schwannoma	7
therapy remains primarily surgical	7
small vestibular tumors (<1	7
lip-reading skills may be enhanced by instruction	7
ocular involvement	7
treatment concentrates on prevention of secondary complications	7
spinal tumors may make epidural analgesia difficult	7
it is not clear if earlier surveillance (i	7
evaluation of immunologic status to include:	7
proliferative response of peripheral blood mononuclear cells to stimuli	7
evaluation for viruses with lymphotrotropic capacity (i	7
, ebv and cmv)	7
assessment of cognitive development and intellectual abilities	7
infections	7
the spectrum of recurrent infections in nbs is not opportunistic	7
puberty and fertility	7
females are infertile	7
similarly, no male paternity has been reported	7
affected individuals	7
breast self-examination and ultrasonographic evaluation recommended in affected females	7
carriers (heterozygotes)	7
parents	7
at-risk sibs	7
similarly, unnecessary exposure to ionizing radiation should be avoided	7
mri of the brain in neonates	7
developmental assessment throughout the first years of life	7
no effective treatment for severe glycine encephalopathy exists	7
flusser et al 2005	7
van hove et al, unpublished]	7
it increases alertness	7
nmda receptor site antagonists	7
use of each has resulted in improved seizure control	7
this may be different in mildly affected children	7
blood concentration can be monitored	7
seizure control is important for symptomatic benefit	7
various antiepileptic drugs have been used with variable success	7
most affected individuals need physical therapy	7
scoliosis is managed with standard techniques	7
patients on sodium benzoate should have plasma carnitine concentration monitored	7
severely affected individuals should be monitored for scoliosis	7
for benign hereditary chorea*	7
pulmonary consultation for further evaluation and treatment of pulmonary dysfunction	7
endocrinology consultation for further evaluation and treatment of thyroid abnormalities	7
chorea	7
children: 0	7
adults: 37	7
5 mg/day starting dose divided in 2-3 doses	7
of note:	7
other neurologic manifestations	7
pulmonary dysfunction	7
treat asthma and interstitial lung disease as needed	7
thyroid hormone replacement therapy is recommended	7
plotting of growth parameters on ns growth charts	7
urinalysis if the urinary tract is anomalous	7
there is substantial early mortality associated with hypertrophic cardiomyopathy	7
significant short stature compared with normal peers	7
documented response to gh treatment in studies	7
no standard dose has been established	7
the increase in height sd varies from 0	7
6 to 1	7
behavioral evaluation as needed	7
ophthalmologic evaluation is warranted	7
at 23 months of life	7
5 months) [walsh et al 2010]	7
observation for clinical evidence of venous stasis or ulcer disease	7
infants with npd-a	7
ophthalmologic examination, if not yet performed	7
comprehensive neurologic evaluation	7
compete blood count	7
serum chemistries including liver function tests	7
dietary consultation	7
occupational and physical therapy evaluations	7
chest radiograph to assess the extent of interstitial lung disease	7
bone age in children under age 18 years	7
liver biopsy in individuals with evidence of deteriorating liver function	7
severe neurodegenerative form (npd-a)	7
progressive neurologic disease	7
regular consultation with a dietician should be provided	7
sleep disorder	7
most affected individuals have thrombocytopenia	7
individuals with symptomatic pulmonary disease may require supplemental oxygen	7
variable results have been reported with hsct	7
, statins for treatment of hypercholesterolemia)	7
nutrition status	7
occupational and physical therapy needs	7
fatigue	7
bleeding, shortness of breath	7
extremity pain	7
physical examination including assessment of neurologic function	7
pulmonary function testing and chest radiograph	7
individuals who have splenomegaly should avoid contact sports	7
mri of the head	7
no curative therapy for npc exists	7
sleep disturbances are common in npc	7
a clinical trial is being considered	7
radiologic examination of trunk and extremities for skeletal malformations	7
abdominal and pelvic ultrasounds examination to identify visceral malformations	7
chest imaging to evaluate for lung hypoplasia	7
echocardiogram to identify cardiac involvement	7
magnetic resonance imaging to determine brain involvement	7
evaluation of neurologic history and eeg for evidence of seizures	7
psychoeducational evaluations to define delays and facilitate appropriate interventions	7
orthopedic evaluation to determine the presence of scoliosis/kyphosis	7
oral aromatic retinoids (etretinate) to ameliorate cutaneous symptoms	7
topical statins	7
dermatologic surgery	7
other medical care as appropriate based on clinical findings	7
antiepileptic drugs (aed) to control seizures	7
ophthalmologic management of ocular abnormalities	7
neurologic surveillance of seizures for readjustment of medications if necessary	7
orthopedic surveillance for scoliosis/kyphosis	7
ophthalmologic care	7
surgery may improve peripheral binocularity or appearance	7
nystagmus surgery remains highly controversial	7
photodysphoria (discomfort in bright light	7
additional classroom aids may include:	7
high contrast reading materials (black on white)	7
large font texts or xerographically enlarged worksheets	7
computers and tablets with zoom-magnification text software	7
skin that burns with sun exposure needs protection	7
an early (pediatric) dermatologic consultation is warranted	7
assessment for strabismus	7
a hat with a brim (e	7
avoid prolonged exposure of the skin to the sun	7
formal, age-appropriate assessment of development and behavior	7
evaluation of cns involvement	7
blood pressure and serum creatinine concentration	7
audiology evaluation if cleft palate is present	7
removal of accessory teeth	7
orthodontia for malocclusion	7
surgery to repair syndactyly, if present	7
routine management of seizures	7
physical examination to assess deformities and presence of joint laxity	7
hearing assessed through formal audiology	7
physical medicine treatment	7
avoid sudden acceleration/deceleration movements	7
and avoid throwing a child in the air	7
older children should not ride on amusement park rides	7
physical activity serves a number of purposes	7
analgesics can be used to control pain from fractures	7
casts should be small and lightweight	7
these studies are still ongoing	7
a study comparing pamidronate to zoledronic acid was completed	7
to date, the results have not been published	7
basilar impression	7
criteria for surgical intervention are not well defined	7
plastic polymers are sometimes used to coat teeth	7
outcome data are limited	7
management of lethal oi	7
contact sports should be avoided	7
gov]	7
assessment in a pediatric respiratory physiology laboratory, with:	7
neurocognitive assessment to determine baseline function	7
see table 4 for additional details	7
, pulse oximeter) and ventilation (i	7
ongoing studies have not confirmed this report	7
hirschsprung disease	7
tumors of neural crest origin	7
phox2b variant	7
annual in-hospital comprehensive testing 1	7
annual neurocognitive assessment	7
annual 72-hr holter and ecg	7
hirschsprung disease assessment	7
tumors of neural crest origin assessment	7
parm genotype:20/24, 20/25	7
parm genotype: 20/26, 20/27	7
parm genotype: 20/2820/33	7
nparm	7
x 3	7
deletion/ duplication 4	7
ideally, children with cchs should not go swimming	7
no treatment for opa1 is of proven efficacy	7
for treatment of ataxia, see ataxia overview	7
individuals with an opa1 pathogenic variant are advised:	7
not to smoke	7
to moderate their alcohol intake	7
to use sunglasses to limit uv exposure	7
valerio carelli, university of bologna)	7
full clinical examination	7
full radiologic skeletal survey	7
audiometry (see deafness and hereditary hearing loss overview)	7
ear, nose, and throat examination	7
renal tract ultrasound examination	7
hand and foot malformations may also require surgery	7
surgical correction of limb bowing has not been reported	7
apnea prevention	7
clinical evaluation for development of orthopedic manifestations (e	7
age-appropriate assessment of development and intellectual abilities	7
assessment of anal position and patency	7
cranial imaging	7
treatment as needed by an ophthalmologist	7
surgical intervention as needed for hypospadias	7
surgical treatment of medically significant laryngotracheoesophageal (lte) abnormalities	7
surgical management for cleft lip/palate and other craniofacial anomalies	7
neuropsychological support	7
surgical intervention for imperforate anus	7
surgical repair as needed for heart defects	7
all primary manifestations are present at birth	7
cardiac follow-up for those with cardiac defects	7
ptosis	7
however, the procedure requires general anesthesia	7
food should be cut into small pieces	7
to reduce the risk for these complications:	7
annual flu vaccination is recommended for elderly affected individuals	7
dietary supplements should be added if weight loss is significant	7
plasma amino acid analysis	7
laboratory values that reflect nutritional status (e	7
pt/ptt and fibrinogen	7
developmental/neuropsychological/psychological evaluation	7
care of hyperammonemic coma	7
rapid lowering of the plasma ammonia	7
ammonia scavenger therapy	7
citrulline is supplemented at 170 mg/kg/day or 3	7
8g/m2/day (enterally)	7
patient weight	7
components of infusion solution	7
loading 1 and maintenance dose 2, 3	7
sodium phenylacetate & sodium benzoate 4	7
arginine hcl injection, 10%	7
arginine hcl 5	7
<25 kg	7
undiluted: 2	7
0 ml at 100 mg/ml	7
200 mg/kg	7
≥25 kg	7
40 ml at 100 mg/ml	7
4,000 mg/m2	7
protein intake	7
recommendations for ammonia scavenger therapy:	7
0 g/m2/day of sodium phenylbutyrate and 3	7
it is typically performed by age six months	7
attention deficit/hyperactivity disorder (adhd)	7
seizure disorders	7
learning disability/intellectual disability	7
also see urea cycle disorders overview	7
minimize risk of respiratory and gastrointestinal illnesses through hand hygiene	7
provide multivitamin and vitamin d supplementation	7
use antipyretics appropriately	7
valproate	7
haloperidol	7
stress, especially physical stress	7
potentially also psychological stress	7
at the same time, preemptive measures (e	7
gov, lichter-konecki et al 2013]	7
current gene therapy approach	7
questions to elicit a patient’s history of:	7
epistaxis	7
poor wound healing	7
bleeding in association with injury or trauma	7
bleeding with dental extractions	7
additional oral bleeding	7
post-surgical bleeding	7
in females:	7
heavy menstrual bleeding	7
postpartum bleeding	7
bleeding during pregnancy	7
bleeding in association with ovulation	7
evaluation by a hematologist with training in hemostasis	7
for menstruating females:	7
ghosh et al 2013	7
high-risk activities such as contact sports	7
the first pregnancy ended in miscarriage at 19 weeks	7
pancreatectomy	7
issues to consider prior to referral for tpiat:	7
the operation is irreversible	7
pain relief is not universal	7
chronic pancreatitis	7
cholecystokinin (cck) and its analogs (e	7
, mineral oil, olestra), or	7
, orlistat), or	7
routine screening of patients with chronic pancreatitis for glucose intolerance	7
however, small meals may minimize pancreatic exocrine stimulation	7
circumstances to avoid	7
evaluation of renal structure by renal ultrasound examination	7
urinalysis to evaluate for the presence of blood and protein	7
esrd is treated with renal replacement therapy (i	7
, dialysis and/or renal transplantation)	7
no disease-specific guidelines have been developed	7
follow up by an ophthalmologist to monitor vision	7
audiometric evaluation with periodic follow up	7
registration or institutional access required)	7
most are benign and can be completely excised	7
preoperative	7
a liberal sodium diet	7
, 3 days prior to surgery)	7
postoperative	7
sdhc, sdhd,	7
in persons with sdhb pathogenic variants, periodic (e	7
sdhc, sdhd, sdhaf2, or max	7
, pre-eclampsia)	7
vision (comprehensive ophthalmologic assessment)	7
treatment focuses on symptomatic therapy	7
no specific metabolic diet is recommended	7
neurologic function	7
early intervention services should be provided	7
seizures are present in approximately one third of affected individuals	7
standard antiepileptic drugs (aeds) may be used	7
no type of aed is contraindicated	7
no curative therapy is presently available for pbd, zss	7
hearing should be evaluated annually	7
annual ophthalmologic evaluation is indicated	7
visual field testing is much more helpful	7
coagulation factors and other synthetic liver functions should be monitored	7
persons with overt hepatic dysfunction require more routine monitoring	7
the use of routine neuroimaging is uncertain	7
individuals with peroxisomal disorders may develop a progressive leukodystrophy	7
pch2	7
919g>t (p	7
ala307ser)	7
all other subtypes are very rare	7
the main problems to manage:	7
central visual impairment	7
epilepsy, which is amenable to standard treatments	7
physiotherapy can be helpful	7
pch4 and pch5	7
respiratory support is usually given for a limited time	7
no treatment for the condition is available	7
birth is usually normal and uncomplicated	7
fetal akinesia often causes congenital contractures	7
clonus persists after birth and is usually severe	7
absence of respiratory movement necessitates mechanical support at birth	7
thorough clinical examination to assess each affected area	7
palmoplantar keratoderma	7
however, trimming too aggressively can greatly increase pain	7
topical therapies to remove the hyperkeratosis:	7
occlusive ointments are often poorly tolerated	7
nail dystrophy	7
particularly troublesome nails can be successfully removed surgically	7
oral leukokeratosis	7
follicular hyperkeratosis	7
leukokeratosis with laryngeal involvement	7
cysts	7
intralesional injection of steroid (e	7
if necessary, cysts can be excised	7
consistent, regular care of the conditions is necessary	7
antibiotics may be indicated when infection occurs	7
asn171lys mutated allele [leachman et al 2010]	7
several persons have been treated with statins	7
the results from studies are mixed	7
pulse oximetry, with overnight saturation studies if borderline	7
nasal congestion and/or sinus symptoms	7
chronic/recurrent ear infections	7
at present, no specific therapies can correct ciliary dysfunction	7
, vigorous exercise)	7
routine immunizations to protect against respiratory pathogens:	7
pertussis	7
haemophilus influenzae type b	7
pneumococcal vaccine	7
annual influenza virus vaccine	7
this approach, however, is controversial	7
nasal congestion and sinus infections	7
chronic/recurrent ear infection	7
male infertility	7
situs abnormalities	7
appropriate preventive measures:	7
brain mri and mrs analysis	7
minimize intercurrent infections as environmental stressors	7
individuals with pc deficiency are very brittle metabolically	7
monitor lactate levels regularly	7
the ketogenic diet, which aggravates life-threatening metabolic acidosis	7
the precise molecular diagnosis in these cases is uncertain	7
special education programs should be offered	7
5 mg for infants and 2 mg for adults	7
studies have indicated that higher doses may enhance intellectual development	7
such therapy is required for life	7
regular assessments of intellectual function should be offered	7
if not, treatment can be withdrawn	7
specifically, the silent nucleotide change c	7
routine interictal eeg	7
routine clinical imaging to rule out structural abnormalities	7
, carbamazepine, phenytoin, valproate)	7
, avoidance of unattended swimming)	7
vestibular function studies	7
hearing habilitation (hearing aids as early as possible)	7
educational programs designed for individuals with hearing impairment	7
semiannual or annual examination by an endocrinologist familiar with pds	7
provision should be made for any special educational needs	7
estrogen can be administered orally or topically	7
before considering pregnancy, uterine size should be assessed	7
for individuals with hearing loss:	7
avoid ototoxic medication such as aminoglycosides if alternatives are available	7
neurologic evaluation of motor function	7
psychiatric evaluation and (if needed) neuropsychological examination	7
weight loss	7
adequate caloric intake must be ensured to prevent weight loss	7
use of central respiratory depressants (e	7
echocardiography for congenital heart malformations	7
abdominal ultrasound examination for renal anomalies	7
additional management is symptomatic and expectant	7
regular developmental assessments	7
agents that increase risk of glaucoma (e	7
, corticosteroids) are to be avoided	7
clinical history	7
chest radiograph	7
thoracic society 2000, american thoracic	7
society & european respiratory society 2002]	7
transplantation are good candidates	7
five-year survival rates post transplant in	7
non-pharmologic treatments:	7
oxygen therapy may improve exercise tolerance in patients with	7
hypoxemia	7
pulmonary rehabilitation is a recommended option for patients who would	7
benefit	7
ipf	7
immunosuppressive/cytotoxic agents, and antifibrotic agents	7
however, at least	7
two antifibrotic pharmacologic interventions recently approved may be an option	7
see therapies under	7
investigation	7
prevention and prompt treatment of acute exacerbations	7
treatment of coexisting comorbidities if appropriate including:	7
gastroesophageal reflux disease (gerd)	7
pulmonary embolism	7
lung cancer	7
coronary artery disease	7
pneumothorax	7
aspiration	7
the patient's individual diagnosis and status	7
surveillance would follow the	7
guidelines for ipf [raghu et	7
al 2011] or the specific type of iip	7
those who are stable may be	7
pulmonary function studies including the following to serially monitor	7
disease course [raghu	7
et al 2011]:	7
saturation change at baseline	7
monitoring for progression of disease by hrct of the chest	7
oxygen saturation by resting pulse oximetry	7
suspected of an underlying possibility for ctd-related ild	7
monitoring for any side effects known from pharmacologic treatments	7
symptom control	7
possible those who would benefit from initiation of treatment	7
1994a, schwartz et al 1994b]	7
it is recommended that every five years, asymptomatic	7
standardized questionnaire to assess the presence of respiratory	7
family members are considered to have a positive screening	7
evaluation (i	7
, to possibly have pulmonary fibrosis) if they	7
family members	7
radiologic and histopathologic abnormalities suggestive of possible	7
early interstitial lung disease	7
it is unknown if these findings would	7
become symptomatic fpf in the subjects	7
see genetic	7
genetic counseling purposes	7
several therapies remain under investigation for the treatment of ipf	7
anticoagulation, and various chemokine and monoclonal antibodies among other	7
targets remain under investigation as potential treatments	7
two antifibrotic	7
pirfenidone [king et al	7
2014] and nintedanib [richeldi et al 2014]	7
the former has	7
gov for access to information	7
recording of symptoms of hyperviscosity syndrome and their severity:	7
hyperviscosity syndrome symptoms:	7
headache	7
dizziness	7
altered mentation, sense of distance	7
visual disturbances	7
tinnitus	7
paraesthesia	7
low performance	7
fatigue, lassitude	7
myalgia, muscle weakness	7
hyperviscosity syndrome severity:	7
mild	7
does not interfere with normal activities	7
moderate	7
interferes with some activities	7
marked to severe	7
interferes with most or all activities	7
no management guidelines have been published	7
the majority of individuals with pfcp require no regular treatment	7
when symptoms of the hyperviscosity syndrome are evident	7
hyperviscosity symptoms (see	7
evaluations following initial diagnosis)	7
in the presence of persistent symptoms perform phlebotomy	7
consider additional aspirin treatment	7
thromboembolic events	7
provide acute treatment according to established practice for the event	7
evaluate for other thrombophilic risk factors	7
consider additional aspirin treatment in all patients	7
consider life-long anticoagulation (e	7
always maintain good hydration	7
avoid activities that potentially increase blood viscosity (e	7
, mountain climbing, scuba diving, smoking)	7
any activity that would potentially increase blood viscosity	7
if the epor pathogenic variant in the family is known	7
if no pathogenic variant has been identified in the family	7
the following are recommended in all cases:	7
for those with preserved renal function (i	7
73 m2):	7
baseline urinalysis (spot and 24 hour collection)	7
for those with a gfr <60 ml/min/1	7
73 m2	7
for those with a gfr <30 ml/min/1	7
in addition to the above evaluations:	7
the general therapies for nephrolithiasis benefit all individuals with ph1	7
patients should be advised to seek early medical attention	7
alkalinzation of urine (ph 6	7
2-6	7
15 mg/kg or 0	7
3-0	7
treatment of kidney stones	7
swl	7
ureteroscopy	7
percutaneous nephrolithotomy and ureteroscopy	7
reduction of oxalate biosynthesis	7
agt is a pyridoxal phosphate (plp)-dependent enzyme	7
7 mmol/1	7
phe152ile pathogenic allele	7
73 m2/day)	7
transplantation (tx) options:	7
simultaneous liver - kidney	7
sequential liver - kidney	7
isolated kidney	7
isolated liver	7
hemodialysis (hd) strategy:	7
perioperative ± postoperative based on pox & gfr	7
preoperative & perioperative	7
sometimes perioperative	7
ckd category / residual gfr	7
ckd category 3 (30<gfr<59)	7
option in carefully selected patients	7
ckd category 4 (15<gfr<29)	7
option	7
ckd category 5 (gfr <15)	7
infantile form (esrd <2 yrs)	7
use of deceased vs	7
living donors for either or both organs	7
, gfr >60 ml/min/1	7
secondary complications may arise as a result of systemic oxalosis	7
preserved renal function (i	7
ongoing urinalysis (spot and 24-hour collections)	7
gfr <60 ml/min/1	7
gfr <30 ml/min/1	7
intravascular volume depletion	7
the importance of maintaining dilute urine cannot be overemphasized	7
asymptomatic individuals:	7
can be monitored periodically for renal function and urinary oxalate	7
should maintain adequate hydration and avoid high-oxalate foods	7
in addition:	7
for those with the pathogenic variant p	7
gly170arg or p	7
phe152ile, pyridoxine should be supplemented	7
several novel therapies are under investigation	7
oxalate-degrading bacteria	7
a human strain of o	7
brevis, streptococcus thermophilus, and bifidobacterium infantis	7
cerevisiae, and fructooligosaccharide	7
longum, b	7
infantis, lactobactillus acidophlus, l	7
plantarum, l	7
paracasei, and l	7
this study must be validated in individuals with ph1	7
in agxt-deficient mice colonized with o	7
advances have been made to circumvent the colonization of o	7
other bacterial species	7
acidophilus, bifidobacgerium breve, and b	7
longum	7
hepatocyte transplantation	7
the exact protocol is outlined in the paper	7
pyridoxamine	7
chemical chaperones	7
gly170arg, p	7
phe152ile,or p	7
manipulation of the metabolic pathway	7
auxiliary liver transplant	7
assessment of renal function	7
bone x-rays to look for radiodense metaphyseal bands	7
ophthalmic examination of the retina to look for oxalate crystals	7
evaluation of cardiac function by echocardiography	7
adequate fluid intake (>2	7
5 l/m2 surface area/day)	7
urinary inhibitors of calcium oxalate crystallization:	7
potassium citrate (0	7
frequency of testing depends on the center	7
quarterly	7
six monthly to annually	7
excessive ascorbate (i	7
, vitamin c	7
>1000 mg/day)	7
assessment of kidney function by serum creatinine and egfr	7
maintainance of high oral fluid intake (>2	7
5 l/m2 bsa)	7
oral administration of an inhibitor of calcium oxalate crystallization	7
avoidance of supersaturation of calcium oxalate in the blood	7
avoidance of marked dietary oxalate excess	7
simple avoidance of marked dietary oxalate excess is recommended	7
24 hour urine oxalate and supersaturation study	7
delays in treatment of acute stone episodes	7
nephrotoxic agents	7
marked dietary oxalate excess	7
high-dose ascorbic acid	7
, heterozygous for one hoga1 pathogenic variant)	7
adequate fluid intake should be maintained throughout the pregnancy	7
humans cannot degrade oxalate	7
preliminary studies suggest that oral administration of o	7
formigenes could reduce oxalate excretion in individuals with ph	7
serum electrolyte analysis	7
noninvasive blood pressure measurement	7
metabolic abnormalities and hypertension generally improve within one week	7
different thiazide diuretics exist, with different dosing regimens	7
measurement of serum potassium concentration and blood pressure	7
assessment for cortisol deficiency	7
cranial mri to establish the location and extent of hamartoma	7
visualization of the epiglottis by laryngoscopy	7
limb radiographs to distinguish postaxial polydactyly from central polydactyly	7
renal ultrasonography to evaluate for renal anomalies	7
surgical consultation for imperforate anus or anal stenosis if present	7
anal atresia or stenosis should be treated in standard fashion	7
, hypothalamic hamartoma)	7
during childhood:	7
annual screening for developmental delay or learning disorders	7
complete medical history and family history	7
in children: consideration of neurodevelopmental evaluation	7
urinalysis with cytospin	7
for women age ≥30 years at diagnosis*:	7
breast screening (at minimum mammogram	7
mri may also be incorporated)	7
transvaginal ultrasound or endometrial biopsy	7
if asymptomatic, observation alone is prudent	7
when symptomatic, topical agents (e	7
current suggested screening by age follows:	7
cowden syndrome	7
pediatric (age <18 years)	7
yearly skin check with physical examination	7
adult	7
yearly thyroid ultrasound** and dermatologic evaluation	7
women beginning at age 30 years:	7
monthly breast self-examination**	7
yearly breast screening (at minimum mammogram)	7
mri may also be incorporated	7
yearly transvaginal ultrasound or endometrial biopsy**	7
for men and women:	7
colonoscopy beginning at age 35 years**	7
frequency dependent on degree of polyposis identified	7
bannayan-riley-ruvalcaba syndrome	7
screening recommendations have not been established for brrs	7
proteus syndrome/proteus-like syndrome	7
, pain, deformity) are significant	7
a clinical trial specifically directed at phts recently concluded	7
a baseline renal ultrasound to evaluate for structural renal abnormalities	7
leg-length discrepancy secondary to segmental somatic overgrowth	7
cardiac abnormalities (i	7
, structural cardiovascular disease and arrhythmias)	7
renal abnormalities	7
speech, swallowing, and feeding difficulties	7
neurologic and neurosurgical manifestations	7
hmeg	7
somatic overgrowth, vascular, lymphatic and musculoskeletal manifestations	7
a medical history with attention to:	7
childhood cancer	7
breathing or sleep problems	7
a detailed neurologic evaluation	7
cloves syndrome	7
therefore, diligent surgical care and monitoring are recommended	7
fibroadipose hyperplasia	7
assessment for cognitive or behavioral problems	7
child behavior specialist to aid with behavioral concerns	7
child neurology evaluation if there are concerns about seizure episodes	7
gastroenterology evaluation to establish treatment regimen for chronic constipation	7
infant feeding assessment to address early hypotonia as needed	7
behavioral modification for self-injurious behavior or anxiety	7
eyeglasses or surgery as needed for amblyopia	7
orthopedic treatment of scoliosis as indicated	7
standard care for other medical issues	7
colonoscopy beginning at age eight years	7
polyps	7
this strategy has two goals:	7
from st	7
intussusception should be treated in a standard manner	7
malignancies should be treated in a standard manner	7
site	7
procedure	7
age at initial screening (yrs)	7
interval	7
stomach	7
upper endoscopy	7
small intestine	7
capsule endoscopy or mre 2	7
8, 18 3	7
large intestine	7
colonoscopy	7
breast	7
breast self-examination	7
clinical breast exam	7
6 months	7
breast mri or digital mammography 4, 5, 6	7
ovary, cervix, uterus	7
transvaginal ultrasound & serum ca 125	7
pelvic exam w/pap smear 6	7
18-20	7
mri-mrcp or endoscopic ultrasound	7
1-2 years	7
testes	7
testicular exam	7
ultrasound if symptomatic or abnormality on exam	7
birth to teenage years	7
early diagnosis and treatment	7
surveillance as outlined in surveillance	7
ophthalmologic assessment for evidence of retinopathy	7
intramuscular botulinum toxin	7
intrathecal and intraventricular baclofen	7
ablative pallidotomy or thalmotomy	7
referral for adaptive aids as needed (e	7
, a walker or wheelchair for gait abnormalities)	7
other manifestations	7
treatment and interventions for retinopathy as per ophthalmology	7
oral assessment for consequences of trauma	7
swallowing evaluation and regular dietary assessments to assure adequate nutrition	7
see related genetic counseling issues	7
clinicians should check clinicaltrials	7
gov regularly and maintain contact with pkan investigators	7
pantothenate	7
pantothenate has no known toxicity in humans	7
docosahexanoic acid (dha)	7
when "white coat" hypertension (i	7
flank pain	7
cyst hemorrhage and gross hematuria	7
nephrolithiasis	7
5), and administration of allopurinol	7
cyst infection	7
cyst infection is often difficult to treat	7
therapeutic agents of choice include trimethoprim-sulfamethoxazole and fluoroquinolones	7
chloramphenicol has shown therapeutic efficacy in otherwise refractory disease	7
end-stage renal disease (esrd)	7
females appear to do better than males	7
complications directly related to adpkd are rare	7
polycystic liver disease	7
and the results are often short-lived	7
ruptured or symptomatic intracranial aneurysm	7
asymptomatic aneurysms	7
those aneurysms measuring 5	7
if the size increases, surgery is indicated	7
the management of aneurysms 6	7
0-9	7
0 mm in size remains controversial	7
surgical intervention is usually indicated for aneurysms larger than 10	7
early detection of hypertension	7
intracranial aneurysms	7
cardiac valvular abnormalities	7
colon diverticulosis	7
presymptomatic diagnosis:	7
permits early detection and treatment of complications and associated disorders	7
reassures those found to be unaffected	7
the literature on pregnancy and pkd is limited	7
vasopressin v2 receptor antagonists	7
8% per year compared to 5	7
5% in the untreated group	7
somatostatin analogs	7
serum electrolyte concentrations to identify electrolyte abnormalities (e	7
, hyponatremia, hyperkalemia)	7
urinalysis to assess for the urinary concentration and proteinuria	7
renal ultrasonography (consider high-resolution technology when available)	7
early recognition and treatment of dehydration is critical	7
and (2) the risk for ascending cholangitis	7
administration of synthetic bile acids	7
portosystemic shunting may be necessary to treat progressive portal hypertension	7
dual-organ transplantation	7
see table 2 (pdf) and figure 1	7
feeding and growth	7
influenza type b	7
meningococcus) is indicated	7
mineral balance, monitored by assessing calcium and phosphorous	7
hydration status	7
agents to avoid	7
for affected individuals with hypertension, sympathomimetic agents	7
potentially hepatotoxic agents (e	7
mri to rule out secondary causes of pkd	7
clinical genetics consultation and testing for pathogenic variants in prrt2	7
see acmg management guidelines for pku	7
treatment of classic pku	7
restriction of dietary phenylalanine	7
maintain blood tyr in the normal range	7
sapropterin (kuvan®)	7
reviewed in ho & christodoulou [2014]	7
large neutral amino acids (lnaa) transporters	7
treatment for non-classic hyperphenylalaninemia	7
neuropsychiatric testing may be considered to identify learning differences	7
bone health assessment	7
women with pah deficiency	7
preconception	7
assessment of early osteopenia risk	7
discontinuation of lnaa treatment	7
post partum	7
provide coordinated care in the post-partum period	7
enzyme substitution	7
cell-directed therapies	7
liver repopulation with pah-expressing cells is being investigated	7
gene therapies	7
only symptomatic treatment is available	7
epileptic seizures may worsen the individual's condition	7
the effect of bisphosphonates has not been studied	7
however, clinical trials have not been performed	7
probably reliable only after age four years	7
family history to identify other affected or at-risk individuals	7
those with severe dysphagia may require feeding by gastrostomy	7
proper wheelchair seating and physical therapy may help prevent scoliosis	7
mri to rule out secondary causes of pnkd	7
response to pharmacologic treatment is poor	7
however, clonazepam or diazepam can be effective	7
no long-term sequelae are associated with pnkd	7
monitoring medication requirements and dosage is appropriate	7
no disease-modifying drug treatment exists for pnpla6-related disorders	7
speech therapy [sapir et al 2003]	7
swallowing therapy	7
assistive walking devices and ankle-foot orthotics	7
drugs to reduce muscle spasticity (e	7
, baclofen [oral or intrathecal], tolperison	7
botox® injections) and urinary urgency (e	7
, oxybutynin)	7
hypothyroidism is treated with thyroid hormone replacement (e	7
, levothyroxine) at the time of diagnosis	7
reduce spasticity	7
and prevent contractures	7
inactive, sedentary lifestyle	7
exposure to medications or chemicals that exacerbate neuropathy	7
spasticity generally does not change significantly with pregnancy	7
pediatric neurology consultation	7
physiotherapy evaluation	7
occupational therapy evaluation	7
speech and language pathology assessment	7
rehabilitation physician (i	7
, physiatrist) consultation	7
neuropsychology evaluation	7
dentistry consultation	7
endocrine consultation	7
dysphagia management is therefore important	7
hypersalivation is managed with the multidisciplinary team and an otolaryngologist	7
treatment must be individualized	7
therapies to consider include rehabilitation (e	7
, oromotor therapy, behavioral therapy)	7
medical therapy (e	7
, anticholinergic medications, botulinum toxin injections)	7
and, in severe cases, surgery (e	7
learning difficulties are likely to progress slowly	7
patients should be followed regularly by an endocrinologist	7
patients need to be followed regularly by an ophthalmologist	7
no general surveillance guidelines have been developed to date	7
monitoring should be individualized	7
foods that are likely to lead to choking	7
medications acting on d2 receptor blockers (e	7
speech evaluations for those with perisylvian polymicrogyria	7
vision and hearing evaluation as clinically appropriate	7
the following treatment is recommended:	7
speech therapy for those with language impairment	7
occupational therapy for those with language impairment	7
education of parents about common seizure presentations	7
plasma acth concentration	7
acth stimulation test	7
severe obesity	7
therefore, lifestyle measures should be instigated	7
fair skin	7
growth hormone (gh) deficiency	7
, hexachlorobenzene)	7
evaluation for hepatitis c and/or human immunodeficiency virus infection	7
treatment is highly effective	7
iron reduction	7
iron chelation therapy (e	7
serum ferritin concentration should be measured before starting phlebotomy treatment	7
for persons with the hfe genotypes p	7
cys282tyr or p	7
low-dose anti-malarial agents	7
combining both treatment modalities (i	7
pct may also improve after treatment of coexisting hepatitis c	7
pct should be treated first in most individuals:	7
vaccination against hepatitis a and b is appropriate	7
surveillance is usually performed annually	7
susceptibility factors (if known) (e	7
exposure to sunlight in symptomatic phase	7
pregnancy is generally not complicated by f-pct	7
neurovisceral symptoms	7
most acute neurovisceral attacks require hospital admission	7
harmful medications should be discontinued	7
cutaneous symptoms	7
patients should wear protective clothing and avoid exposure to sunlight	7
topical steroids are of little or no benefit	7
acute attack	7
weekly or biweekly hemin infusions may prevent frequent noncyclical attacks	7
however, published experience is lacking	7
photocutaneous	7
the presence of other synchronous dicer1-related conditions	7
extent of disease spread (staging)	7
pleuropulmonary blastoma types i and ir	7
no metastatic potential is associated with this type	7
pleuropulmonary blastoma types ii and iii	7
brain mri to evaluate for metastatic disease	7
rarely, spine mri for a paraspinal or intraspinal extension	7
ct of the abdomen to assess for liver metastases	7
ciliary body medulloepithelioma	7
evaluations for synchronous	7
pleuropulmonary blastoma (ppb)	7
surgical management	7
individuals receiving neoadjuvant chemotherapy may have marked tumor reduction	7
chemotherapy alone is insufficient to eradicate solid ppb	7
pleural effusions	7
drainage of pleural effusions should be approached with caution	7
surgery for metastases	7
therapeutic resection of bone and liver metastases is rarely indicated	7
type i ppb	7
types ii and iii ppb	7
aggressive chemotherapy is necessary	7
ppbregistry	7
radiation therapy	7
treatment failure	7
sertoli-leydig cell tumor	7
juvenile granulosa cell tumor (jgct)	7
hyperthermic chemotherapy has been used by some investigators	7
gynandroblastoma	7
the malignant potential of gynandroblastoma is not yet clear	7
cystic nephroma	7
multinodular goiter (mng) and thyroid cancer	7
observation with or without biopsy	7
ciliary body medulloepithelioma (cbme)	7
the four management options include:	7
observation	7
local resection	7
however, many of these tumors will progress	7
enucleation	7
long-term survival is common after this definitive therapy	7
orbital exenteration	7
nasal chondromesenchymal hamartoma (ncmh)	7
however, complete extirpation is preferred	7
immediate management issues may include interventions for obstructive hydrocephalus	7
an aggressive surgical approach is associated with prolonged survival	7
ppb	7
thyroid gland neoplasia	7
thyroid physical examination in a patient of any age	7
ovarian stromal tumors	7
cbme	7
visual inspection of the eye and orbit	7
botryoid erms	7
ncmh	7
nasal endoscopy as warranted by ophthalmologic signs (e	7
a medical genetics consultation is recommended	7
medications in use for pah include the following:	7
endothelin blockers (oral)bosentanambrisenanmacitentan	7
phosphodiesterase inhibitors (oral)sildenafiltadalafil	7
guanylate cyclase stimulator (oral)riociguat	7
calcium channel blockers	7
adjunctive agents	7
mean survival after lung transplantation is about five years	7
fluid balance	7
exercise regimen	7
nutrition management	7
infusion pump management	7
central venous catheter	7
appetite-suppressant medications (e	7
hypoxia	7
newer effective therapies may decrease the risk	7
antiangiogenesis strategies	7
growth factor inhibitors	7
endothelial progenitor cells/stem cells in lung repair	7
developing therapies against right-ventricle remodeling	7
no specific therapy for ppd is available	7
pain due to secondary osteoarthritis may respond to nsaids	7
physical therapy may help preserve joint mobility	7
immobilization (e	7
, casting) should be avoided	7
angular deformities of lower limbs	7
progressive joint stiffness	7
, hip and knee replacement)	7
progressive stiffness and deformities of the spine	7
scoliosis and mild kyphosis can be managed with bracing	7
no specific guidelines for surveillance have been published	7
recommendations include the following:	7
avoid immobilization (e	7
, casting)	7
therapy is aimed at controlling symptoms that may cause discomfort	7
myoclonus can sometimes be mitigated by clonazepam	7
issues related to dysphagia are often difficult to resolve	7
however, no successful clinical results have been reported	7
physical examination to evaluate for splenomegaly	7
complete blood count to evaluate for anemia and thrombocytopenia	7
consultation with a wound care specialist	7
no curative treatment is available	7
care is preferably provided by a multidisciplinary team	7
antibiotic prophylaxis should also be considered in the appropriate setting	7
abdominal ultrasound examination to assess liver and spleen size	7
follow up as recommended by a pulmonologist and immunologist	7
adenovirus-mediated gene transfer	7
intracellular delivery of liposome-encapsulated prolidase	7
am cortisol can be used to evaluate adrenal hormone production	7
growth hormone	7
, recombinant) gh	7
tsh	7
lh and fsh	7
usually sex steroids are used to maintain secondary sex characteristics	7
acth	7
growth should be carefully monitored	7
complete blood count to evaluate for cytopenias	7
amylase and lipase to evaluate for pancreatitis	7
immunology consult	7
neonatal/acute decompensation	7
in-patient management	7
assess and manage ventilation and circulation as necessary	7
determine the need for sepsis workup and antibiotics	7
reverse catabolism by giving intravenous glucose and lipids	7
dextrose solutions exceeding the concentration of 12	7
5% require a central line placement	7
additional calories can be provided using parenteral lipid emulsion	7
manage protein intake to reduce propiogenic precursors	7
remove toxic compounds	7
pharmacologic detoxification:	7
oral n-carbamoylglutamate (carglumic acid	7
manage pancreatitis using standard practices	7
home management of metabolic status	7
at-home detection and monitoring of urine ketones	7
diet modification under the direction of the metabolic team	7
management of arrhythmias is similar to that from other causes	7
dermatologic manifestations (e	7
pre-prandial plasma essential amino acids	7
plasma albumin	7
prealbumin	7
hemoglobin	7
plasma ammonia	7
plasma vitamin d	7
essential fatty acid profile	7
additional calories can be provided using protein-free formulas	7
the optimal dose of levocarnitine has not been established	7
levocarnitine can be given enterally and intravenously	7
antimicrobial therapy	7
biotin supplementation	7
management during episodes of metabolic decompensation includes:	7
avoidance of fasting (e	7
, using intravenous dextrose)	7
increasing calorie intake to prevent catabolism (e	7
, intravenous fat emulsion)	7
olt in patients with pa is not curative	7
sedation and perioperative management	7
emergency situations	7
clinical evaluation should include assessment of the following:	7
interval assessment for the need of g-tube	7
neurologic evaluation including survey for seizures and movement disorders	7
interval ophthalmologic evaluation including dilated eye examination	7
evaluation for clinical signs of cardiomyopathy (e	7
laboratory evaluation should include the following:	7
complete blood count and differential to monitor for cytopenias	7
renal function tests	7
amylase and lipase as needed to evaluate for pancreatitis	7
other evaluations:	7
dexa scan	7
brain mri, mrs, and eeg as clinically indicated	7
neuroleptic antiemetics (e	7
evaluation for dvts	7
evaluation of pe	7
bullous pulmonary disease	7
psychosocial issues	7
juvenile/adult onset	7
serum uric acid concentration	7
joint examination for evidence of gout	7
assessment of renal function and renal structural integrity (e	7
, renal ultrasound examination)	7
infantile onset	7
0 mg/dl (360 μmol/l)	7
febuxostat, a newer urate-lowering xanthine oxidase inhibitor	7
note: excretion of >1	7
high daily fluid intake (i	7
, ≥2 l/day in the adult)	7
xanthinuria does not respond to urinary alkalinization	7
360 μmol/l)	7
plasma xanthine is cleared efficiently and does not accumulate	7
anchovies, sardines) in excess	7
and an audiology evaluation	7
however slight deterioration in their vision was noted	7
several expert groups (e	7
giessen, germany)	7
burtonsville, md)	7
cholecystokinin (cck) and its analogues (e	7
13c-mixed triglyceride breath test	7
72-hour fecal fat	7
sudan stain	7
, mineral oil, olestra)	7
, orlistat)	7
chronic pancreatitis is associated with a gradual loss of function	7
prevention of primary manifestations in hereditary pancreatitis is limited	7
however, this treatment cannot yet be recommended	7
surgical methods are standard	7
symptomatic lower limb malalignment	7
evidence of kyphoscoliosis	7
symptoms related to joint hypermobility	7
evaluation of high-risk individuals (i	7
a target inr of 2	7
5 (therapeutic range: 2	7
anticoagulation is recommended:	7
indefinitely for those with recurrent idiopathic vte	7
(see prevention of primary manifestations	7
f2 20210g>a heterozygotes:	7
is recommended for all women:	7
should be considered for:	7
all women received a course of postpartum anticoagulation	7
all asymptomatic homozygous women	7
trialregister	7
nl, ntr 3361)	7
studies suggesting that prophylactic anticoagulation improves pregnancy outcome:	7
5% and 15	7
ophthalmology examination	7
electrodiagnostic tests may be indicated in some cases	7
consider echocardiogram	7
assessment of pulmonary function	7
consider ultrasound of the urinary tract	7
appropriate radiographs	7
if hip dysplasia and/or scoliosis is suspected	7
assessment of serum vitamin d levels	7
assessment of bone density	7
if osteoporosis or osteopenia is suspected	7
evaluation of anterior pituitary hormones	7
if necessary	7
miscellaneous/other	7
cognitive/developmental delay	7
see global developmental disability/ intellectual disability educational issues	7
management by a neurologist	7
, dystonia, dyskinesia, dysconjugate eye movements)	7
vision deficits	7
correction of refractive errors	7
vision support	7
standard treatment for strabismus & exophoria	7
supplementary oxygen (at night) & rarely tracheostomy	7
ambulatory peripheral saturation monitoring may be required	7
congenital heart defect	7
frequent aspiration (or high risk of aspiration)	7
a percutaneous endoscopic gastrostomy tube may be considered	7
medical management	7
referral to a gastroenterologist may be required in severe cases	7
congenital urogenital defect	7
management as per current practice for the specific urogenital defect	7
progressive neuropathic scoliosis may require spinal fusion	7
osteoporosis/osteopenia	7
instability in standing position	7
neuropathic hip dysplasia, progressive subluxation, & dislocation	7
consideration of hip reconstructions w/varus derotational proximal femoral osteotomies	7
vitamin d deficiency	7
vitamin d supplementation	7
anterior pituitary hormone deficiencies	7
standard treatment as directed by an endocrinologist	7
global developmental disability/ intellectual disability educational issues	7
, scoliosis, hip dislocation)	7
, feeding, grooming, dressing)	7
monitoring by developmental pediatrics	7
long-term	7
eeg & video eeg monitoring	7
ophthalmologic & vision evaluations	7
monitoring for dysphagia & constipation	7
monitoring for musculoskeletal complications including hip dysplasia & scoliosis	7
endocrinology consultation	7
nutritional consultation	7
x-rays are necessary to establish the diagnosis	7
feeding, hyperphagia, and obesity	7
therapies, education and behavior management	7
initiate appropriate educational programming in children:	7
social skills training groups have been beneficial	7
however, preservation of fertility is not an issue	7
standard treatment is appropriate	7
angulo & miller, unpublished data]	7
schulze et al 2001	7
vats & cassidy, unpublished data]	7
sleep issues	7
skin picking	7
management of strabismus is as for any infant	7
adulthood	7
affected individuals generally require a sheltered employment environment	7
diabetes mellitus rarely occurs in the absence of obesity	7
if osteoporosis develops, consider treatment with a bisphosphonate	7
starting with lower doses is recommended	7
every month in infancy	7
every six months in the first decade of life	7
at least annually thereafter	7
cryptorchidism can recur after orchidopexy	7
therefore, testicular position should be monitored	7
obtain history of any sleep disturbance	7
if present, obtain a sleep study	7
obtain history for behavioral and psychiatric disturbance at least annually	7
cardiac stress testing	7
doppler evaluation of peripheral vasculature	7
no specific treatment for pxe exists	7
regular examination by an ophthalmologist with expertise in retinal disease	7
regular physical examination with specific attention to the cardiovascular system	7
monitoring by the affected individual for black tarry stool	7
periodic monitoring of serum lipid concentrations	7
participation in such activities should be discouraged	7
rapid-onset dystonia-parkinsonism (rdp)	7
neuropsychological testing to evaluate cognitive or memory problems	7
alternating hemiplegia of childhood (ahc)	7
brain imaging to evaluate the cerebellum	7
audiogram and hearing specialist consultation to evaluate sensorineural hearing loss	7
for all phenotypes	7
occupational therapy to maximize motor function	7
speech therapy for dysarthria	7
standard therapies for the following are appropriate:	7
episode prophylaxis (avoiding triggers	7
prophylactic medications	7
flunarizine	7
chloral hydrate	7
other sleep inducers	7
epilepsy management utilizes existing anticonvulsants	7
symptomatic treatment includes hearing and visual aids	7
there is no known reason to avoid vaccinations	7
fever	7
excessive exercise (such as running track)	7
emotional excitement	7
excessive or atypically strenuous exercise (e	7
illness	7
irregular sleep, missing a nap, delayed bedtime	7
consideration of spine imaging to identify and characterize avms/avfs	7
capillary malformations (cms)	7
avms/avfs	7
, embolization vs	7
surgery)	7
cardiac overload	7
hemihyperplasia and/or leg length discrepancy	7
lymphangiography to evaluate for lymphatic malformations may be considered	7
ultrasound evaluation of the kidneys for cysts	7
prostheses	7
intervention and/or special education if developmental delays are detected	7
annual screening for developmental delays or learning disorders	7
mr imaging of brain (with mr spectroscopy)	7
cataract extraction may preserve some vision	7
orthopedic procedures have improved function in some individuals	7
note: improved nutrition does not enhance linear growth	7
influenza vaccine and rsv monoclonal antibody should be provided	7
dha can be measured in plasma	7
oral supplementation should be provided if levels are low	7
leu292ter allele [dranchak et al 2011]	7
neurology	7
ataxia, neuropathy, myography, and electrophysiologic assessment	7
radiology	7
physical examination of hands, feet, and knees	7
radiologic assessment of hands and feet	7
cardiology	7
dietary restriction of phytanic acid intake	7
avoidance of sudden weight loss	7
lifelong treatment with hydrating creams	7
treatment of acute presentation	7
no curative therapy currently exists for refsum disease	7
annual cardiac examination to identify cardiomyopathy and concomitant arrhythmias	7
treatment options for the eye include enucleation	7
cryotherapy	7
radiation therapy using episcleral plaques	7
detection of subsequent rb after initial diagnosis	7
detection of second non-ocular tumors in individuals with retinoblastoma	7
young or uncooperative children may require examination under anesthesia	7
visual acuity	7
goldmann visual field	7
optical coherence tomography	7
legal use of telescopic lenses may vary by locale	7
retinoschisis affects primarily the inner retinal layers	7
older children and adults need less frequent monitoring	7
possible drawbacks of using viral vectors (e	7
history of sleep and/or breathing problems	7
screening for prolonged qtc by ecg and holter monitoring	7
examination for scoliosis	7
psychosocial support for families is an integral part of management	7
they are tolerated better than milk of magnesia	7
periodic ecg to screen for prolonged qtc	7
examination at regular intervals for the progression of scoliosis	7
prokinetic agents (e	7
, cisapride)	7
antipsychotics (e	7
, thioridazine), tricyclic antidepressants (e	7
, imipramine)	7
antiarrhythmics (e	7
, quinidine, sotolol, amiodarone)	7
anesthetic agents (e	7
, thiopental, succinylcholine)	7
antibiotics (e	7
, erythromycin, ketoconazole)	7
l-carnitine was tested in a double-blind trial	7
a statistical increase in global dna methylation was seen	7
sleep study and pulmonary consultation	7
other consultations depending on clinical problems	7
consultation with a medical geneticist/genetic counselor	7
high dose supplementation	7
supportive care	7
respiratory support	7
physiotherapy to avoid contractures	7
occupational therapy for support in activities of daily living	7
orthotics for limb and trunk bracing	7
speech and language therapy to avoid choking and respiratory problems	7
wheel chair as needed	7
low vision aids for those with decreased visual acuity	7
routine management of scoliosis to avoid long term respiratory problems	7
routine management of depression	7
general examination	7
discussion of any problems with riboflavin supplementation	7
avoid dietary restriction of riboflavin	7
recommended doses during pregnancy are 10 mg/kg/day	7
bone age measurement to evaluate growth potential	7
craniofacial examination for signs of craniosynostosis	7
individuals of any age	7
evaluation of those with headache and vertigo for chiari malformation	7
pharmacologic treatment focuses on improving pain and correcting bone deformation	7
low dose	7
high dose	7
50 to 0	7
75 µg daily	7
in these individuals, surgical treatment is frequently pursued	7
the literature consists of case series	7
craniofacial treatment	7
sensorineural hearing loss has been reported in persons with xlh	7
see hereditary hearing loss and deafness overview, management	7
see treatment of manifestations, pharmacologic treatment	7
hyperparathyroidism is associated with treatment for xlh	7
no long-term studies have been conducted	7
if tertiary hyperparathyroidism is identified, surgical evaluation is warranted	7
alkaline phosphatase level	7
intact parathyroid hormone level	7
renal ultrasound examination to assess for nephrocalcinosis	7
evaluation can be accomplished by:	7
assessment for possible cryptorchidism	7
abdominal ultrasound examination for investigation of renal anomalies	7
echocardiogram to evaluate for a cardiac defect	7
formal cognitive assessment if developmental delay is present	7
corrective surgeries may be required for repair of:	7
abnormal penile insertion/penoscrotal position	7
hormone therapy may be helpful for males with micropenis	7
orthodontic treatment is typically required	7
pregnancy in affected women appears to be generally uncomplicated	7
dental assessment for misaligned, crowded teeth	7
radiographic documentation of the forearm shortening and hand anomalies	7
and (2) growth hormone deficiency	7
echocardiogram to evaluate for structural heart defects	7
corrective surgeries may be required for the following:	7
syndactyly repair	7
severe scoliosis secondary to hemivertebrae and rib abnormalities	7
cleft lip and cleft palate repair	7
hormone therapy should be monitored by a pediatric endocrinologist	7
orthodontic treatment is usually required	7
preoperative cardiac evaluation for the presence of congenital heart defects	7
no treatment is required	7
no adverse drug effects have been documented in rotor syndrome	7
the list includes:	7
anticancer drugs - methotrexate and irinotecan	7
sartans – olmesartan and valsartan	7
rifampicin	7
mycophenolic acid	7
torsemide	7
thiazolidine diones – pioglitazone and rosiglitazone	7
glinides – nateglinide and repaglinide	7
lopinavir	7
fexofenadine	7
speech and language assessment	7
occupational therapy assessment	7
general management guidelines for those with systemic involvement:	7
nutritional support (e	7
management may include consideration of tracheostomy and artificial ventilation	7
referral to a pediatric neurologist for seizure management	7
of note, seizures may be refractory to treatment	7
aggressive management of fever and infection	7
the following evaluations should be considered:	7
regular assessments of neurodevelopment, speech, and language	7
rrm2b-related mitochondrial dna depletion syndrome and mitochondrial neurogastrointestinal encephalopathy	7
rrm2b-related multiple mtdna deletions with external ophthalmoplegia	7
care will be directed by clinical findings	7
the following general evaluations are recommended:	7
ecg advised biannually (kss phenotype)	7
assessment and plotting of growth curves	7
for north american children, see the magic foundation	7
for children with diaphoresis, evaluation for hypoglycemia	7
5 epimutations possibly because children with 11p15	7
initial treatment is use of a shoe lift	7
neurodevelopment	7
gastrointestinal disorders should be aggressively managed	7
craniofacial anomalies	7
orthognathic surgery is rarely required	7
referral of males with cryptorchidism to a urologist	7
referral of males with micropenis to an endocrinologist	7
androgenic hormone therapy as indicated	7
neoplasia	7
monitoring of growth with special attention to growth velocity	7
close monitoring of speech and language development	7
dental and orthodontic evaluations	7
echocardiogram or evaluation by cardiologist for structural heart defects	7
assessment for gastroesophageal reflux as warranted	7
assessment for presence of cryptorchidism in males	7
orthopedic assessment of thumbs and halluces, joints and spine	7
standard treatment for hearing loss if identified	7
standard treatment for cardiac defects if identified	7
aggressive management of gastroesophageal reflux and constipation	7
standard treatment for cryptorchidism if identified	7
surgical repair of significantly angulated thumbs or duplicated halluces	7
appropriate treatment for sleep apnea if identified	7
annual follow-up evaluation for ophthalmologic abnormalities	7
yearly audiologic screens	7
monitoring as per routine for cardiac or renal anomalies	7
regular dental and orthodontic follow up	7
ophthalmologic examination to evaluate for cataracts	7
visually significant cataracts require surgical removal	7
annual evaluation by a physician familiar with rts	7
monitoring of growth	7
ecg evaluation	7
complete cessation of symptoms is the goal	7
it is therefore important that:	7
icd	7
doses should be altered as needed	7
lifestyle modifications are advised based on genotype	7
that has documented lqts	7
in which evaluation for lqts has not been performed	7
or both of the following:	7
follow-up experience with these drugs is still limited	7
most affected individuals live normal lifestyles	7
adequate posture should be maintained when lying prone and sitting	7
monitor as follows:	7
ibuprofen (brufen®):	7
give with care in those with evidence of cardiomyopathy	7
avoid in those with congestive heart failure	7
medical history and physical examination including neurologic examination	7
brain mri examination and referral to a neurologist	7
referral to a hematologist/oncologist	7
hematologic manifestations	7
complete blood count annually	7
annual evaluation of gait, coordination, and speech	7
neurologic examination to evaluate the grade of ataxia and neuropathy	7
neurophysiologic examinations	7
enmg (electroneuromyography)	7
sep (somatosensory evoked potentials)	7
vep (visual evoked potentials)	7
treatment is symptomatic:	7
sensory axonal neuropathy	7
physiotherapy and orthoses to prevent foot and spine deformity	7
supportive shoes, splints, and braces	7
foot care to treat calluses and ulcerations	7
a walker, wheelchair, physiotherapy, occupational therapy	7
some patients have benefited from lamotrigine or levetiracetam	7
small children	7
neurophysiologic studies when clinically indicated	7
brain mri every three to five years	7
neurologic examination annually	7
audiologic and ophthalmologic examinations every one to two years	7
eeg and brain mri at least during status epilepticus	7
neurologic evaluation every three to six months is appropriate	7
, diphenylhydantoin)	7
results have not been published (nct00683943)	7
nerve conduction tests	7
neuropsychological tests	7
canes and walkers help prevent falling	7
no dietary factor that curtails symptoms has been documented	7
general and neurologic examination	7
nerve conduction studies	7
medical genetics or neurogenetics consultation	7
occupational therapy, including home adaptations	7
physiotherapy and assessment for cane and wheelchair	7
ankle-foot orthotics (afos) for those with neuropathy	7
weight control can help to facilitate ambulation	7
tremor rating and gait ataxia assessment	7
evaluation for peripheral neuropathy and autonomic dysfunction	7
modest success has been observed in some affected individuals	7
supplements of antioxidants, which may have some beneficial effects	7
treatment of psychiatric syndromes as needed	7
technical assistance with writing and other fine-motor tasks	7
recommended:	7
education of affected individuals and their families	7
epileptic seizures can be improved by treatment with anticonvulsive medications	7
alcohol and sedating drugs can exacerbate ataxia	7
weight gain during pregnancy can further impair gait ataxia	7
gait, coordination, and speech should be evaluated annually	7
alcohol and sedation may make gait and coordination worse	7
treatment of symptomatic tremor has not been reported in sca15	7
neuropsychological testing to evaluate for dementia and/or psychiatric disturbance	7
brain mri to evaluate areas and degree of atrophy	7
neurology consultation, if not completed prior to initial diagnosis	7
treatment of seizures with antiepileptic drugs (aeds)	7
treatment of dystonia with local injections of botulinum toxin	7
the side effects of psychotropic medications and aeds (e	7
affected women may be on medications (e	7
, antiepileptics) to control the symptoms of sca17	7
baseline assessment of cognition	7
careful clinical and neurologic evaluation	7
periodic speech assessment if dysphagia becomes a problem	7
, isoniazid)	7
evaluation of cognitive abilities	7
at present, only symptomatic treatments are available	7
these include the following:	7
crutches (less often canes) and walkers	7
speech/language therapy for dysarthria and swallowing difficulties	7
surgical intervention as needed for severe ptosis	7
weight control can facilitate ambulation	7
monitoring of speech and swallowing difficulties is recommended	7
gait assessment	7
symptoms of restless legs syndrome may respond to these agents	7
non-pharmacologic therapy is important in sca3:	7
general anesthesia may be problematic	7
neurologic examination with appropriate scoring protocols:	7
clinical genetics consultation and genetic counseling	7
specific treatment for sca36 is currently not available	7
walking aids to facilitate ambulation and mobility	7
the use of a wheelchair is rare	7
speech therapy and communication devices for those with dysarthria	7
the utility of cochlear implants in sca36 is unknown	7
surveillance of speech and ambulation	7
, salicilates)	7
environmental noise at work and in everyday life (e	7
medical, neurologic, family and social history	7
swallow evaluation for aspiration risk and counseling	7
vestibular suppressants may reduce vertigo and/or osscilopsia	7
canes, walking sticks, and walkers help prevent falling	7
note: rbd is rare in individuals with sca6	7
continuous positive airway pressure may be used for sleep apnea	7
driving ability should be assessed by professionals periodically	7
cerebellar ataxia	7
use of canes and walkers helps prevent falls	7
affected individuals should get plenty of rest	7
symptoms are often aggravated by fatigue	7
carnitine levels	7
compound heterozygous for pathogenic variant and a susceptibility variant	7
free carnitine levels were normal in all individuals	7
routine visits to a neurologist are appropriate	7
brain mri if not previously performed	7
cognitive and behavioral neuropsychological evaluation	7
no published treatment guidelines exist	7
, dravet syndrome	7
see scn1a-related seizure disorders and differential diagnosis)	7
sodium channel blockers	7
other aeds	7
vagus nerve stimulator	7
cannabinoids	7
sleep hygiene	7
monitor with eeg and other modalities (e	7
audiologic screening for hearing loss	7
examination for cleft palate	7
examination of upper and lower extremities for anomalies	7
measurement of height and growth velocity	7
it prevents the following:	7
in most cases, cranioplasty precedes palatal repair	7
ophthalmologic abnormalities are treated in a standard fashion	7
, gymnastics, football, soccer)	7
, headache, reduced school performance) are identified	7
audiologic screening throughout childhood is indicated	7
screen for sleep-disordered breathing at all visits	7
discussions to update recommendations are ongoing	7
pancreatic imaging by ultrasound	7
bone densitometry as clinically indicated	7
assessment of serum aminotransferase levels	7
routine monitoring (see surveillance) is recommended	7
hematologic abnormalities	7
note: discussions to update and maintain recommendations are ongoing	7
some drugs (e	7
cbc with differential to evaluate for microcytic anemia	7
measurement of serum bilirubin concentration to evaluate for jaundice	7
skeletal survey to evaluate for dysostosis multiplex	7
eeg when relevant	7
assessment for upper airway sufficiency if macroglossia is present	7
renal ultrasound examination to evaluate for genitourinary malformations	7
abdominal/pelvic ultrasound examination to evaluate for intra-abdominal tumors	7
abdominal ultrasound examination to evaluate for visceral anomalies	7
further studies (e	7
, mri) if findings are suspicious	7
examination for evidence of skeletal anomalies requiring intervention (e	7
, scoliosis during period of rapid growth rate)	7
development assessment including speech and language assessment	7
prompt treatment of hypoglycemia if present	7
ophthalmologist for management of vision problems	7
neurologist if seizures are present	7
oncologist if a tumor is identified	7
for males with sgbs1:	7
monitoring for hypoglycemia in the newborn period	7
radiographs as needed	7
monitoring of renal function if renal anomalies are present	7
every three months until age four years	7
every four months from age four to seven years	7
biannually after age seven years	7
the following screening recommendations require further study to determine benefit	7
wilms tumor	7
gonadoblastoma or hepatocellular carcinoma	7
every six months between ages four and seven years	7
neuroblastoma	7
every six months from age four to seven years	7
severe scoliosis, c1/c2 abnormality)	7
surgical evaluation for hernia repair, if indicated	7
surgical intervention for aneurysms may be indicated	7
surgical repair of abdominal hernias may be indicated	7
cleft palate and craniosynostosis require management by a craniofacial team	7
surgical fixation of cervical spine instability may be necessary	7
clubfoot deformity may require surgical correction	7
pectus excavatum may be severe	7
rarely, surgical correction is indicated for medical reasons	7
physiotherapy	7
physiotherapy may help increase mobility in individuals with joint contractures	7
activities that cause joint pain or injury	7
for infants just diagnosed with short syndrome:	7
measurement of length and weight	7
assessment for evidence of insulin resistance/diabetes mellitus	7
axenfeld-rieger anomaly or related anterior chamber ocular anomalies	7
dental anomalies	7
insulin resistance/diabetes mellitus	7
periodic hearing assessments in childhood	7
successful pregnancies have occurred in women with short syndrome	7
if present, diabetes mellitus is managed as appropriate	7
hematology consultation	7
infants	7
cbc and reticulocyte count	7
measurement of hbf (%)	7
baseline vitamin d	7
renal and liver function tests	7
older individuals	7
see surveillance	7
a systematic approach to pain management should be reviewed regularly	7
vaso-occlusive pain episodes (including dactylitis)	7
, cold, dehydration)	7
nsaids (e	7
fever/suspected infection	7
individuals with temperature greater than 38	7
rapid triage and physical assessment	7
urgent cbc and reticulocyte count	7
acute chest syndrome (acs)	7
perform chest x-ray examination	7
incentive spirometry should be encouraged	7
aplastic crisis	7
blood transfusion may be necessary	7
splenic sequestration	7
the following general approach is reasonable:	7
, thrombotic disease, obstructive sleep apnea)	7
optimization of scd-related therapy to stop progression (e	7
stroke	7
cerebral hemorrhage requires immediate neurosurgical consultation	7
chronic transfusion has been shown to reduce silent infarcts	7
priapism	7
ongoing education is essential to help minimize morbidity and mortality	7
maintaining hydration and avoiding extremes of climate	7
monitoring for signs and symptoms requiring acute medical intervention	7
early detection of chronic complications	7
updates on new therapies	7
chronic red blood cell transfusion therapy	7
prevention of stroke recurrence	7
treatment of chronic pain refractory to other therapies	7
chronic renal failure	7
recurrent episodes of acs	7
severe end-organ damage	7
metabolism into nitric oxide, a potent vasodilator	7
overall improvement in blood flow	7
reduction of vascular inflammation	7
hydroxyurea can have potentially significant toxicity, including myelosuppression	7
gov/ct2/show/nct01179217)	7
timely administration of vaccines is essential	7
iron overload	7
the following are general guidelines compiled from several sources	7
comprehensive medical and social evaluation	7
routine dental care is recommended	7
mental health and neurocognitive assessment	7
annual laboratory assessment should include the following:	7
cbc with differential and reticulocyte count	7
ldh as a marker of hemolysis	7
vitamin d level	7
assessment of stroke risk	7
end-organ evaluation	7
chest x-ray examination	7
pulmonary function tests (pfts)	7
six-minute walk test	7
sleep study (to assess nighttime hypoxemia)	7
iron overload by mri	7
environmental controls include avoiding the following:	7
extremes of temperature (e	7
physical exhaustion	7
extremely high altitude without oxygen supplementation	7
cocaine	7
the field is changing rapidly	7
gov for the status of current studies	7
prevention of hbs polymerization	7
decreasing adhesion to the endothelium	7
modifying inflammatory responses	7
antioxidants therapy	7
multiple antioxidants are being studied	7
rejuvenation of nitric oxide (no) stores	7
induction of fetal hemoglobin	7
glu6val) with a normal allele	7
this leaves the endogenous sickle allele intact	7
the status of these trials is changing rapidly	7
gov for the most up-to-date information	7
brain ct or mri	7
psychological testing if indicated	7
there is no effective treatment for xlsa/a	7
weighted eating utensils may help promote independent skills in childhood	7
speech therapy may improve intelligibility problems resulting from dysarthria	7
hepatic and systemic iron overload does not occur	7
referral to a nephrologist for evaluation	7
dental evaluation after teeth are present	7
detailed history for headaches or neurologic abnormalities	7
assessment for osteopenia	7
orthopedic manifestations	7
treatment of scoliosis and/or kyphosis is standard	7
immunologic manifestations	7
individuals with autoimmune problems have had variable responses to treatment	7
infectious disease manifestations	7
hypothyroidism can be treated with levothyroxine supplementation	7
regular monitoring of the hips	7
annual monitoring of renal, immune, and hematologic status	7
heat, stress, and lack of sleep	7
vaccinations with live vaccines	7
anti-cancer therapies	7
individuals with siod usually have normal growth hormone studies	7
assessment of liver function	7
white blood count is <3	7
5x109/l	7
neutrophil count is <2	7
0x109/l	7
platelet count is <150x109/l	7
routine monitoring of:	7
height and weight using age and gender appropriate growth charts	7
swallowing and diet to assure adequate nutrition	7
ambulation and speech	7
environmental manganese exposure (i	7
high manganese content of total parenteral nutrition	7
foods very high in manganese, including: cloves	7
and pumpkin, sesame, and sunflower seeds	7
neurologic assessment of the movement disorder	7
ophthalmology assessment of vision and eye movements	7
evaluation of caloric intake and feeding by a nutritionist	7
speech and language therapy assessment of communication and swallowing	7
physiotherapy evaluation of postural issues and tone	7
orthopedic review of any fixed contractures / joint dislocations	7
although the role of atypical tranquilizers (e	7
treatment of status dystonicus	7
standard protocols are used in an intensive care setting	7
regular swallowing assessment to evaluate risk for aspiration	7
drugs with anti-dopaminergic side effects (e	7
cardiac evaluation (ecg and echocardiogram) for congenital defects	7
nutritional assessment for feeding problems and poor weight gain	7
renal ultrasound evaluation for renal anomalies	7
hearing evaluation for either sensorineural or conductive hearing loss	7
cholesterol supplementation	7
dental management can be challenging	7
recurrent otitis media may require tympanostomy tube placement	7
airway management during anesthesia may be challenging	7
determine if caloric intake is adequate	7
determine if gastrostomy tube placement and fundoplication are indicated	7
orthopedic evaluation to assess contractures	7
see spinal muscular atrophy	7
feeding/growth	7
manage gastroesophageal reflux disorder in the standard manner	7
use oral suctioning as needed	7
in some cases artificial ventilation and tracheostomy may be employed	7
manage accordingly	7
standard precautions against infection are appropriate	7
, a clinical geneticist)	7
affected children frequently die in infancy or early childhood	7
the following are indicated on a routine basis:	7
monitoring for scoliosis and kyphosis	7
nutrition/feeding assessment	7
time required to complete a feeding	7
evidence of fatigue during a feeding/meal	7
weight plotted on standard growth curves	7
respiratory function assessment	7
normal breathing pattern versus abdominal breathing pattern	7
sleep assessment	7
activities of daily living	7
health issues specific to sma	7
scoliosis occurs frequently in individuals with sma ii	7
no surgical complications were identified	7
hip dislocation is another orthopedic concern in sma	7
individuals with sma are evaluated at least every six months	7
weaker children are evaluated more frequently	7
small-molecule therapy approaches	7
increasing smn protein production	7
neuroprotective and other approaches	7
rna-based therapy approaches	7
subcutaneous injections extended the median life span 25-fold	7
complete review of systems at the time of diagnosis	7
comprehensive speech/language pathology evaluation	7
early evaluation by physical and/or occupational therapists	7
a change in behavior or attention warrants reevaluation	7
specific screening for adrenal function	7
[hildenbrand & smith 2012]	7
no well-controlled treatment trials have been reported:	7
thus, dosages may not be exact	7
enclosed bed system for containment during sleep	7
treatment with diet or medication as indicated	7
treatment with corrective lenses as indicated for ophthalmologic abnormalities	7
treatment of recurrent otitis media with tympanostomy tubes as needed	7
recommended annually:	7
thyroid function, including free t4 and tsh	7
fasting lipid profile	7
routine urinalysis to evaluate for occult urinary tract infections	7
monitoring for scoliosis	7
significant changes in her sleep pattern were also documented	7
assessment of seizures, including eeg if seizures are suspected	7
formal audiologic evaluation	7
neurologic evaluation for consequences of cranial nerve entrapment	7
radiographic and imaging studies	7
the bones in sclerosteosis are thick and dense	7
surgical intervention may be difficult and prolonged	7
standard neurosurgical instruments may not be sufficient (i	7
tooth extraction may be difficult	7
management by an orthodontic or craniofacial team is recommended	7
annually from infancy onwards for the following:	7
assessment for increased intracranial pressure and medullary compression	7
neurologic and otologic examination for consequences of cranial nerve entrapment	7
clinical appraisal and lateral skull radiograph as indicated	7
referral for audiologic assessment	7
thus, the threshold for referral should be low	7
when clinical problems (e	7
antibiotic prophylaxis is indicated in individuals with vesicoureteral reflux	7
the following are appropriate at the clinical evaluation:	7
thorough history to identify known clinical sequelae of sotos syndrome	7
cardiac auscultation	7
examination for curvature of the spine	7
urine dipstick to assess for quiescent urine infection	7
referral to the appropriate clinical specialist if problems are identified	7
note: cancer screening is not recommended	7
examination by an experienced pediatric ophthalmologist	7
baseline neurodevelopmental assessment	7
care includes:	7
early referral to an experienced multidisciplinary team	7
referral to special educational services for visually impaired infants	7
referral to endocrinologist for growth or hypogonadism concerns	7
referral to physiotherapist if any evidence of motor impairment exists	7
referral to special educational services for neurodevelopmental problems as needed	7
parent/caregiver training in seizure management	7
the following measures are suggested:	7
annual hearing test	7
neurodevelopmental assessment annually for the first five years of life	7
neuropsychological testing to assess the cognitive impairment and decline	7
neuro-urologic examination for those with sphincter disturbance	7
electrophysiologic investigations (e	7
, enmg, vep, sep)	7
no specific drug treatment or cures exist for spg11	7
physiotherapy for stretching of the spastic muscles to prevent contractures	7
anti-spastic drugs such as baclofen and tizanidine	7
anticholinergic drugs are indicated for urinary urgency	7
psychiatric manifestations should be treated in accordance with standard practice	7
early regular physiotherapy helps to prevent contractures	7
regular electrophysiologic investigations (e	7
physiotherapy is appropriate	7
foot deformities are corrected by surgical treatment	7
occipitofrontal circumference (ofc)	7
gross motor and fine motor skills	7
school performance	7
emotional status, including presence or absence of emotional lability	7
skeletal abnormalities and skeletal x-rays as needed	7
improve muscle strength (through resistance exercise)	7
improve cardiovascular fitness	7
oxybutynin is helpful in reducing urinary urgency	7
see also hereditary spastic paraplegia overview	7
provide good nursing care and physiotherapy during disease progression	7
monitor for dysphagia to reduce risk of aspiration	7
cognitive testing	7
repeat skeletal survey	7
urologic evaluation in persons with prominent urinary bladder hyperactivity	7
spasticity can be treated with:	7
oral baclofen or tizanidine	7
chemodenervation with botulinum a or b toxins	7
see also prevention of secondary complications	7
referral to orthotic services may be helpful	7
urinary urgency can be treated with anticholinergic antispasmodic drugs	7
symptomatic treatment includes use of the following:	7
antispastic drugs for leg spasticity	7
anticholinergic antispasmodic drugs for urinary urgency	7
regular physiotherapy for stretching of spastic muscles	7
no specific drug treatments or cures exist for spg7	7
this approach may offer hope for future treatment strategies	7
urodynamic evaluation	7
antispasmodic drugs (e	7
no significant toxicity limits their use	7
evaluation for other (e	7
, renal and cardiac) anomalies	7
routine treatment of inguinal herniae	7
surgical intervention as needed if scoliosis is significant	7
expert management of these clinical problems is indicated	7
neurologic consultation	7
neuropsychological evaluation depending on the severity of manifestations	7
social services consultation depending on the severity of manifestations	7
l-dopa (0	7
optimal therapeutic level is determined by clinical response	7
tetrahydrobiopterin (bh4	7
monoamine oxidase inhibitors (selegeline)	7
serotonin reuptake inhibitors (sertraline)	7
melatonin	7
dopamine agonists (bromocriptine, pramipexole)	7
anticholinergics	7
methylphenidate	7
neuroleptics and other dopamine antagonists (e	7
, metoclopramide)	7
neuroimaging (mri)	7
5 years [escalera et al 2010]	7
and speech therapy [gropman 2003]	7
regular neurologic and developmental assessments are indicated	7
the refractory epilepsy was finally controlled with magnesium valproate	7
in addition, the eeg demonstrated improved background organization	7
evaluation of palate by a craniofacial specialist	7
baseline audiogram	7
refractive errors should be corrected with spectacles	7
myringotomy tubes are often required	7
annual examination by a vitreoretinal specialist is appropriate	7
more advanced testing (e	7
evaluation for possible hemolysis/ hemolytic anemia	7
monitoring liver function (e	7
evaluation for arthralgias and/or arthritis	7
some of these treatments have only been partially effective	7
current treatment therapies focus on the following:	7
treatments should begin at the time of diagnosis	7
often existing xanthomas regress	7
partial ileal bypass surgery (i	7
sitosterolemia does not respond to standard statin treatment	7
margarines and other products containing stanols (e	7
global developmental delay, cognitive dysfunction and intellectual disability	7
seizure management is symptomatic	7
other neurologic findings	7
emg to assess myopathy	7
bracing for scoliosis and kyphosis	7
blepharoplasty for significant ptosis	7
hearing aids and/or cochlear implantation for sensorineural hearing loss	7
routine developmental and neurologic assessment	7
periodic nutritional and growth assessment	7
periodic hearing evaluation	7
periodic ophthalmologic examination	7
echocardiogram to assess for cardiomyopathy	7
ophthalmologic examination for evidence of ptosis and/or strabismus	7
nutritional and growth assessment	7
brain mri to assess for cerebellar atrophy	7
nerve conduction studies to rule out a peripheral neuropathy	7
no pregnancy complications have been reported	7
complete nutritional evaluation, including evaluation for intestinal malabsorption	7
evaluation for immune deficiency	7
agents such as gabapentin should be considered	7
gentle handling may reduce pain that is worsened with movement	7
splinting of affected joints may provide comfort	7
consultation with a pain management specialist may be helpful	7
palliative care may be an option in severe cases	7
a nutritionist should follow affected individuals	7
protein-losing enteropathy	7
an effective long-term treatment is lacking	7
dermatitis	7
perianal masses may be excised, but may recur	7
contractures are typically progressive	7
immune system/infections	7
routine nutritional assessment is appropriate	7
platelet count if this has not been completed	7
orthopedic evaluation of both upper and lower limbs	7
echocardiography to assess for cardiac anomalies	7
evaluation of renal structure and function	7
the treatment for thrombocytopenia is platelet transfusion as needed	7
almost all develop thrombocytopenia during pregnancy	7
emg/ncs to document the regions of involvement	7
screening for depression and need for psychosocial support	7
routine screening for depression at clinic visits is appropriate	7
complete history and physical examination, including ophthalmologic examination	7
family history, including ethnicity	7
referral to a pediatric neurologist and/or ophthalmologist	7
but the clinical response is unpredictable and generally poor	7
none has been successful	7
doors syndrome	7
clinical genetics consultation, including dysmorphology examination	7
audiology consultation	7
otolaryngology consultation	7
ophthalmology consultation	7
dental consultation	7
heart ultrasound	7
the management of epilepsy in many genetic epilepsies is complex	7
refer to an urologist or nephrologist as indicated	7
manage according to the anomalies detected	7
yearly dental evaluation is appropriate	7
baseline evaluation by a cardiologist including an echocardiogram	7
imperforate anus	7
immediate surgical intervention is required	7
thumb malformations	7
, removal of additional thumbs)	7
annual hearing evaluation is indicated	7
medications that cause renal or otic toxicity should be avoided	7
the palate for clefts	7
swallowing function	7
birth to 2 years: airway and feeding difficulties	7
13 years to 18 years: orthognathic surgery	7
generally, bone reconstruction precedes soft tissue corrections	7
reconstruction can prevent the progression of facial asymmetry	7
maxillomandibular reconstruction	7
orthognathic procedures are typically indicated before age 16 years	7
misaligned teeth often require orthodonture	7
nasal reconstruction, if needed, should follow orthognathic surgeries	7
assessment of respiratory status by respiratory rate and skin color	7
medical genetics consultation and genetic counseling	7
other measures:	7
medication to control seizures, as in the general population	7
shunt placement, when hydrocephaly is identified	7
suboccipital decompression for relief of craniocervical junction constriction	7
hearing aids, when hearing loss is identified	7
routine assessment of neurologic status on physical examination	7
audiology assessment	7
eeg for seizure activity	7
it can be addressed on three levels:	7
maternal	7
avoidance of emergency c-section for fetal distress	7
fetal	7
familial	7
x-ray evaluation for vertebral anomalies	7
supplemental oxygen should be administered as needed	7
tetra-amelia syndrome is usually diagnosed prenatally	7
other individualized ambulatory devices may be indicated	7
complete neurologic assessment including baseline nerve conduction studies	7
evaluation of the heart:	7
carpal tunnel release surgery for carpal tunnel syndrome	7
vitrectomy for vitreous involvement	7
orthotopic liver transplantation (oltx)	7
age younger than 60 years	7
disease duration less than five years	7
no significant cardiac or renal dysfunction	7
fapwtr	7
org/ram_fap	7
severe polyneuropathy (norris score <55/81)	7
permanent urinary incontinence	7
marked postural hypotension	7
a fixed pulse rate	7
inhibition of synthesis of variant ttr	7
stabilization of variant ttr	7
inhibition of aggregation of amyloidogenic intermediates	7
disruption of insoluble amyloid fibrils	7
this study is currently fully enrolled	7
results are anticipated in december, 2012	7
however, no obvious benefit could be detected	7
serum concentration of testosterone to assess testicular function	7
serum concentration of estradiol to assess ovarian function	7
therapeutic phlebotomy	7
periodic phlebotomy (i	7
the usual therapy is weekly phlebotomy	7
camaschella & roetto, unpublished observation]	7
treatment of clinical complications	7
in some cases, joint replacement has been performed	7
diabetes mellitus may require lifelong insulin treatment	7
medicinal iron	7
mineral supplements	7
excess vitamin c	7
neurologic evaluation and eeg to assess possible seizures	7
glycopyrolate or scopolamine to improve drooling	7
standard anticonvulsant medication to control seizures, if present	7
placement of permanent feeding tube to avert malnutrition	7
diet restrictions to prevent aspiration	7
regular orthopedic evaluations to monitor scoliosis or joint problems	7
aspiration of food should be avoided to prevent pneumonia	7
clinical examination to assess the severity of motor disturbances	7
evaluation for associated psychiatric symptoms or cognitive impairments	7
, 0	7
mild form (th-deficient drd)	7
individuals demonstrate complete responsiveness of symptoms to levodopa treatment	7
individuals show a marked response to levodopa	7
very severe form (th-deficient progressive infantile encephalopathy)	7
individuals are extremely sensitive to levodopa	7
2 to 1	7
orthopedist consulation for skeletal abnormalities	7
long qt interval	7
beta-blockers	7
pacemaker	7
implants	7
the possibility of reduced immune response should be considered	7
surgical release of syndactyly	7
drugs and dietary practices that could lead to hypoglycemia	7
neurology consultation with comprehensive neurologic examination	7
consultation with a pediatric pulmonologist to evaluate pulmonary function	7
brain mri in patients with encephalopathy or seizures	7
currently there is no definitive treatment	7
management should involve a multidisciplinary team	7
soon after diagnosis is established:	7
measurement of height	7
at an older age, only for trps ii	7
dental examination for supernumerary teeth	7
cardiac evaluation (once)	7
management of trps is principally supportive	7
ectodermal features	7
hair	7
however, reported results vary	7
hands	7
regular simple analgesia (e	7
physiotherapy may aid mobility	7
exostoses	7
monitor linear growth in childhood	7
routine developmental assessments in childhood	7
ratios of 70%-89% are classified as mild	7
ratios lower than 70% are classified as severe	7
restriction of dietary trimethylamine and its precursors	7
choline	7
dietary choline is absorbed through the small intestine	7
trimethylamine n-oxide	7
intake of such vegetables should be restricted	7
use of acid soaps and body lotions	7
trimethylamine is a strong base (pka 9	7
thus, at ph 6	7
0, less than 0	7
02% of trimethylamine exists as the volatile free base	7
sequestering of trimethylamine produced in the gut	7
suppression of intestinal production of trimethylamine	7
enhancement of residual fmo3 enzyme activity	7
counseling	7
affected individuals and their families benefit from counseling	7
avoid or eat in moderation	7
drugs that are metabolized by the fmo3 enzyme	7
for example, the antipsychotic clozapine	7
the monoamine oxidase b inhibitor deprenyl	7
the anti-histamine ranitidine	7
the anti-estrogen tamoxifen	7
these compete for residual fmo3 activity	7
neuroimaging including brain mri when clinically indicated	7
high-dose thiamine supplementation:	7
invariably improves the hematologic picture	7
additional treatment	7
red blood cell transfusion for severe anemia is indicated	7
treatment has included cochlear implant [hagr 2014]	7
ongoing management of the primary disease is essential	7
hematologic tests (cbc, reticulocyte count)	7
assessment of developmental milestones and cognitive function	7
assessment of functional disability and equipment needs by a physiotherapist	7
in some instances intrathecal baclofen pumps can be considered	7
dystonia can be managed with:	7
baclofen or intramuscular botulinum toxin when associated with spasticity	7
trihexyphenidyl or tetrabenazine	7
dysarthria may warrant augmentative communication tools	7
anticonvulsant medications should be used when seizures are present	7
calcium and vitamin d supplementation as required to prevent osteoporosis	7
annual flu vaccination	7
fall prevention strategies, adaptive equipment (e	7
at least yearly:	7
medical evaluation including physical examination to assess weight and medications	7
evaluation by orthopedists to assess for scoliosis and joint dislocation	7
annual neurologic evaluation to assess symptoms and any emerging complications	7
detailed dermatologic inspection/exam	7
detailed clinical dental inspection/exam	7
screening for hypertension by obtaining an accurate blood pressure measurement	7
baseline routine electroencephalogram (eeg)	7
evaluation for tsc-associated neuropsychiatric disorder (tand)	7
subependymal giant cell astrocytomas (segas)	7
additional trials are underway to confirm these preliminary findings	7
renal angiomyolipoma	7
facial angiofibromas	7
cardiac rhabdomyomas	7
, outflow tract obstruction) was surgery	7
however, response to treatment is highly individual	7
oxygen therapy is necessary with impaired lung function	7
persons with severe disease require lung transplantation	7
perform screening for tand features at least annually	7
perform detailed clinical dermatologic inspection/exam annually	7
avoid the following	7
estrogen use in adolescent and adult females	7
nephrectomy (see treatment of manifestations, renal angiomyolipoma)	7
growth, feeding, and nutrition	7
cbc with platelet count	7
serum concentration of electrolytes	7
clinical genetics consultation is indicated for all affected individuals	7
management guidelines have been published	7
acute management of liver failure	7
nitisinone (orfadin®)	7
nitisinone is generally prescribed at 1	7
0 mg/kg/day	7
individual requirements may vary	7
nitisinone is typically given in two divided doses	7
low-tyrosine diet	7
3 mg/dl)	7
transplant recipients require long-term immunosuppression	7
transplant recipients may also benefit from low-dose (0	7
initiation of therapy (baseline)	7
first 6 months:	7
after 6 months of rx: every 6-12 months	7
after 2 years of rx: every 6-12 months	7
as clinically indicated	7
every 3 months	7
tyrosinemia type i markers	7
plasma concentration of methionine, phenylalanine, tyrosine	7
blood / urine succinylacetone	7
x(urine)	7
blood nitisinone concentration	7
hemoglobin, hematocrit, wbc, platelet count	7
liver evaluation	7
serum afp concentration	7
pt/ptt	7
bilirubin	7
alt/ast/ggt	7
alkaline phosphatase	7
ct or mri 1	7
renal studies	7
bun / creatinine	7
urine: po4, ca, prot/cr ratio	7
skeletal evaluation	7
x-ray of wrist (for rickets)	7
avoid inappropriate protein intake	7
org for more information on medication exposure during pregnancy	7
average survival was less than age ten years	7
ct and mri identify affected muscles with high specificity	7
heavy muscle force training of weak muscles should be avoided	7
organ system	7
constitutional	7
ophthalmologic eval	7
feeding eval	7
orthopedic eval	7
if club feet and/or scoliosis is present	7
if neurologic history suggests presence of seizures	7
psychiatric eval	7
if behavioral problems are present	7
ocular abnormalities (nystagmus/strabismus)	7
ophthalmologic management	7
oral feeding difficulties	7
g-tube feeding	7
braces and/or corrective surgery	7
self-injurious behavior	7
behavior modification therapy	7
hypo/hypertonia, gross motor delays, sensory processing difficulties	7
physical therapy, occupational therapy	7
absent speech	7
sign language instruction	7
consider alternate forms of communication	7
annual evaluation with the following specialists is appropriate:	7
pediatrician for growth assessment	7
neurologist to identify and manage seizures	7
orthopedist for evaluation of contractures and back examination for scoliosis	7
ophthalmologist for ocular manifestations and corrective therapy if needed	7
urinalysis and urine culture for occult or chronic infection	7
urinary tract ultrasound examination	7
micturating cystourethrogram	7
uroflowmetry or urodynamic testing	7
assessment of bowel voiding	7
urinary tract infections warrant rapid and complete treatment	7
antibiotic prophylaxis may also be considered	7
bowel	7
constipation is managed as for the general population	7
clinical genetics	7
consultation with a clincial geneticist and/or genetic counselor	7
balance	7
they should therefore exercise caution while swimming	7
hearing aids are helpful	7
environmental trauma (e	7
, noise) or a genetic susceptibility (e	7
in such individuals, cochlear implantation may be warranted	7
abr, dpoae	7
ophthalmologic evaluation for retinal hemangioblastomas	7
abdominal ultrasound examination after age 16 years	7
audiologic evaluation for hearing loss associated with endolymphatic sac tumors	7
no guidelines exist for the management of vhl lesions	7
cns hemangioblastoma	7
two patients required additional surgery	7
retinal hemangioblastoma	7
3% and 4	7
3%, respectively [young et al 2012]	7
pheochromocytomas	7
pheochromocytomas should be surgically removed	7
laparoscopic approaches have been shown to be effective	7
partial adrenalectomy could be considered	7
one long-term follow-up study (9	7
partial adrenalectomy is also therapy of choice in children	7
in 10 vhl patients 18 successful operations were performed	7
after follow up (median 7	7
pancreatic cysts and neuroendocrine tumors	7
a tumor of ≥3 cm	7
a pathogenic variant in exon 3	7
a tumor with a doubling rate <500 days	7
twenty-nine patients were symptomatic	7
epididymal or broad ligament papillary cyst adenomas	7
annual blood pressure monitoring starting at age one year	7
monitoring for complications is as follows:	7
cns lesions	7
visceral lesions	7
annual abdominal ultrasound	7
retinal angiomas	7
the best way to detect elst is unknown	7
other guidelines originate from denmark and the netherlands	7
two recent studies evaluated tumor progression	7
such test results need to be interpreted with caution	7
, vhl syndrome or other hereditary disorder)	7
many experimental therapies target these misregulated signaling pathways	7
preclinical investigation of ptc124 effects on vhl is ongoing	7
measurement of baseline liver transaminases	7
cardiac echocardiography	7
[behrend et al 2012]	7
however, the efficacy remains controversial	7
severe exercise (e	7
myocardial irritation (e	7
, cardiac catheterization)	7
dehydration (risk for acute tubular necrosis)	7
formal testing of cognitive function	7
physical therapy to promote ambulation	7
biopsy is usually not necessary for diagnosis	7
treatment is required for any symptomatic vmcm lesion	7
during pregnancy, affected women may develop small new lesions	7
an appropriate dose is 0	7
625 ml/kg) or 150 mg/m2 (3	7
75 ml/m2)	7
measurement of immunoglobulin concentrations prior to ivig infusions	7
broncho-alveolar lavage to diagnose pneumocystis jirovecii infection	7
viral cultures or lung function studies as needed	7
cerebrospinal imaging to diagnose leukodystrophy when clinically indicated	7
agents known to predispose to hvod (e	7
penetrance is complete (i	7
defibrotide was prophylactically continued until two months post transplant	7
a homozygous sp110 pathogenic variant (c	7
642delc) was identified on molecular genetic testing	7
defibrotide was given as hvod prophylaxis	7
defibrotide was able to be discontinued at day 60	7
seventy days following hsct he developed seizures	7
ct showed widespread calcifications	7
desmopressin	7
intranasal preparations are also available	7
intravenous infusion of vwf/fviii clotting factor concentrates	7
in those who are non-responsive to desmopressin (i	7
virus inactivation procedures eliminate potential pathogens	7
indirect treatments	7
fibrinolytic inhibitors (i	7
hormonal treatments (i	7
treatment by vwd type	7
type 1 vwd	7
treatments that directly increase vwf levels (e	7
indirect treatment with fibrinolytic inhibitors or hormones is often effective	7
type 2a vwd	7
indirect treatments can be beneficial	7
type 2b vwd	7
[federici et al 2009]	7
indirect treatments (i	7
, fibrinolytic inhibitors) can be useful	7
type 2m vwd	7
type 2n vwd	7
type 3 vwd	7
desmopressin is not effective in type 3 vwd	7
indirect treatments may also be beneficial	7
vwf levels are higher in the neonatal period	7
delayed, secondary postpartum bleeding may be a problem	7
, orthostasis)	7
assess cognitive function and psychiatric manifestations (e	7
evaluate levodopa response	7
pharmacotherapy	7
to reduce or delay side effects (e	7
patients treated with ergot-derived dopamine agonists require periodic echocardiograms	7
droxidopa may be used to treat orthostasis	7
plastic surgery	7
feeding and hearing evaluation	7
management is supportive/symptomatic	7
cleft lip	7
management is surgical, dental, and orthodontic	7
lip pits	7
popliteal pterygium	7
syndactyly may require surgery	7
the genital anomalies may result in infertility	7
some individuals may have pressure-equalizing tubes placed	7
neonatal period and infancy	7
assessment of prelinguistic speech-language development	7
longitudinal evaluation and treatment	7
evaluations should be carried out routinely through adolescence	7
routine dental evaluation should continue throughout life	7
these evaluations should continue throughout adolescence	7
visual field examination	7
photographic fundus documentation	7
optical coherence tomography (oct), if available	7
orthoptic assessment	7
refractive error is corrected by spectacles or contact lenses	7
visually disabling cataract is treated by cataract surgery	7
annual ophthalmologic examination by a vitreoretinal specialist is indicated	7
referral to immunologist for management	7
platelet count and size	7
t-cell subsets	7
immunoglobulin levels	7
wiskott-aldrich syndrome	7
[buchbinder et al 2014]	7
hematopoietic cell transplantation (hct)	7
eczema	7
topical steroids are the mainstay of therapy	7
autoimmune disease	7
x-linked thrombocytopenia (xlt)	7
, risk of secondary malignancy, infertility)	7
x-linked neutropenia (xln)	7
intravenous immune globulin	7
routine childhood immunizations	7
live vaccines should be avoided	7
splenectomy	7
platelet transfusions	7
platelet transfusions should be administered judiciously (e	7
, for significant bleeding and surgical procedures)	7
thorough history to identify clinical features associated with weaver syndrome	7
the presence of an abdominal mass warrants immediate investigation	7
where possible, measurement of parental heights	7
camptodactyly	7
occasionally toe camptodactyly may require surgical intervention	7
physiotherapy may also be beneficial	7
ligamentous laxity	7
evaluation by a medical geneticist	7
cardiac echocardiogram	7
physical examination for cancers common in werner syndrome (e	7
, thyroid nodules, skin tumors)	7
ophthalmologic examination including slit lamp examination	7
assessment of coping and psychological fitness in light of prognosis	7
infants with werner syndrome are unaffected at birth	7
control of type 2 diabetes mellitus	7
use of cholesterol-lowering drugs if lipid profile is abnormal	7
muscle atrophy is a potential complication	7
surgical treatment of ocular cataracts	7
treatment of malignancies in a standard fashion	7
screening for type 2 diabetes mellitus at least annually	7
annual lipid profile	7
annual ophthalmologic examination for cataracts	7
smoking and excess weight increase the risk of atherosclerosis	7
trauma to the extremities should be avoided	7
wolfram syndrome and wolfram-like syndrome	7
glucose tolerance test (if not already performed)	7
neuroimaging with mri	7
baseline psychologic assessment	7
treatment follows routine practices for insulin-dependent diabetes mellitus	7
wfs	7
psychiatric difficulties	7
neurogenic bladder	7
treatment of central diabetes insipidus follows routine practices	7
treatment of gastroparesis and celiac disease follows routine practices	7
(see celiac disease	7
diabetes mellitus: tests of glucose tolerance	7
optic atrophy: ophthalmologic examination	7
sensorineural hearing loss: audiologic examination including speech discrimination testing	7
diabetes insipidus: assessment of concentrating ability of the urine	7
puberty: monitoring for signs of onset of puberty	7
diabetic retinopathy	7
microalbuminuria	7
regular audiologic examination including speech discrimination testing is appropriate	7
measurement of growth parameters and plotting on growth charts	7
, clubfoot, scoliosis, kyphosis)	7
complete blood count to evaluate for hematopoietic dysfunction	7
baseline liver ultrasound to evaluate for hepatic adenoma	7
sleeping problems	7
if no medical factors (e	7
hepatic adenomas	7
other structural anomalies (e	7
antibiotic prophylaxis is indicated for vesicoureteral reflux	7
complete blood count annually to evaluate for hematopoietic dysfunction	7
and creatinine clearance test	7
consideration of routine liver ultrasonography to evaluate for liver adenomas	7
plotting of growth parameters on williams syndrome growth charts	7
measurement of blood pressure in all four limbs	7
echocardiogram, including doppler flow studies	7
urinary system evaluation	7
ultrasound examination of the bladder and kidneys	7
calcium determinations	7
serum concentration of calcium or ionized calcium	7
cognitive/behavioral	7
self-calming techniques can help manage anxiety	7
hypertension is usually treated medically	7
hypercalcemia	7
management of hypercalcemia involves the following:	7
hydration status should be assessed	7
increase water intake as indicated	7
but the serum concentration of calcium must be monitored	7
vitamin supplements containing vitamin d should be avoided	7
refractory hypercalcemia may be treated with oral steroids	7
eye, ear, nose, and throat	7
hyperopia is treated with corrective lenses	7
dacrostenosis is treated as in the general population	7
recurrent otitis media may be treated with tympanotomy tubes	7
dental care may require assistance with daily brushing and flossing	7
orthodontic referral should be considered for treatment of malocclusion	7
infants often benefit from feeding therapy	7
urinary tract abnormalities	7
hypothyroidism is treated with oral thyroxine therapy	7
range of motion exercises to prevent or ameliorate joint contractures	7
electrocardiogram prior to surgery	7
awareness of the risk for myocardial insufficiency and cardiac arrest	7
interval / age	7
in infants – toddlers	7
annual / all ages 1	7
every 2 years	7
serum concentration of calciumthyroid function and tsh level	7
every 10 years	7
in adults	7
thyroid function test yearly until age 3 years	7
medical evaluation	7
vision screening to monitor for refractive errors and strabismus	7
monitoring of blood pressure in both arms	7
serum concentration of calcium	7
thyroid function and tsh level	7
evaluation for cataracts	7
pregnancies in women with ws are high risk	7
upper gi endoscopy to exclude or confirm esophageal varices	7
detailed clinical neurologic assessment	7
brain mri to assess for structural alteration	7
assessment of kidney function	7
treatment is life long, including during pregnancy	7
d-penicillamine (chelator)	7
pyridoxine must be given along with d-penicillamine	7
zinc (metallothionein inducer)	7
, vegetarians) consult with a trained dietitian	7
zinc has been used effectively during pregnancy	7
org for more information on medication use during pregnancy	7
curcumin	7
the hearing loss in ws1 is typically non-progressive	7
hence, repeat audiogram would usually not be necessary	7
assessment of scalp hair	7
speech and language assessment of dysarthria and dysphagia	7
no specific treatment exists for wss	7
all treatment is symptomatic	7
note: standard replacement hormonal treatment will not promote fertility	7
low igf-1	7
standard treatment	7
l-thyroxine replacement therapy	7
treatment is symptomatic and cosmetic only	7
movement disorders	7
benzodiazepines, especially clonazepam	7
its use in wss has not been documented	7
dysarthria	7
consultation with a speech therapist may be helpful	7
nutritional management by a knowledgeable nutritionist is helpful	7
monitor for endocrine abnormalities:	7
hypogonadism at age 12-14 years	7
diabetes mellitus in the teens and later	7
hypothyroidism in the teens and later	7
dystonia may require monitoring by a neurologist	7
monitor hearing annually	7
adrenal function tests [dubey et al 2005]	7
pulmonary evaluation, if scoliosis compromises respiratory function	7
dermatologic evaluation to exclude other causes of the phenotype	7
ophthalmologic evaluation for congenital cataracts and other eye abnormalities	7
developmental assessment (after the newborn period)	7
renal ultrasound examination for possible kidney anomalies	7
hearing evaluation to detect hearing loss	7
treatment is symptomatic and should be tailored to each patient	7
orthopedic management of leg length discrepancy	7
surgical correction of polydactyly	7
cataract extraction and correction of vision	7
dermatologic management of skin lesions	7
regular follow-up of ophthalmologic abnormalities	7
ongoing follow-up with dermatologist	7
routine monitoring of any existing cardiac and/or renal abnormalities	7
regular hearing evaluations	7
a dental evaluation by age one year is recommended	7
hypohidrosis	7
some individuals may benefit from "cooling vests	7
hypodontia	7
orthodontics may be necessary	7
dental implants in adults can support aesthetic and functional dentition	7
lubrication eye drops can be helpful for dry eyes	7
individuals with severe hypohidrosis can have marked heat intolerance	7
there are no other special recommendations for pregnancy management	7
the results of the study were inconclusive	7
for additional information on the clinical trial click here	7
no formal management guidelines exist	7
the following are general considerations	7
hypogammaglobulinemia is treated with ivig	7
no formal surveillance guidelines exist	7
the following are general considerations:	7
a complete ophthalmologic evaluation	7
evaluation by a neurologist	7
evaluation by an epileptologist if seizures are present	7
evaluation by a hematologist if findings suggest a bleeding diathesis	7
treatment with antiepileptic agents	7
many individuals with periventricular nodular heterotopia have dyslexia	7
consultation with a specialist in immunodeficiency	7
hla-matched bone marrow transplantation from a relative is preferred	7
cord blood from normal infants is now being banked	7
bmt after age 3	7
administration of immunoglobulin	7
live vaccines	7
transfusion of non-irradiated blood products	7
the following investigations are underway:	7
assessment of speech	7
assessment of swallowing	7
surface electromyography (emg) study	7
pharmacologic treatment of dystonia	7
anticholinergic agents and benzodiazepines	7
the benzodiazepine associated with the best response is clonazepam	7
zolpidem	7
risperidone seems less effective than haloperidol in controlling dystonia	7
pharmacologic treatment of parkinsonism	7
surgical treatment of dystonia and parkinsonism	7
recording eye movements to evaluate the nystagmus waveform:	7
amplitude, frequency, and conjugacy	7
foveation dynamics	7
null point width determination	7
optical devices	7
pharmacologic	7
a complete blood count with differential	7
baseline chest and sinus x-rays	7
bacterial infections	7
both routes provide good therapeutic concentrations of serum igg	7
a variety of brands of gammaglobulin are available	7
such reactions may disappear over time	7
at least once a year:	7
chest x-rays or cts and sinus films	7
total parenteral nutrition may be required	7
institute appropriate antimicrobial therapy for infections	7
treat lymphomas and gi cancer	7
the following methods are used to prevent infection:	7
intravenous immune globulin (ivig)	7
monitor and treat pulmonary complications:	7
bronchoscopic evaluations as indicated	7
perform annual endoscopic evaluation	7
at routine visits, monitor for the following:	7
chronic neutropenia	7
chronic diarrhea and resulting malnutrition	7
if present, screen for ova and parasites	7
autoimmune disorders with history, physical examination, and cbc	7
review of medical history for developmental progress and seizures	7
assessment of growth in infants and children	7
assessment of cognitive and adaptive functions by neuropsychological testing	7
auscultation of the heart for evidence of structural defect	7
examination of the genitalia for cryptorchidism and other anomalies	7
the following treatments are recommended:	7
early intervention programs and special education for developmental delays	7
(syndrome-specific growth charts are not available	7
developmental progress should be monitored throughout infancy and childhood	7
use the schirmer test to detect dry eyes	7
deep tendon reflex testing	7
auditory	7
premalignant lesions (e	7
this involves electrodesiccation/curettage or surgical excision	7
calcification of ligaments and tendons	7
however, no controlled studies have been reported	7
author, personal communication]	7
periodic audiograms	7
artificial sources of uv	7
certain light sources (e	7
cigarette smoke	7
regular monitoring with pregnancy tests is indicated	7
psychiatric evaluation if psychiatric illness is suspected	7
spine x-ray and orthopedic evaluation if kyphoscoliosis is present	7
nutritional evaluation and counseling if obesity is present	7
recurrent bacterial infections are treated with standard antibiotics	7
standard management is recommended for the following:	7
behavioral and psychiatric problems	7
kyphoscoliosis	7
eye problems	7
the following routine monitoring is recommended:	7
assessment of developmental progress and cognitive abilities	7
screening for behavioral and psychiatric problems	7
dexascan to evaluate for osteopenia	7
testosterone-replacement therapy	7
regression of gynecomastia may occur with testosterone replacement therapy	7
monitoring during testosterone replacement therapy should include the following:	7
such testing should then be performed annually	7
ongoing psychosocial support	7
consultation with a clinical immunologist	7
consultation for hematopoietic stem cell transplantation	7
outcomes are the best with hla-matched, related donors	7
matched unrelated donor	7
umbilical cord blood donor	7
all individuals were alive at a median of 13	7
5 years of follow up	7
two individuals receiving myeloablative conditioning have developed premature ovarian failure	7
delay of immunizations until immune reconstitution	7
complete blood counts	7
liver and renal function	7
immune status	7
donor and recipient chimerism	7
individuals with zap70-related cid should avoid the following:	7
non-irradiated blood products	7
live virus vaccinations	7
contaminated water sources	7
exposure to fungus-enriched environments (e	7
nonviral transfer methods (e	7
